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STELLINGEN 
1. Consumptie van vette vis heeft een gunstig effect op het risico voor coronaire 
hartziekten. 
2. De betere samenstelling van voedingsvetten door de verlaging van het 
transvetzuurgehalte heeft de gemiddelde kans op de ontwikkeling van 
coronaire hartziekten in Nederland sinds 1990 verminderd. 
3. Zutphenaren zijn geen vetkleppen. 
Reactle op Het Parool, 15 maart 2001 
4. Voor het verkrijgen van een evenwichtig beeld over de relatie tussen 
voedingsstoffen en het risico op coronaire hartziekten moeten editors en 
onderzoekers gestimuleerd worden ook negatieve resultaten te publiceren. 
5. Openbaarheid van wetenschappelijke bevindingen stimuleert de productie van 
voedingsmiddelen met een gezondheidsclaim. 
6. De kwaliteit van de wetenschapsjournalistiek kan verbeterd worden als 
journalisten zich niet alleen zouden richten op internationale tijdschriften met 
een hoge impact factor. 
7. Bij het beoordelen van de gezondheidseffecten van nieuwe genetisch 
gemodificeerde voedingsmiddelen is meer sprake van angst dan van risico. 
8. Voor een duikende voedingsonderzoeker heeft de uitspraak 'zo gezond als een 
vis' meerdere betekenissen. 
Stellingen behorende bij het proefschrift 'Prospective studies on diet and coronary 
heart disease. The role of fatty acids, B-vitamins and arginine'. 
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ABSTRACT 
In this thesis, the results of prospective studies on fatty acids, B-vitamins and arginine 
and the occurrence of coronary heart disease have been described. The results presented 
are mainly based on the Zutphen Elderly Study. In this study of 939 men aged 64-84 
years, detailed information was available on dietary intake, biological risk factors, 
incidence of major chronic diseases, vital status and causes of death between 1985 and 
1995. In addition, data of 5 cohorts from Finland, Italy and the Netherlands, and of all 
16 cohorts of the Seven Countries Study were used to investigate specific hypotheses on 
diet-heart relations in an international setting. 
Using repeatedly collected data of serum cholesterol, dietary and lifestyle factors in the 
Zutphen Elderly Study, we observed that changes in intake of saturated fat, 
polyunsaturated fat, dietary cholesterol and alcohol, and changes in weight were 
significantly related to changes in total and/or HDL cholesterol concentrations. The 
strengths of the observed associations are comparable to those obtained in experimental 
studies performed in younger populations. This indicates that public health strategies on 
dietary interventions and weight reduction in order to improve cholesterol concentrations 
are relevant also at old age. 
The average trans fatty acid intake decreased 2.4% of energy in the Zutphen Elderly 
Study between 1985 and 1995, mainly due to industrial lowering of the trans fatty acid 
content in edible fats. Such a decrease in trans fatty acids intake is compatible with a 
23% reduction in risk of coronary heart disease. Changes in food composition with 
respect to the trans fatty acid content are therefore important from a public health 
perspective. 
Using the Finnish, Italian and Dutch data of the Seven Countries study, fatty fish 
consumption was estimated to reduce the relative risk of coronary heart disease 
mortality with 34%. For total or lean fish consumption no effect was observed. People at 
risk for coronary heart disease are therefore advised to eat fish, preferably fatty fish at 
least once a week, to reduce their risk for coronary heart disease. 
We did not find evidence for a protective effect of intake of a-linolenic acid on coronary 
heart disease incidence in the Zutphen Elderly Study. However, the strong association 
between the intake of a-linolenic acid and trans fatty acids complicated studying this 
relationship. Of the B-vitamins, only the intake of folate and vitamin B6 were 
independently inversely associated with homocysteine in the Zutphen Elderly Study. In 
this cohort, intake of different B-vitamins did not protect against coronary heart disease, 
although there is a suggestion for a protective effect of vitamin B2. Arginine intake was 
not associated with the risk of coronary heart disease mortality, neither in the Seven 
Countries Study, nor in the Zutphen Elderly Study. Results of prospective and 
intervention studies are needed before definite statements can be made about the 
potential protective effect on coronary heart disease of B-vitamins, arginine and a-
linolenic acid. 
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cholesterol.6,7 Only a small (non-significant) inverse relation between cis 
monounsaturated fatty acids and serum cholesterol was observed. Recent 
controlled dietary intervention studies investigated the effect of different fatty 
acids and dietary cholesterol on LDL and HDL cholesterol.8"10 These studies show 
that LDL cholesterol is increased by a high intake of saturated fatty acids and 
dietary cholesterol and is decreased by a high intake of cis polyunsaturated fatty 
acids. High intake of saturated fatty acids, mono- and polyunsaturated fatty 
acids and dietary cholesterol increase HDL cholesterol. This effect diminishes 
with increasing unsaturation of the fatty acids and is smallest for dietary 
cholesterol. 
In conclusion, strong indirect evidence is available that confirms the hypothesis 
relating dietary saturated, mono- and polyunsaturated fatty acids to coronary 
heart disease. However, in primary and secondary prevention trials, only modest 
reductions in coronary heart disease events were shown by dietary fat 
modification (mainly on the replacement of saturated fatty acids, often 
associated with changes in polyunsaturated fatty acids and/or dietary 
cholesterol).11 Several inadequacies of these trials have been discussed, 
including limitations in study design (e.g. sample size and follow-up period) or 
the inclusion criteria (e.g. subject's susceptibility based on baseline diet and 13 
absolute risk).12,13 The results of secondary prevention trials generally suggest 
that an overall reduction in fat is less effective compared to replacement of 
saturated to unsaturated fatty acids.14 The extent to which coronary heart 
disease risk can be reduced by dietary fat modification is generally small and 
depends on the type of modification (including the intensity of the dietary 
change),15,16 and the population at risk. In addition, other dietary factors may 
also be important for the prevention of coronary heart disease.17 
Trans fa t t y acids 
Trans fatty acids are formed when oils are partly hydrogenated to produce fats 
with better texture and stability. Trans fatty acids are also naturally produced in 
the rumen of cattle. In the eighties, levels of trans fatty acids in commonly used 
sources with hydrogenated fat such as hard margarines amounted to 50% in the 
Netherlands.18 Up to that point, there had generally been little concern about the 
large quantities of commercially produced trans fatty acids.19 At that time, 
dietary experiments on the effect of trans fatty acids on serum cholesterol were 
difficult to interpret because changes in trans fatty acids intake were often 
associated with changes in intake of saturated or cis unsaturated fatty acids.20 
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Specific experiments on trans fatty acids examined only their effect on total 
cholesterol concentrations and showed inconsistent results.21,22 
Interest in trans fatty acids was renewed in the early nineties, when several 
controlled dietary intervention studies showed that a high intake of trans fatty 
acids not only increased total and LDL cholesterol, but also decreased HDL 
cholesterol concentrations.20 Consequently, the food industry in the Netherlands 
decided to reduce the trans fatty acids content in margarines and spreads to less 
then 5% in 1995.23 This resulted in a decline in trans fatty acid intake in several 
European countries including the Netherlands.24 Information on the size of this 
decline in intake of trans fatty acids and, consequently, its effect on the 
prevention of coronary heart disease is lacking. 
OTHER DIETARY EFFECTS ON CORONARY HEART DISEASE 
Besides the effect of diet on serum cholesterol and lipoprotein fractions, dietary 
factors may also affect the risk of coronary heart disease by other mechanisms. 
During the 1980s, new trials were initiated based on the idea that dietary habits 
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 could be protective in relation to coronary heart disease. In the DART trial, the 
hypothesis was tested whether fatty fish consumption protects against coronary 
heart disease.25 In two other secondary prevention trials, the IEIS and Lyon diet 
heart trial, comprehensive dietary changes with regard to the Indian diet26 and a 
Mediterranean-type of diet27 were studied. In these two trials, the experimental 
group consumed a diet low in intake of total fat and saturated fatty acids and 
high in intake of n-3 fatty acids (from marine and/or plant origin), fruits, 
vegetables, legumes and cereals compared to the control group. With regard to 
the clinical result, these dietary trials were remarkably successful in reducing the 
risk of coronary heart disease and all-cause mortality. These trials suggest that a 
wider range of dietary factors than fatty acids, acting by different mechanisms, 
play a role in the development of coronary heart disease. 
Based on the available evidence, at least three groups of dietary factors may be 
associated with the risk of coronary heart disease: n-3 fatty acids, B-vitamins 
and arginine. Main sources of n-3 fatty acids are (fatty) fish, major sources of B-
vitamins are vegetables, meat, milk and potatoes, and sources of arginine are 
meat, milk and cereals. 
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N-3 fa t t y acids 
Low rates of coronary heart disease in Greenland, together with a high 
consumption of fish, have led to the speculation that seafood consumption 
prevents coronary heart disease.28 Further epidemiological studies on the 
association between fish consumption and coronary heart disease, however, 
showed inconsistent results.29 Some inconsistencies in the relation between fish 
consumption and coronary heart disease across populations may be explained by 
difference in the intake of n-3 fatty acids from fish. N-3 fatty acids 
eicosapentaenoic (C20:5 n-3) and docosahexaenoic (C22:6 n-3) acid are 
probably the protective components of fish, and their concentration depends on 
the type of fish. High-dose marine n-3 fatty acids have been shown to affect 
beneficially human lipid profiles30 and blood pressure.31 N-3 fatty acids from fish 
have antithrombotic effects in vitro, due to the reduced production of 
thromboxane A2 by arachidonic acid, since eicosapentanoic acid competes with 
archidonic acid for its enzymes32 (figure 1). Furthermore, in animal models, n-3 
fatty acids prevent insulin resistance33 and the development of ventricular 
fibrillation.34 However, human experiments on the effect of a limited intake of n-
3 fatty acids obtained from a habitual diet with regular fish consumption were 
limited and inconsistent. Some prospective studies on the association of both fish j 5 
consumption and marine n-3 fatty acids with coronary heart disease mortality ™"— 
observed a stronger beneficial effect of fish consumption than of the intake of n-
3 fatty acids.35,36 Therefore, evidence on the protective effect of fish (including 
the responsible protective components) is inconclusive. 
Besides n-3 fatty acids derived from fish, another n-3 fatty acid is present in the 
green tissue of plants: oc-linolenic acid (C18:3 n-3). oc-Linolenic acid is the basic 
n-3 fatty acid and can be elongated and desaturated into eicosapentaenoic acid 
in animals and humans37 (figure 1). Eicosapentaenoic and docosahexaenoic acid 
are found in fish, due to the conversion of oc-linolenic acid from phytoplankton.38 
Although the capacity of humans to elongate and desaturate a-linolenic acid is 
small, a-linolenic acid intake was associated with substantial changes in platelet 
behavior.39 a-Linolenic acid itself, or its conversion into eicosapentaenoic acid, 
may play a role in the protection against coronary heart disease. However, until 
now, evidence on the relation between a-linolenic acid intake and coronary heart 
disease is limited. 
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Figure 1: Metabolism of, and prostanoids formed from, n-6 en n-3 
unsaturated fatty acids.17 
16 B-vi tamins 
Homocysteine is a sulfur-containing amino acid that may be involved in the 
development of atherosclerosis. Many case-control and cohort studies showed 
that elevated blood concentrations of homocysteine are associated with 
increased risk for cardiovascular diseases.40,41 Several mechanisms have been 
suggested to underlie this association, including platelet aggregation, increased 
blood coagulation or reduced thrombolysis and endothelial dysfunction and 
injury.42 However, there is some doubt about the causal association between 
homocysteine and vascular diseases, since homocysteine concentrations are 
related with several other cardiovascular risk factors and with an early decline in 
renal function, which is common in atherosclerosis.43 
Homocysteine is formed at demethylation of the dietary essential amino acid 
methionine. Four B-vitamins serve as either coenzyme or substrate for one of 
the homocysteine metabolic pathways; folate, vitamins B2, B6 and B12.44 Folate 
(as a substrate in the form of 5-methyl-tetrahydrofolate) and vitamin B12 (as a 
coenzyme) are involved in the remethylation reaction converting homocysteine 
to methionine. Vitamin B2 is the coenzyme of methylenetetrahydrofolate 
reductase, which catalyzes the conversion of tetrahydrofolate to 5-methyl-
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tetrahydrofolate. Vitamin B6 is a coenzyme for two enzymes involved in the 
transsulphuration of homocysteine to cysteine. 
Until now, most studies on the association between B-vitamins and coronary 
heart disease were case-control studies. The majority studied circulating levels 
of B-vitamins, instead of dietary intake of the vitamins. The results of these 
studies have been inconsistent.41 However, underlying diseases or short-term 
variations in nutrient intake may have influenced plasma vitamin levels and, 
consequently, the association with coronary heart disease risk. Prospective 
studies relating B-vitamin intake to coronary heart disease risk may provide 
more insight in the causality of the relation between B-vitamin intake, 
homocysteine and coronary heart disease. 
Arg in ine 
Another potential protective dietary factor in the relation with coronary heart 
disease is arginine. Arginine is a semi-essential amino acid, and is the precursor 
of nitric oxide. Nitric oxide is an important mediator of vasodilatation. It is 
synthesized by vascular endothelium to regulate the vascular tone in normal 
conditions and alterations of such control in disease status. Apart from 17 
vasodilatation, nitric oxide has also anti-clotting and anti-adhesive properties " 
that may inhibit atherosclerosis.45 Impaired availability of nitric oxide has been 
identified in patients with risk factors for coronary heart disease such as 
hypercholesterolemia, atherosclerosis and hypertension. From experimental 
studies, the hypothesis is derived that arginine intake could restore the impaired 
endothelial function and increased platelet activation in these patients. However, 
contradictory results were shown in dietary experiments, dependent on the risk 
profile of the experimental group, dose and duration of arginine therapy.46 The 
association between dietary arginine and the risk of coronary heart disease in 
human populations has not been investigated yet. 
RATIONALE OF T H I S THESIS 
The multiple aspects of diet to affect the risk of coronary heart disease outlined 
above creates challenges for conducting studies to investigate these 
relationships. Until now most research has been done in dietary intervention 
studies, investigating the relation between (a high dose of) nutrients and risk 
factors for coronary heart disease. It is essential to interpret the results of 
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promising dietary factors in the light of coronary heart disease incidence using 
prospective population-based studies. Such information will give insight in the 
impact of nutrient intake at a practical dose, the interrelationships between 
nutrients and, if consistent with other evidence, can be directly related to public 
health relevance. The studies described in this thesis focus on three different 
(classes of) nutrients: fatty acids, B-vitamins and arginine. These nutrients have 
great potential, however, the evidence from prospective studies on the relation 
between these dietary constituents and coronary heart disease is limited and/or 
inconclusive. 
STUDY POPULATIONS 
In this thesis, data are used of cohorts from the Seven Countries Study.47 In 
1960, Zutphen, a small industrial town located in the eastern part of the 
Netherlands, was selected for the Dutch contribution to the Seven Countries 
Study. Another 15 cohorts of men aged 40-59 years from United States, Japan, 
Greece, former Yugoslavia, Finland and Italy were also enrolled and examined. 
Although in most cohorts dietary data were collected at baseline in small random 
samples only, in Zutphen individual dietary information has been collected in 
1960, 1965 and 1970, and in the two cohorts from Finland in 1969 and in two 
cohorts from Italy, in 1965 and 1970. In 1985, the Zutphen cohort was renamed 
the Zutphen Elderly Study, and the surviving sample was extended with a 
random sample of other men from the town of Zutphen in the same age 
category. Hypotheses in this thesis are investigated using data of the Zutphen 
Elderly Study, and when data are available, using the cohorts of Finland, Italy 
and the Netherlands and intercohort comparisons of the Seven Countries Study. 
O U T L I N E OF T H I S THESIS 
In this thesis, prospective studies on the relations between different dietary 
constituents and the occurrence of coronary heart disease are addressed. Four 
studies describe the relation between dietary fatty acids and serum cholesterol 
concentrations and/or the risk of coronary heart disease. In CHAPTER 2, we 
report on the association between changes in lifestyle and dietary factors, such 
as different fatty acids on changes in serum total and HDL cholesterol in an 
elderly population. Concerning the recent changes in trans fatty acid content of 
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hydrogenated fats, we estimate the decline in trans fatty acid intake between 
1985 and 1995 in a Dutch population of elderly men in CHAPTER 3. 
Furthermore, in this chapter, we relate trans fatty acid intake to the 10-year risk 
of coronary heart disease. 
To get more insight in the beneficial effect of n-3 fatty acids, we conducted two 
studies. In CHAPTER 4, we report on the association between lean and fatty fish 
consumption, which are different in n-3 fatty acid content, and coronary heart 
disease risk in middle-aged men from Finland, Italy and the Netherlands. In 
CHAPTER 5 the association between oc-linolenic acid intake and the risk of 
coronary heart disease in elderly men is described. 
Furthermore, three studies deal with (determinants of) amino acids as potential 
protective nutrients in relation to the risk of coronary heart disease. In 
CHAPTER 6, the association between B-vitamin intake and the risk of coronary 
heart disease is examined as well as the extent to which the associations are 
explained by serum homocysteine concentrations. Chapter 7 and chapter 8 deal 
with the association between arginine and coronary heart disease risk. In 
CHAPTER 7, prospective data from the 16 population cohorts of the Seven 
Countries Study are used to estimate the association between arginine intake 
and 25-year coronary heart disease mortality in middle-aged men at cohort 
level. In CHAPTER 8, detailed dietary data of the Zutphen Elderly Study are 
used to estimate the association between arginine and 10-year coronary heart 
disease risk at individual level. 
Finally, the main results, methodological considerations, public health 
implications and recommendations for future research are discussed in 
CHAPTER 9. 
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anges in met 
and body weight predict 
changes in total and HDL 
concentrations: 
A longitudinal study of 
elderly men 
Improvement in lifestyle and dietary habits favorably modifies total and high densi 
lipoprotein (HDL) cholesterol concentrations, but little is known about the cholester 
lowering effect of these determinants in old age. We investigated the cholester 
modifying effect of lifestyle and diet in a longitudinal cohort study of elderly men. Tl 
study population consisted of 234 men born between 1900 and 1920 and participating 
each dietary and clinical examination of the Zutphen Elderly Study at baseline (1985 
and after 5 and 10 years of follow-up. Changes in total and HDL cholester 
concentrations, body weight, smoking, physical activity, and dietary variables as alcoh 
use, saturated and trans unsaturated fat, cholesterol and fiber were calculated over 
five year periods. Repeated measurements were performed using a mixed longitudir 
model. After adjustment for age, carbohydrate intake and the other parameters, 1% 
energy increase in polyunsaturated fat intake was associated with 0.03 mmol/L reductii 
in total cholesterol concentrations. Weight loss was associated with decreased tot 
cholesterol concentrations, although non-significantly in men without chronic disease 
One extra glass of alcohol or 5 kg weight loss were both associated with 0.04 mmol 
increased HDL cholesterol concentrations. Increased intake of saturated fat and dieta 
cholesterol were significantly related to increased HDL cholesterol concentrations. Tl 
size of the observed associations is comparable to those from experimental studi 
performed in younger populations. This study showed that, even in old age, it remai 
important to change weight and diet to improve the lipid profile. 
INTRODUCTION 
Despite a fall in serum cholesterol concentrations at older age,1"6 prospecti\ 
studies indicate that high total cholesterol concentrations still convey i 
increased risk for future coronary heart disease events in elderly persons.7"10 Tr 
association between high density lipoprotein (HDL) cholesterol concentratioi 
and coronary heart disease among older persons is less clear.8"10 Meta-analys 
of trials showed that cholesterol lowering medication remains effective in o 
age.11 Improvement in lifestyle or dietary habits in the elderly population cou 
also favorably modify the total and HDL cholesterol concentrations, and cou 
therefore be important in the prevention of coronary heart disease. Boc 
weight,12 smoking,13 physical activity,14 alcohol use15 and dietary factors i 
saturated16"18 and trans fatty acids,19 dietary cholesterol16"18 and fiber20 are ; 
known to influence the cholesterol concentrations in adults. However, there 
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not much experimental evidence on the cholesterol lowering effect of lifestyle 
and diet in elderly populations. 
Besides trials, longitudinal data can be used to determine whether lifestyle and 
dietary factors could modify cholesterol concentrations in old age. Furthermore, 
a longitudinal population-based study provides information about the 
effectiveness of each of these factors in changing cholesterol concentrations in 
daily practice. All previous longitudinal studies showed that weight change was a 
predictor of the change in total and HDL cholesterol.6,21"24 Changes in physical 
activity and smoking habits were less consistently associated with changes in 
cholesterol.6#22,24 Of these longitudinal studies, only one was performed among 
elderly people,6 and others were performed in younger age-groups.21"24 In 
addition, one longitudinal study dealt with diet and total cholesterol in a 
population of elderly men and women, however, only the unadjusted correlation 
coefficients were reported.4 
The Zutphen Elderly Study contains longitudinally repeated measurements of 
total and HDL cholesterol as well as of lifestyle and dietary factors over a 10 year 
period. Therefore, we were able to investigate the impact of naturally occurring 
changes in body weight, smoking, physical activity, and changes in intake of 25 
dietary factors such as alcohol, fatty acids, cholesterol and fiber on the change in — 
total and HDL cholesterol concentrations in elderly men. 
SUBJECTS AND METHODS 
Study population 
The Zutphen Elderly Study is a longitudinal investigation of chronic disease risk 
factors in elderly male inhabitants of Zutphen, a town in the eastern part of the 
Netherlands. It represents a continuation of the Zutphen Study, the Dutch 
contribution to the Seven Countries Study.23 In 1985, 367 of the 555 participants 
of the original cohort still alive, were re-examined. In addition, a random sample 
of 711 other men from the town of Zutphen in the same age group were asked 
to participate. This resulted in a total population of 939 men (response rate 
74%) born between 1900 and 1919, which formed the cohort of the Zutphen 
Elderly Study. Dietary and clinical examination including cholesterol 
determinations took place in 1985, 1990 and 1995. Complete data on 
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cholesterol, lifestyle and diet were available for 806 men in 1985, 491 men in 
1990 and 259 men in 1995. 
LJirlTirl t^HBllftOFi 1*11*1 
All relevant data were collected according to a standardized protocol in the 
period between March and June of each examination year. Clinical examinations 
were conducted by trained medical staff at a local survey site in 1985 and 1990 
and by paramedical staff at home in 1995. 
Non-fasting venous blood samples were used for cholesterol determinations 
which were conducted in the same standardized lipid laboratory (Department of 
Human Nutrition and Epidemiology, Wageningen University, the Netherlands), 
according to WHO criteria. Cholesterol was determined enzymatically with the 
CHOD-PAP mono-testkit from Boehringer Mannheim.26 HDL cholesterol was 
isolated after precipitation of apo-lipoprotein B containing particles by dextran 
sulphate-Mg2+.27 In all three examination rounds the combined within and 
between variation coefficients for total and HDL cholesterol were below 3%. 
Mean bias with regard to target values of serum pools provided by the Centers 
26 for Disease Control (Atlanta, USA) was +0.2% in 1985, +0.9% in 1990 and -
1.1% in 1995 for total cholesterol. For HDL cholesterol the mean bias from the 
control sera was -0.3% in 1985, +4.2% in 1990, and -0.7 in 1995. 
Information about the habitual food consumption was collected using the cross-
check dietary history method, adapted to the Dutch situation.28 Each participant, 
and if possible also his wife, was interviewed about his average food 
consumption pattern in the month before the interview. A checklist of foods and 
quantities of food bought per week were used to calculate and to verify the 
participant's food consumption pattern. A national database of food composition 
tables containing information about energy and nutrients including alcohol was 
specially composed for the analysis of dietary trends.29 For the present analyses, 
the edition of 1986-1987, 1989-1990 and 1996 of this database was used. In 
addition, time-specific tables were compiled with total trans fatty acid contents of 
consumed foods around 1980, around 1990 and in 1995.30 
Body weight was measured without shoes and in underwear in 1985 and 1990, 
and in daily clothing in 1995. In the calculations for 1995, 1.5 kilograms were 
subtracted from recorded weight to correct for the additional clothes. 
Information on cigarette smoking was obtained by a standardized questionnaire 
and categorized into 'no smoking' and 'current smoking'. Minutes of physical 
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activity (mainly walking, cycling, hobbies, sports, gardening and work) per week 
were calculated using a self-administered questionnaire originally designed for 
retired men.31 Information on cholesterol lowering medication use was obtained 
through a standardized questionnaire in 1985 and 1990. Cholesterol lowering 
diet was used as proxy for cholesterol lowering medication use in 1995. 
Information on the presence or history of cardiovascular diseases was obtained 
using the Dutch translation of the Rose questionnaire.32 Diabetes mellitus or any 
form of cancer was reported using a standardized questionnaire. Diagnosis of 
each disease was verified with hospital discharge data and with written 
information from the subject's general practitioner. 
Stat is t ical methods 
Statistical analyses were carried out using SAS (version 6.12) statistical analysis 
computer package. Changes in cholesterol concentrations, body weight and 
dietary variables from 1985 to 1990 and from 1990 to 1995 were calculated as 
the 1990 value minus the 1985 value and the 1995 value minus the 1990 value. 
Changes in cigarette smoking were classified as quit smoking, start smoking or 
no change in smoking behavior. 27 
Repeated measurements were performed using a mixed longitudinal model with 
a compound symmetry covariance structure by means of the SAS Proc Mixed 
Procedure.33 The dependent variables were 5 years changes in total and HDL 
cholesterol. The independent variables were quitting smoking, and 5 years 
change in body weight, physical activity, intake of fiber, dietary cholesterol, 
intake of energy percentages of saturated fat, monounsaturated fat, 
polyunsaturated fat and trans fatty acids, and for HDL cholesterol also 5 years 
change in alcohol consumption. Analyses were performed with or without 
adjustment for the other determinants. Age at examination year and intake of 
carbohydrates were additionally included as confounders. Start smoking was not 
included as a determinant into the models, due to the small numbers of starters 
(3.4%) during 10 years of follow up. Because change in energy intake was not 
associated with change in cholesterol concentrations, and additional adjustment 
for change in energy intake did not alter the results, the results shown were not 
adjusted for change in energy intake. Additional analyses were performed taking 
into account the mean bias from the control sera of the total cholesterol and the 
HDL cholesterol concentrations. Analyses were performed on men who 
participated in each examination in order to account for selective dropout. A total 
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of 239 men participated in each of the three examinations; 5 men were omitted 
from the present analyses because of cholesterol lowering medication in 1985 
and 1990 (n=4) , or 1995 ( n = l ) . An additional analysis was performed for men 
with at least 2 out of 3 examinations (1985 and 1990 or 1995) (n=494). 
Furthermore, analyses were performed for men participating in all 3 
examinations but without a history of cardiovascular diseases, cancer or diabetes 
(n=133). 
RESULTS 
At baseline, over 95% of the Zutphen Elderly population lived independently. 
Mean age of the men was 69.4 years (SD=4.3 years) (table 1). Twelve percent 
of the men had a history of cardiovascular diseases at baseline, which consisted 
mainly of coronary heart disease. Mean body weight of the participants was 78 
kg (SD=11 kg) and a quarter of the men were cigarette smokers. The study 
population spent on average 99 minutes/day on physical activity. 
28 Table 1. Characteristics (mean ± standard deviation) of participants in the 
Zutphen Elderly Study 1985-1995 (n=234). 
1985 1990 1995 
Total cholesterol (mmol/L) 6.08 ±1.03 6.04 ±1.02 5.51 ±1.04 
Adjusted for bias from control sera 6.07±1.03 5.98 ±1.01 5.45 ±1.03 
HDL cholesterol (mmol/L) 1.13 ±0.26 1.15 ±0.28 1.17 ±0.32 
Adjusted for bias from control sera 1.13 ±0.26 1.10 ±0.27 1.18 ±0.32 
Age (years) 
Body weight (kg) 
Physical activity (min/week) 
Cigarette smoking (%) 
History of cardiovascular diseases (%) 12.0 
History of diabetes mellitus (%) 
History of cancer (%) 
69.5 ±4.3 
77.9 ±10.4 
692 ±510 
25.6 
4.3 
2.6 
74.5 ±4.3 
77.3 ±10.5 
618 ±510 
21.4 
19.7 
10.3 
9.4 
79.5 ±4.3 
74.4 ±11.2 
411 ±423 
17.5 
28.2 
11.5 
12.8 
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During 10 years of follow-up, the mean level of total cholesterol decreased from 
6.08 mmol/L to 5.51 mmol/L (table 1). The change in total cholesterol was most 
pronounced between 1990 and 1995. The mean level of HDL cholesterol 
increased from 1.13 mmol/L to 1.18 mmol/L. Mean body weight, physical activity 
and alcohol consumption decreased during follow-up. 
The baseline diet was high in saturated fat (about 17% of total energy intake), in 
trans fat (about 4% of total energy intake) and in fiber (about 26 g/d) (table 2). 
Mean energy intake decreased during the first 5 year of follow up, and slightly 
increased during the second 5 year of follow up. Independent of energy intake, 
mean daily intake of saturated fat, monounsaturated fat, trans fatty acids, 
dietary cholesterol and fiber decreased during follow-up, whereas the mean daily 
intake of polyunsaturated fat increased (table 2). 
Table 2. Daily nutrient intake (mean ± standard deviation) of participants 
in the Zutphen Elderly Study 1985-1995 (n=234). 
1985 1990 1995 
Energy (MJ) 9.3 ±1.9 8.5 ±1.8 8.6 ±1.8 
Alcohol (g) 14.4 ±17.8 11.3 ±14.3 10.6 ±13.8 
Carbohydrates (% of energy) 41.3 ±7.1 43.8 ±7.0 43.1 ±6.8 
Saturated fat (% of energy) 17.7 ±3.4 15.9 ±3.4 16.7 ±3.5 
Monounsaturated fat (% of energy) 14.9 ±3.0 14.5 ±2.5 13.7 ±2.5 
Polyunsaturated fat (% of energy) 7.0 ±2.8 7.3 ±3.3 7.1 ±3.1 
Trans fatty acids (% of energy) 3.9 ±2.0 2.8 ±1.3 1.9 ±0.6 
Dietary cholesterol (mg/MJ) 29.4 ±8.2 27.2 ±7.3 27.7 ±8.3 
Dietary fiber (g) 25.9 ±6.8 24.2 ±6.7 23.3 ±6.2 
Table 3 shows the unadjusted and adjusted associations of changes in body 
weight, smoking, physical activity and dietary factors with change in total 
cholesterol using a repeated measurement model. Unadjusted analyses showed 
that increase in intake of saturated fat, dietary cholesterol and decrease in 
polyunsaturated fat intake were significantly associated with increased serum 
total cholesterol concentrations. After adjustment of age, carbohydrate intake 
and the other parameters, weight change and change in intake of 
polyunsaturated fat were significantly associated with the change in total 
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cholesterol (table 3). The comparable unadjusted and adjusted B-coefficients 
(p=0.10) for trans fatty acids suggests that trans fatty acid intake might also 
modify total cholesterol concentrations. 
Table 3. Regression coefficients relating five year changes in serum total cholesterol 
(mmol/L) to 5-years changes in body weight, smoking and dietary variables in a 
repeated measurement model: the Zutphen Elderly Study. 
Unadjusted Adjusted* 
SE SE 
Body weight (kg) 0.014 0.008 
Physical activity (min/week) -0.00004 0.00006 
Quitting cigarette smoking (yes/no) 0.040 0.132 
Daily intake of 
Saturated fat (% of energy) 0.021 0.010 
Monounsaturated fat (% of energy) 0.000005 0.012 
Polyunsaturated fat (% of energy) -0.031 0.011 
Trans fatty acids (% of energy) 0.031 0.019 
Dietary cholesterol (mg/MJ) 0.012 0.004 
Dietary fiber (g) -0.007 0.006 
0.07 0.015 0.008 0.05 
0.49 -0.00007 0.00006 0.28 
0.77 -0.005 0.129 0.97 
0.04 0.012 0.014 0.39 
0.80 -0.026 0.017 0.13 
0.005 -0.032 0.013 0.02 
0.12 0.035 0.022 0.10 
0.006 0.007 0.005 0.14 
0.20 -0.005 0.006 0.36 
p=regression coefficient, SE= standard error, p=p-value 
* all parameters plus age at examination and carbohydrate intake (% of energy) were included 
in the model. 
The repeated measurement analyses of determinants of change in HDL 
cholesterol concentrations showed that a decrease in weight and increase in 
alcohol consumption were significantly associated with increase in HDL 
cholesterol in the unadjusted and adjusted analyses (table 4). Increased alcohol 
consumption with one glass per day or weight loss of 5 kg were both associated 
with 0.04 mmol/L increased concentrations of HDL cholesterol. Increased intake 
of saturated fat and dietary cholesterol were also significantly associated with 
increased HDL cholesterol. The changes in other parameters did not have an 
impact on the changes in concentrations of HDL cholesterol. After additional 
adjustment of total and HDL cholesterol concentrations for the bias from the 
control sera, comparable associations were found (data not shown). Similar 
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associations were also observed in the total population of men who participated 
in at least two examinations (n=494) (data not shown). 
Among the participants who participated in all three examinations, 43% of the 
men had a history of diagnosed cardiovascular diseases, cancer or diabetes after 
10 year of follow-up. Adjusting for these common chronic diseases and serum 
albumin levels in the analyses did not alter the results (data not shown). 
However, subgroup analyses in men free of any common chronic disease in 1995 
(n=133) showed no association between changes in body weight and total 
cholesterol changes (adjusted analyses: 13=0.0004; p=0.97 compared to 
13=0.03; p=0.01 for the 101 men with chronic diseases). 
Table 4. Regression coefficients relating five year changes in serum HDL cholesterol 
(mmol/L) to 5-years changes in body weight, smoking, physical activity and dietary 
variables in a repeated measurement model: the Zutphen Elderly Study. 
Unadjusted Adjusted* 
SE p B SE 
Body weight (kg) -0.007 0.002 0.001-0.008 0.002 0.001 
Physical activity (min/week) 0.00002 0.00002 0.31 0.000007 0.000020.63 
Quitting cigarette smoking (yes/no) 0.013 
Daily intake of 
Alcohol (g) 0.003 
Saturated fat (% of energy) 0.005 
Monounsaturated fat (% of energy) 0.002 
Polyunsaturated fat (% of energy) -0.002 
Trans fatty acids (% of energy) -0.008 
Dietary cholesterol (mg/MJ) 0.002 
Dietary fiber (g) -0.002 
0.034 
0.001 
0.003 
0.003 
0.003 
0.005 
0.001 
0.001 
0.70 
0.001 
0.05 
0.50 
0.45 
0.88 
0.08 
0.14 
0.022 
0.004 
0.008 
0.006 
0.005 
-0.005 
0.003 
-0.002 
0.033 
0.001 
0.004 
0.005 
0.004 
0.005 
0.001 
0.001 
0.50 
0.001 
0.04 
0.24 
0.19 
0.40 
0.05 
0.26 
p=regression coefficient, SE= standard error, p=p-value 
*all parameters plus age at examination and carbohydrate intake (% of energy) were included 
in the model. 
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DISCUSSION 
The results from our longitudinal analyses showed that changes in body weight 
and changes in intake of polyunsaturated fat were significantly related to 
changes in total cholesterol, and that changes in body weight, alcohol use, intake 
of saturated fat and dietary cholesterol attribute to the changes in HDL 
cholesterol concentrations at old age. 
Change in body weight was a consistent predictor of total and HDL cholesterol in 
other longitudinal studies among the elderly6,34 or middle-aged populations.21"24 
Consistent with the results of another elderly population,6 the associations did 
not change after adjustment for the presence of common chronic diseases. In 
the present study, however, subgroup analyses on the men free of common 
chronic diseases suggest that the observed association between change in 
weight and changes in total cholesterol depends on disease status. Consistent 
with other longitudinal studies,6,22 we showed that change in weight was an 
independent predictor of change in HDL cholesterol. 
As in the present study, change in alcohol consumption was positively associated 
32 with change in HDL cholesterol among elderly men and women of the Rancho 
—— Bernardo Study.6 Moreover, in the same study, change in physical activity was 
not associated with changes in cholesterol concentrations, as in our study. This 
could be due to the inappropriate intensity of physical activity at older age.6 In 
contrast with other longitudinal studies,6,22,24 we did not observe an association 
between quitting smoking and cholesterol concentrations. Since the proportion of 
the men that quit smoking was only 11% in the present study, this might be too 
small to investigate this issue properly. 
Several longitudinal studies have studied the impact of dietary changes on total 
cholesterol. However, to our knowledge, this is the first longitudinal study to 
determine whether changes in diet predict changes in HDL cholesterol. In the 
present study, changes in intake of polyunsaturated fat was associated with 
changes in total cholesterol and changes in alcohol use, intake of saturated fat 
and dietary cholesterol were associated with changes in HDL cholesterol. In a 
population of elderly men and women, the intake of total fat and dietary 
cholesterol was significantly positively correlated with total cholesterol 
concentrations.4 In a longitudinal study among middle-aged men, dietary 
cholesterol was positively associated with total cholesterol concentrations.21 
Change in Keys score (summarizing the intake of cholesterol, saturated and 
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polyunsaturated fat) was positively associated with changes in total and LDL 
cholesterol concentrations in young and middle-aged adults.23,35 
For a correct interpretation of our results we will address some methodological 
issues. Habitual food consumption was measured in all three examinations using 
the cross-check dietary history method, which is acknowledged as a valid 
method in an epidemiological setting.28 Intake of dietary components was 
calculated taking into account changes in food composition in time. To reduce 
residual confounding we included all dietary and lifestyle factors potentially 
related to changes in serum cholesterol into one model. Furthermore, the 
contribution of morbidity to the associations between lifestyle and dietary factors 
and cholesterol concentrations was determined. We observed that the impact of 
body weight on total cholesterol was absent in men without cardiovascular 
diseases, cancer and diabetes mellitus. The interpretation of this finding was 
hampered, however, because especially among elderly people, disease status is 
determined by multiple other diseases. Therefore, further studies need to 
investigate this issue. 
Table 5 summarizes our results together with the results of meta-analyses of 
experimental studies.12,15"20 Physical activity was not included as the effect of 33 
aerobic exercise studied in controlled trials14 is not comparable with the effect of — 
an increase in overall physical activity in minutes per week as in the present 
study. For the significant associations in our observational analyses as well as for 
non-significant associations, e.g. those between trans fatty acids and total 
cholesterol and between polyunsaturated fat and HDL cholesterol, the size of the 
estimates is comparable to those from experimental studies (table 5). 
Concerning the relation of saturated fat and total cholesterol and of trans fatty 
acids and HDL cholesterol, we observed somewhat smaller estimates compared 
to the results of three meta-analyses of experimental studies. Also weaker 
associations were observed for dietary fiber, however, the experimental studies 
only included soluble fiber while in the present analyses, due to lack of 
information on these nutrients, total fiber was included. 
It is obvious that, because of methodological differences (e.g. the age of the 
study population, the follow-up time and the control for identifiable differences), 
comparison of the evidence from randomized, controlled studies and the results 
of the present observational study is difficult.36 However, the consistency in 
these results suggests that the efficacy of weight and dietary changes on lipid 
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profile under controlled conditions in generally younger populations is 
comparable to those in daily practice in an elderly population. 
Table 5. Results from meta-analyses of intervention trials on the effect of 
body weight and dietary factors on changes in total and HDL cholesterol in 
comparison with present results of the Zutphen Elderly Study (ZES). 
Changes in cholesterol (mmol/L) 
Total cholesterol HDL cholesterol 
ZES Trials Ref.no ZES Trials 
Body weight (kg) 0.02t 0.05 12 -0.008 -0.009 12 
Alcohol (g) - 0.004 0.003 15 
Saturated fat (% of energy) 0 .01* 0.04 ie 0.008 0.007 17 
0.05 17,18 0.012 i6 
0.013 is 
Monounsaturated fat (% of energy) -0.03* 0.003 ie 0.006* 0.006 is 
0.005* is 0.009 16 
3 4 Polyunsaturated fat (% of energy) -0.03 -0.02 16,17 0.005* 0.005 is 
~™~ -0.03 is 0.007 16 
Trans fatty acids (% of energy) 0.04* 0.03 19 -0.005* -0.02 19 
Dietary cholesterol (mg) 0.0008* 0.0006 17 0.0003 0.0001 is 
0.0007 is 
Dietary fiber (g) -0.005* -0.05 20 -0.002* -0.003* 20 
ZES=Zuthen Elderly Study, Ref. no= reference number 
*not-statistically significant association. 
t Change in total cholesterol per kg increase in body weight in total study population 
(n=234). Total cholesterol changed not-significantly by 0.0004 (p=0.97) per kg 
increased body weight in subgroup of men without common chronic diseases. 
Our results suggest that, even in old age, it remains important to change weight 
or dietary habits to improve the lipid profile. Increase in polyunsaturated fat 
intake was the dietary factor that was most consistently associated with 
decreased total cholesterol concentrations in our elderly men. For HDL 
cholesterol, decreased body weight and increased alcohol consumption, intake of 
saturated fat and dietary cholesterol are significantly related to increased HDL 
cholesterol concentrations. Due to the high risk of coronary heart disease with 
Serum cholesterol responses to diet and lifestyle 
age, such beneficial effects on cholesterol concentrations could have a large 
impact on public health. 
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Association between 
intake and 10-year risk of 
coronary heart disease 
in the Zutphen Elderly Study: a 
prospective population based 
study 
Claudia M Oomen, Marga C Ocke, Edith JM Feskens, Marie-Agnes J 
uan Frn-Raart FranslKnk naan Krnmhnnt lanr.f>t9nni-2!i7-7Afi-!i1 
Evidence on the relation between trans fatty acid intake and coronary heart disease i: 
limited. We investigated this relation in a Dutch population with a fairly high trans fatt 
acid intake, including trans fatty acids from partly hydrogenated fish oils. Wi 
prospectively studied 667 men of the Zutphen Elderly Study aged 64-84 years and frei 
of coronary heart disease at baseline. We used dietary surveys to establish thi 
participants' food consumption patterns. Information on risk factors and diet wa 
obtained in 1985, 1990, and 1995. After 10 years of follow-up from 1985-95, there wen 
98 cases of fatal or non-fatal coronary heart disease. Between 1985 and 1995, averagi 
trans fatty acid intake decreased from 4.3% to 1.9% of energy. After adjustment for age 
body mass index, smoking, and dietary covariates, trans fatty acid intake at baselim 
was positively associated with the 10-year risk of coronary heart disease. The relativi 
risk for a difference of 2% of energy in trans fatty acid intake at baseline was 1.28 (95°/ 
CI 1.01-1.61). This study shows that a high intake of trans fatty acids (all types o 
isomers) contributes to the risk of coronary heart disease. The substantial decrease ii 
trans fatty acid intake, mainly due to industrial lowering of trans contents in Dutch edibh 
fats, could therefore have had a large public-health impact. 
INTRODUCTION 
Concern about the adverse health effects of trans isomers of unsaturated fat t 
acids has increased since 1990 after the results of controlled dietary interventioi 
studies.1"7 Results of these studies showed a detrimental effect of trans fa t t 
acids on LDL and HDL cholesterol. Evidence that intake of trans isomers affect 
the rate of coronary heart disease is derived from population-based studies dom 
in the USA.8"11 Until now, a fairly small number of observational studies havi 
focused on the health effects of trans fatty acids in Europe, with weak o 
equivocal results.12"14 
Trans fatty acids are mainly present in solid fats produced by part hydrogenatioi 
of oils, and are naturally found in products originating from ruminant animals 
The current trans fatty acid intake contributes between 0.5% and 2 . 1 % t< 
energy intake in western Europe,15 and about 2% of total energy intake in th< 
average US diet.16 In the Netherlands, because of publicity about adverse effect 
of trans fatty acids on blood lipoproteins,17 the amount of trans fatty acids in fat 
for use in households has decreased substantially. In frequently used foods, sucl 
as hard margarines, the trans fatty acid content has declined from a maximun 
— Trans fatty acid intake and coronary heart disease 
of 50% in the 1980s to an average 1-2% nowadays.18 Consequently, the 
consumption of trans fatty acids in the Netherlands has decreased greatly. 
Most controlled trials1"4,6 and population-based studies8"12 have focused on the 
effect of isomers with 18 carbon atoms (C18:l trans isomers), since these 
isomers mainly originate from partly hydrogenated vegetable oils and ruminant 
fat. In addition, because of different proportions of C18:l trans isomers, results 
of some observational studies have made a distinction between manufactured 
and ruminant trans fatty acids, and suggested more harmful health effects of 
manufactured trans fatty acids.8'9,13 Although industry in the USA only uses 
partly hydrogenated vegetable oils, in European countries foods have also been 
manufactured with partly hydrogenated fish oils.19,20 An adverse effect of high 
amounts of trans fatty acids from hydrogenated fish oil on blood lipids has 
already been shown.5 However, the health effects of these isomers in quantities 
consumed in daily life are unknown. 
We investigated the association between trans fatty acid intake and the risk of 
coronary heart disease in the Zutphen Elderly Study, a population with a fairly 
high dietary trans fatty acid intake at baseline, including trans fatty acids from 
partly hydrogenated fish oils. 41 
M E T H O D S 
Study populat ion 
The study population consisted of men who participated in the Zutphen Elderly 
Study, an extension of the Zutphen Study. In 1960, the Zutphen Study started 
with a cohort of 878 men from Zutphen (Netherlands) born between 1900 and 
1919, as the Dutch contribution to the Seven Countries Study.21 In 1985, 367 of 
555 participants who were still alive were re-examined. In addition, 711 other 
men from the town of Zutphen in the same age category were asked to 
participate. A total of 939 men (response rate 74%) was examined in 1985, 560 
in 1990 (response rate 78%), and 343 in 1995 (response rate 74%). Of the 343 
men who participated in 1995, a random sample of 280 men took part in the 
dietary survey. Complete information on diet and risk factors was available for 
824 men in 1985. We excluded 157 men with previously diagnosed myocardial 
infarction or angina pectoris, which left 667 men at baseline in 1985, of whom 
435 and 225 participated in the dietary survey in 1990 and 1995, respectively. 
42 
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Data col lect ion 
Dietary surveys and medical examinations were completed between March and 
June in 1985, 1990, and 1995. We obtained information about the habitual food 
consumption with the cross-check dietary history method, adapted to the Dutch 
situation.22 Each participant, and if possible his partner, was interviewed about 
his average food consumption pattern in the month before interview. A checklist 
of foods and quantities of food bought per week was used to calculate and verify 
the participant's food consumption pattern. 
We calculated nutrient intake with corresponding Dutch food tables. Time-
specific tables with trans fatty acid content of consumed foods were compiled.23 
National data were available for edible fats analyzed by the Wageningen 
University, Netherlands, around 1985 and 1990, and by the TRANSFAIR Study24 
in 1995. In 1995, products such as biscuits and pastries (Wageningen University) 
and dairy products and meats (TRANSFAIR Study) were analyzed. The trans 
fatty acid contents of the remaining foods were based on analyses from abroad, 
derived from recipes, or deduced from other foods. Because the gas 
chromatographic method underestimates measurement of trans fatty acids, 
contents were adjusted by taking the combination of gas-liquid chromatography 
of 4,4-dimethyloxazoline derivatives and methyl esters25 or the infra-red 
spectrometry as a reference. 
During medical examinations, we took non-fasting venous blood samples. Serum 
total cholesterol and HDL cholesterol were determined enzymatically.26,27 We 
measured blood pressure in duplicate with a random zero sphygmomanometer 
while participants were supine. Hypertension was defined as use of 
antihypertensive medication, a systolic blood pressure of 160 mm Hg or greater, 
or a diastolic blood pressure of 95 mm Hg or greater. We calculated total 
minutes of physical activity per week,28 information on cigarette smoking, and 
diabetes mellitus, with a questionnaire. We ascertained history of coronary-heart 
disease with the Dutch translation of the Rose questionnaire.29 
Fol low-up 
Incident cases included fatal coronary heart disease plus non-fatal myocardial 
infarction (whichever arose first) occurring between baseline assessment in 1985 
and January, 1995. Three participants were lost to follow-up. We obtained 
information on vital status of the participants from the municipal registries, and 
on cause of death between 1985 and June 1990 from Statistics Netherlands. For 
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deaths thereafter, or if data were not available from Statistics Netherlands, 
information was obtained from hospital discharge data or general practitioners. 
We coded causes of death in accordance with the ninth revision of the 
International Classification of Diseases. Coronary heart disease refers to codes 
410-414. Because the underlying cause of death in elderly people is often 
difficult to establish, we classified coronary heart disease as a primary (n=46) as 
well as a secondary (n=3) cause of death in the analyses. 
We obtained information on non-fatal myocardial infarction by a standardized 
medical questionnaire, or, in case of non-response, by a short questionnaire 
completed by the participants or their closest relative. All reported myocardial 
infarctions were verified with hospital-discharge data. Also, in men who died, 
information on disease history was obtained from the general practitioner. 
Diagnosis of myocardial infarction required at least two of the following criteria: 
a specific medical history, characteristic electrocardiographic changes, and 
specific increases in concentration of enzymes. 
Stat is t ical methods 
All statistical analyses were carried out using the SAS (version 6.12) package. 43 
Men were divided into tertiles on the basis of the contribution of trans fatty acids ~~~ 
to energy intake at baseline. To compare the baseline major risk factors and 
dietary factors across categories of trans fatty acid intake, we used analysis of 
variance for normally distributed variables, the Kruskal-Wallis test for skewed 
variables, and the Chi-square test for categorical variables. 
We used Cox's proportional-hazard analysis to calculate relative risks, with the 
lowest trans fatty acids tertile as the reference group, or including trans fatty 
acid intake as the continuous variable. In the continuous analyses, we estimated 
the relative risk associated with a difference of 2% of energy in total trans fatty 
acid intake. This difference was based on the reports of two prospective 
studies,10,11 which is in agreement with the range in trans fatty acid intake at 
baseline, and the 10-year decrease in trans fatty acid intake in the present 
study. Adjustments were made for age, intake of energy, body mass index, 
smoking, alcohol intake, use of vitamin supplements, intake of saturated fatty 
acids, monosaturated fatty acids, polyunsaturated fatty acids, and cholesterol. 
We also adjusted for fiber because the association between trans fatty acid 
intake and coronary heart disease was strongly attenuated after adjustment for 
fiber in another prospective study.10 Alcohol intake was used as a categorical 
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variable (included as two dummies into the model, with non-drinkers as a 
reference). 
RESULTS 
The mean daily trans fatty acid intake fell from 1985 to 1990 and 1995 (10.9 g 
[SD 6.3] vs. 6.9 [4.0] vs. 4.4 g [1.7]) . The mean contribution of trans fatty acid 
intake to total energy intake decreased from 1985 to 1990 and 1995 (4.3% [SD 
2.2] vs. 2.9% [1.5] vs. 1.9% [0.6]) . There was a similar reduction in trans fatty 
acid intake ( - 2 . 1 % of energy) in the men who were examined in all three 
examination years. The intake of manufactured C18 : l trans (a proxy for partly 
hydrogenated vegetable oils) as well as the manufactured other trans fatty acids 
(including partly hydrogenated fish oils) decreased substantially between 1985 
and 1995, but the intake of ruminant trans fatty acids did not do so (figure 1). 
The Spearman correlation coefficient between the total trans fatty acid intake 
expressed in % of energy in 1985 and 1990 was 0.43, and between 1985 and 
1995 was 0.24. 
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Figure 1. Daily intake of trans fatty acids in the Zutphen 
Elderly Study between 1985 and 1995. 
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Table 1. Characteristics at baseline by tertiles of total trans fatty acid intake. 
Total Trans fatty acid tertile 
(% of energy) 
P value 
Age (yr) 
Body mass index (kg/m2) 
Physical activity (min per week) 
Serum total cholesterol (mmol/L) 
Serum HDL cholesterol (mmol/L) 
Smoking 
Current 
past 
Use of vitamin supplements 
Hypertension 
Diabetes mellitus 
Daily intake of 
Energy (MJ) 
Total fat (% of energy) 
Saturated fat (% of energy) 
Monounsaturated fat (% of energy) 
Polyunsaturated fat (% of energy) 
Cholesterol (mg) 
Carbohydrates (% of energy) 
Protein (% of energy) 
Alcohol (g) 
non-drinkers 
>20 g/d 
Fiber (g) 
(n=667) 
71.1(5.2) 
25.5(3.2) 
611(533) 
6.08(1.11) 
1.14(0.30) 
33% 
49% 
16% 
42% 
6% 
9.2(2.0) 
40.3(6.4) 
18.0(3.6) 
15.3(3.2) 
7.0(2.8) 
273(97.0) 
41.0(7.3) 
14.3(2.6) 
13.8(17.3) 
24% 
27% 
24.9(7.1) 
<3.11 
(n=222) 
71.3(5.5) 
25.5(3.1) 
577(467) 
6.14(1.15) 
1.15(0.31) 
28% 
5 1 % 
2 1 % 
47% 
5% 
8.6(1.9) 
37.1(6.5) 
17.0(3.9) 
13.2(2.8) 
6.9(3.5) 
245(97.4) 
42.2(8.0) 
14.8(2.8) 
17.0(20.0) 
23% 
34% 
24.4(7.2) 
3.11-4.86 
(n=223) 
70.8(5.2) 
25.2(3.2) 
601(500) 
5.94(1.02) 
1.14(0.29) 
3 1 % 
48% 
18% 
42% 
8% 
9.4(2.1) 
39.8(5.2) 
18.3(3.6) 
15.0(2.2) 
6.4(2.4) 
280(89.0) 
42.0(6.6) 
14.3(2.4) 
12.7(16.7) 
23% 
22% 
25.2(6.9) 
>4.86 
(n=222) 
71.3(5.0) 
25.8(3.2) 
656(620) 
6.16(1.13) 
1.12(0.30) 
38% 
48% 
10% 
38% 
5% 
9.5(2.1) 
44.0(5.6) 
18.7(3.1) 
17.7(2.8) 
7.6(2.1) 
292(98.5) 
38.7(6.8) 
13.7(2.5) 
11.7(14.2) 
25% 
24% 
25.1(7.1) 
0.47 
0.13 
0.91 
0.07 
0.64 
0.08 
0.73 
0.003 
0.15 
A 0-25 _ 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
0.05 
0.85 
0.01 
0.46 
Values shown as mean (standard deviation) unless otherwise stated. 
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Table 2. Relative risks of coronary heart disease according to tertiles of 
trans fatty acid intake at baseline. 
Median intake (% of energy) 
No. (%) of cases 
Relative risks (95% CI) 
Crude 
Age + energy adjusted 
Fully adjusted 
Trans fatty acid tertile (% of energy) 
<3.11 
(n=222) 
2.36 
24 (11%) 
1 
1 
1 
3.11-4.86 
(n=223) 
3.87 
30 (14%) 
1.26 (0.74-2.15) 
1.36 (0.79-2.34) 
1.34 (0.76-2.37) 
>4.86 
(n=222) 
6.38 
44 (20%) 
2.03 (1.24-3.34) 
2.19 (1.32-3.62) 
2.00 (1.07-3.75) 
P 
Value* 
0.003 
0.002 
0.03 
*Values were obtained by modeling the median value of each category as a continuous 
variable. 
The total daily intake of trans fatty acids at baseline was positively associated 
with the daily intake of energy, total fat, saturated and unsaturated fat, and 
46 cholesterol, and inversely associated with the daily intake of carbohydrates, 
" protein, alcohol, and the use of vitamin supplements (table 1). No significant 
associations between total trans fatty acid intake and major risk factors were 
recorded. However, although not statistically significant, men with a high intake 
of trans fatty acids were more often smokers and had a higher serum total 
cholesterol concentration, For manufactured trans fatty acids, similar 
associations were noted. By contrast, trans fatty acid intake from ruminant 
sources was inversely associated with the daily intake of energy, 
polyunsaturated fat, and fiber, and positively associated with the daily intake of 
protein. 
During 10 years of follow-up, we documented 98 (15% of the baseline 
population) coronary heart disease cases (including 49 cardiac deaths). Table 2 
shows the crude relative risks of 10-year coronary heart disease frequency for 
the different tertiles of trans fatty acid intake at baseline. The relative risks were 
similar after adjustment for age, body mass index, smoking, use of vitamin 
supplements, intake of energy, alcohol, specific types of fat, dietary cholesterol, 
and fiber. 
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Table 3. Relative risks of coronary heart disease for an increase of 0.5% 
in energy from trans fatty acids from different sources* at baseline. 
Ruminant trans 
fatty acids 
Manufactured 
C18:l trans 
fatty acids 
Other 
manufactured 
trans fatty acids 
Mean (SD) intake 
(% of energy) 
Relative risks (95% CI) 
0.7(0.2) 2.1(1.2) 1.6(1.4) 
Crude 1.11 (0.69-1.78) 1.07 (0.99-1.15) 1.05 (0.99-1.12) 
Age + energy adjusted 1.05(0.66-1.69) 1.08(1.00-1.17) 1.06(0.99-1.13) 
Fully adjusted 1.17(0.69-1.98) 1.05(0.94-1.17) 1.07(0.99-1.15) 
* Intake of ruminant trans fatty acid, manufactured C18:l trans, and other 
manufactured trans fatty acids are included simultaneously. 
In the continuous analyses we calculated the relative risk associated with a 
difference of 2% of energy in total trans fatty acid intake at baseline. Adjusted 
for age and energy intake, this relative risk of 10-year incidence of coronary 
heart disease was 1.29 (95% CI 1.09-1.52). After additional adjustment for body 
mass index, smoking, use of vitamin supplements, intake of alcohol, specific 47 
types of fat, dietary cholesterol and fiber, the relative risk amounted to 1.28 
(1.01-1.61). For fatal coronary heart disease the fully adjusted relative risk for a 
difference of 2% of energy in trans fatty acid intake was 1.33 (0.96-1.86). 
Because of different proportions of C18: l trans isomers in each source, and 
because of different trans isomers from manufactured sources, we assessed the 
difference in effect of ruminant trans fatty acids, manufactured C18: l trans fatty 
acids, and other manufactured trans fatty acids. We did continuous analyses of 
baseline intake on coronary heart disease frequency to take into account the 
difference in range of intake of each type of trans fatty acid, For each 0.5% of 
energy, the fully adjusted relative risk of coronary heart disease for ruminant 
trans fatty acids, manufactured C18: l trans fatty acids, and other manufactured 
trans fatty acid intake was similar (table 3). 
Table 4 summarizes results of previous cohort studies on the association 
between trans fatty acid intake and the risk of coronary heart disease. 
Combining the results of the four prospective cohort studies, the pooled 
variance-weighted relative risk of coronary heart disease associated with a 
difference of 2 % of energy in trans fatty acid intake is 1.25 (95% CI 1.11-1.40; 
figure 2). 
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Table 4. Summary of the effect of an increase of 2 % of energy in trans fatty acid intake 
on coronary heart disease* reported in prospective studies. 
Study population N Sex Number Follow-
of up 
events (years) 
Age+energy 
adjusted 
relative risk 
(95% CI) 
Adjustedt 
relative risk 
(95% CI) 
Nurses' Health Study11 
Health Professionals follow-up 
Study10 
Alpha-Tocopherol Beta-Carotene 
Cancer Prevention Study13 
Zutphen Elderly Study 
80082 
43757 
21930 
667 
women 
men 
men 
men 
939 
734 
1399 
98 
14 1.62(1.23-2.13) 
6 1.59(1.21-2.08) 1.13(0.81-1.58) 
6.1 1.19(1.00-1.41) 1.14(0.96-1.35) 
10 1.29(1.09-1.52) 1.28(1.01-1.61) 
*Defined as non-fatal myocardial infarction and fatal coronary heart disease 
tFor each study, the fully adjusted model is presented here. Details can be found in the original 
papers. 
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DISCUSSION 
We report that high intake of trans fatty acids at baseline was strongly 
associated with the risk of coronary heart disease in Dutch elderly men. Our 
results are similar to those from other prospective studies, such as the 16 
population cohorts of the Seven Countries Study,30 and a US case-control study.9 
However, in the EURAMIC case-control study, no significant overall association 
was noted between the C18:l trans fatty acid content of adipose tissue and the 
risk of first myocardial infarction.12 In this investigation, however, the trans fatty 
acid content of adipose tissue was very low in the Spanish centers. After 
excluding these outlying values, the relative risk for the highest versus the 
lowest quartile was 1.44 (95% CI 0.94-2.20). 
We did not show any actual difference in associations between coronary heart 
disease and ruminant trans fatty acid intake, intake of C18:l trans isomers, and 
other trans isomers from manufactured sources. Human dietary intervention 
studies on blood lipids that used different sources or trans isomers have similar 
results.1,2,4,5 However, in the Nurses' Health Study, a non-significant inverse 
relative risk of coronary heart disease for ruminant trans fatty-acid intake 
(highest vs. lowest quintile) of 0.59 was recorded.8 In two other prospective 
studies, because of the lower intake of trans fatty acids from ruminant sources 
compared with manufactured sources, differences between ruminant and 
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Study Population 
Nurses' Health Study11 
Health Professionals follow-up -
Study10 
Alpha-Tocopherol Beta-Carotene 
Cancer Prevention Study13 
Zutphen Elderly Study 
Pooled 
0.6 
1.62 
1.13 
1.14 
1.28 
1.25 
1.4 1.8 2.2 
Relative risk of coronary heart disease for increase 
of 2% of energy in trans fatty acids (95% CI) 
Figure 2. The fully adjusted relative risks of coronary heart disease for an increase of 2 % 
of energy in trans fatty acid intake at baseline according to prospective population based 
studies, and the pooled variance-weighted relative risk. 
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manufactured trans fatty acids were less clear.9,13 We therefore conclude that 
the health effect of trans fatty acids from ruminant sources and from 
manufactured sources is similar. 
Is the association between trans fatty acid intake and coronary heart disease 
estimated adequately with a baseline measurement in a cohort with a declining 
trans fatty acid intake? In the Nurses' Health Study, a stronger association 
between trans fatty acids and coronary heart disease was reported when 
cumulative average diets were used rather than baseline or only the most recent 
diet.31 Taking into account changes in food composition and dietary habits 
among participants in our study, use of cumulative average diets or the most 
recent diet for the second 5 years of follow-up gave weaker results than those 
for the baseline diet (data not shown). When the intake of trans fatty acids is 
fairly stable, as in the Nurses' Health Study,31 the cumulative average intake 
probably best indicates the long-term intake. However, for our population of men 
aged 64-84 years who changed their trans fatty acid intake only recently, the 
baseline measurement probably better shows the long-term intake. 
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Keeping misclassification to a minimum is essential to adequately detect 
associations with disease or to control for confounding. In our study, habitual 
food consumption was measured by the cross-check dietary history method, 
which is acknowledged as a valid method in an epidemiological setting.22 Trans 
fatty acid contents of mainly Dutch foods were available to calculate trans fatty 
acid intake. Adjustments were made for systematic differences due to different 
analytical methods. Furthermore, the effect of trans fatty acid intake on coronary 
heart disease could be confounded by other dietary or risk factors that were not 
included in our analyses. To lower residual confounding, we adjusted for many 
dietary and lifestyle factors. All had minor effects on the relative risks. Our 
results for fatal coronary heart disease, including non-fatal myocardial infarction, 
were considered. Because of power, we focused on the association of fatal plus 
non-fatal coronary heart disease. 
The reduction in consumption of trans fatty acids in the Netherlands and in the 
use of both partly hydrogenated vegetable and fish oils explains the decline in 
the contribution of trans fatty acids to total energy intake. In 1996, a further 
decrease in trans fatty acid content of edible fats was recorded in the 
Netherlands.15,18 Also, in other European countries, a fall in the trans fatty-acid 
50 content of margarines19 contributed to a decline in trans fatty acid intake.15 The 
~~~ trans fatty acid intake at baseline was much higher than the 2% of energy 
reported in previous studies done in the USA.8,10,11 However, in the USA, the 
trans fatty acid intake remained stable, because a decrease in trans fatty acids 
from margarines was counterbalanced by an increase in trans fatty acids from 
commercially baked products and fast foods.16 
We did not record a clear cross-sectional association between trans fatty acid 
intake and total or HDL cholesterol at baseline. However, by use of longitudinal 
analyses of both trans fatty acids and cholesterol concentrations, there was an 
association in accordance with the results of controlled dietary intervention 
studies (Chapter 2). Also other mechanisms might be implicated in increasing 
the risk for coronary heart disease, since relative risk is higher than can be 
predicted from the effects of trans fatty acids on cholesterol concentrations 
alone.16 Several studies have shown effects of trans fatty acids on 
triglycerides1'4,6,7 and lipoprotein (a) concentrations.5,7 Trans fatty acids might 
have other adverse physiological effects on e.g. thrombotic mechanisms32 or 
insulin resistance.33 
Trans fatty acid intake and coronary heart disease 
Evidence from observational and dietary intervention studies suggests that a 
decrease in trans fatty acid intake has a role in lowering coronary heart disease 
mortality.17 The number of coronary heart disease deaths attributable to trans 
fatty acids in the USA is thought to be substantial.34 The decrease in trans fatty 
acid intake of 2.4% of energy we report could have contributed to about 23% 
less coronary deaths (i.e., about 4600 of 20000 coronary deaths in the 
Netherlands per year). 
Possibilities for further industrial reductions in trans fatty acid contents are 
restricted nowadays to bakery products21 and fast foods.18,35 Also, the 
substitution of trans fatty acids requires further attention, because in the current 
manufacturing process trans fatty acids are partly replaced by saturated fatty 
acids.15-1719 
ACKNOWLEDGMENTS 
The Zutphen Elderly Study was supported by grants of the Netherlands Prevention Foundation. 
CM. Oomen was partly supported by a grant of Unilever Research Laboratory, Vlaardingen, the 
Netherlands to the Wageningen University. We thank Prof. Martrjn B. Katan, Wageningen Centre 5 1 
for Food Sciences, Bomenweg 2, 6703 HD Wageningen, the Netherlands for his comments on an — —" 
earlier draft. 
REFERENCES 
1. Mensink RP, Katan MB. Effect of dietary trans fatty acids on high-density and low-density 
lipoprotein cholesterol levels in healthy subjects. N Engl J Med 1990;323:439-45. 
2. Zock PL, Katan MB. Hydrogenation alternatives: effects of trans fatty acids and stearic acid 
versus linoleic acid on serum lipids and lipoproteins in humans. J Lipid Res 1992;33:399-410. 
3. Nestel PJ, Noakes M, Belling GB, McArthur R, Clifton PM, Abbey JM. Plasma cholesterol-
lowering potential of edible-oil blends suitable for commercial use. Am J Clin Nutr 1992:55;46-
50. 
4. Judd JT, Clevidence BA, Muesing RA, Wittes J, Sunkin ME, Podczasy JJ. Dietary trans-fatty 
acids: effects on plasma lipids and lipoproteins of healthy men and women. Am J Clin Nutr 
1994;59:861-8. 
5. Almendingen K, Jordal O, Kierulf P, Sandstad B, Pedersen JI. Effects of partially hydrogenated 
fish oil, partially hydrogenated soybean oil, and butter on serum lipoproteins and Lp[a] in men. 
J Lipid Res 1995;36:1370-84. 
6. Sundram K, Ismail A, Hayes KC, Jeyamalar R, Pathmanathan R. Trans (elaidic) fatty acids 
52 
Chapter 3 - — - — -
adversely affect the lipoprotein profile relative to specific saturated fatty acids in humans. J 
Nutr 1997;127 Suppl:514-520. 
7. Lichtenstein AH, Ausman LM, Jalbert SM, Schaefer EJ. Effects of different forms of dietary 
hydrogenated fats on serum lipoprotein cholesterol levels. N Engl J Med 1999;340:1933-40. 
8. Willett WC, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Rosner BA, et al. Intake of trans 
fatty acids and risk of coronary heart disease among women. Lancet 1993;341:581-5. 
9. Ascherio A, Hennekens CH, Buring JE, Master C, Stampfer MJ, Willett WC. Trans fatty acids 
intake and risk of myocardial infarction. Circulation 1994;89:941-1001. 
10. Ascherio A, Rimm EB, Giovannucci EL, Spiegelman D, Stampfer M, Willett WC. Dietary fat and 
risk of coronary heart disease in men: cohort follow up study in the United States. BMJ 
1996;313:84-90. 
11. Hu FB, Stampfer MJ, Manson JE, Rimm E, Colditz GA, Rosner BA, et al. Dietary fat intake and 
the risk of coronary heart disease in women. N Engl J Med 1997;337:1491-9. 
12. Aro A, Kardinaal AFM, Salminen I, Kark JD, Riemersma RA, Delgado-Rodriguez M, et al. 
Adipose tissue isomeric trans fatty acids and risk of myocardial infarction in nine countries: 
the EURAMIC study. Lancet 1995;345:273-78. 
13. Pietinen P, Ascherio A, Korhonen P, Hartman AM, Willett WC, Albanes D, et al. Intake of fatty 
acids and risk of coronary heart disease in a cohort of Finnish men. Am J Epidemiol 
1997;145:876-87. 
14. Van de Vijver LPL, Kardinaal AFM, Couet C, Aro A, Kafatos A, Steingrimsdottir L, et al. 
Association between trans fatty acid intake and cardiovascular risk factors in Europe: the 
TRANSFAIR study. Eur J Clin Nutr 2000;54:126-35. 
15. Hulshof KFAM, van Erp-Baart M-A, Anttolainen M, Becker W, Church SM, Couet C, et al. Intake 
of fatty acids in Western Europe with emphasis on trans fatty acids: The TRANSFAIR Study. 
Eur J Clin Nutr 1999;53:143-157. 
16. Ascherio A, Katan MB, Zock PL, Stampfer MJ, Willett WC. Trans fatty acids and coronary heart 
disease. N Engl J Med 1999:340; 1994-1998. 
17. Katan MB. Exit trans fatty acids. Lancet 1995; 346:1245-6 
18. Hulshof PJM, Zock PL, Kosmeijer T, van de Bovenkamp P, Katan MB. Daling transvetzuren, 
maar niet in alle grootverbruikproducten. Voeding 1998:5;24-27. 
19. Aro A, van Amelsvoort J, Becker W, van Erp-Baart M-A, Kafatos A, Leth T, et al. Trans fatty 
acids in dietary fats and oils from 14 European Countries: The TRANSFAIR Study. J Food Comp 
Anal 1998;11,137-149. 
20. Van Erp-Baart M-A, Couet C, Cuadrado C, Kafatos A, Stanley J, Van Poppel G. Trans fatty acids 
in bakery products from 14 European Countries: the TRANSFAIR Study. J Food Comp Anal 
1998;11,161-169. 
21. Keys A, Aravanis C, Blackburn H. Epidemiological studies related to coronary heart disease: 
characteristics of men aged 40-59 in seven countries. Acta Med Scand 1966; 460 Suppl: 1-392. 
22. Bloemberg BPM, Kromhout D, Obermann-de Boer GL, van Kampen-Donker M. The 
reproducibility of dietary intake data assessed with the cross-check dietary history method. Am 
J Epidemiol 1989;130:1047-56. 
Trans fatty acid intake and coronary heart disease 
23. Oomen CM, Feskens EJM, Kok FJ, Brants HAM, van Erp-Baart AJM, Kromhout D. Samenstelling 
van voedingsmiddelentabellen met gehalten aan transvetzuren ten behoeve van 
epidemiologisch onderzoek. Bilthoven: Rijksinstituut voor volksgezondheid en milieu; 2000 
maart. Rapportnr. 441110004. 
24. Van Poppel G, van Erp-Baart M-A, Leth T, Gevers E, Van Amelsvoort J, Lanzmann-Petithory D, 
et al. Trans fatty acids in foods in Europe: the TRANSFAIR study. J Food Comp Anal 
1998;11,112-136. 
25. Aro A, Kosmeijer-Schuil T, van de Bovenkamp P, Hulshof P, Zock P, Katan MB. Analysis of 
C18:l cis and trans fatty acid isomers by the combination of gas-liquid chromatography of 
4,4-dimethyloxazoline derivatives and methyl esters. JAOCS 1998;75:977-985. 
26. Siedel J, Schlumberger H, Klose S, Ziegenhorn J, Wahlefeld AW. Improved reagent for the 
enzymatic determination of serum cholesterol. J Clin Chem Clin Biochem 1981;19:838-839. 
27. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for 
quantification of high density-lipoprotein cholesterol. Clin Chem 1982;28:1379-1388. 
28. Caspersen CJ, Bloemberg BPM, Saris WHM, Merritt RK, Kromhout D. The prevalence of 
selected physical activities and their relation with coronary heart disease risk factors in elderly 
men: the Zutphen Study, 1985. Am J Epidemiol 1991;133:1078-1092. 
29. Rose GA, Blackburn H. Cardiovascular Survey Methods. Geneva, Switzerland: World Health 
Organization; 1968. 
30. Kromhout D, Menotti A, Bloemberg B, Aravanis C, Blackburn H, Buzina R, et al. Dietary 
saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart 
disease: The Seven Countries Study. Prev Med 1995;24:308-315. 
31. Hu FB, Stampfer MJ, Rimm E, Ascherio A, Rosner BA, Spiegelman D, et al. Dietary fat and 
coronary heart disease: A comparison of approaches for adjusting for total energy intake and 
modeling repeated dietary measurements. Am J Epidemiol 1999;149:531-40. 
32. Almendingen K, Seljeflot I, Sandstad B, Pedersen JI. Effects of partially hydrogenated fish oil, 
partially hydrogenated soybean oil, and butter on hemostatic variables in men. Arterioscler 
Thromb Vase Biol 1996;16:375-80. 
33. Christiansen E, Schnider S, Palmvig B, Tauber-Lassen E, Pedersen O. Intake of a diet high in 
trans monounsaturated fatty acids or saturated fatty acids. Effects on postprandial insulinemia 
and glycemia in obese patients with NIDDM. Diabetes Care 1997;20:881-7. 
34. Willett WC, Ascherio A. Trans fatty acids: are the effects only marginal? Am J Public Health 
1994;84:722-724. 
35. Aro A, Amaral E, Kesteloot H, Rimestad A, Thamm M, van Poppel G. Trans fatty acids in french 
fries, soups and snacks from 14 European Countries: The TRANSFAIR Study. J Food Comp Anal 
1998;11,170-177. 
53 
consumption and 
coronary heart disease 
mortality 
in Finland, Italy and the 
Netherlands 
Claudia M Oomen, Edith IM Feskens, Leena Rasanen, Flaminio 
Fidanza, Aulikki M Nissinen, Alessandro Menotti, Frans J Kok, Daan 
tnis association is aue to n-j poiyunsaturatea ratty acias, especially ratty nsn may c 
responsible for this protective effect. The association between total, lean and fatty fis 
consumption and the risk of CHD mortality was examined in 1,088 Finnish, 1,097 Italia 
and 553 Dutch men participants in the Seven Countries Study who were aged 50-6 
years and free of CHD around 1970. After 20 years of follow-up, 242 (22.4%) men i 
Finland, 116 (10.6%) men in Italy and 105 (19.0%) men in the Netherlands had died i 
CHD. Cox proportional hazard analysis showed no association between total fis 
consumption and CHD mortality. After adjustments were made for age, body mass inde: 
smoking, energy intake and relevant dietary variables, the pooled relative risk for th 
highest quartile of total fish compared with no fish consumption in the three countrie 
was 1.08 (95% confidence interval 0.76-1.53). Lean fish consumption also was n< 
associated with CHD mortality in any country- Fatty fish compared with non-fatty fis 
consumption was associated with lower CHD mortality; the adjusted, pooled relative ri< 
for fatty fish consumers was 0.66 (95% confidence interval 0.49-0.90). These dal 
suggest that especially fatty fish is protective against CHD mortality. 
INTRODUCTION 
Since Bang et al. suggested that the low mortality rate from coronary hea 
disease (CHD) among Eskimo compared with Danes may be due to the 
consumption of large quantities of seafood,1 the health effects of fish hav 
attracted considerable scientific interest. Results from several cohort studte 
have suggested that consumption of a small amount of fish is inverse 
associated with CHD mortality.2"7 However, in some studies that examined th 
impact of fish consumption on nonfatal CHD, no association was observed.8,9 ] 
populations whose average fish intake was high, such as those in Finlani 
Norway and Hawaii, also no inverse association between fish consumption ar 
CHD risk was observed.10"13 Among the people in these studies, almost everyor 
eats fish regularly; therefore, these populations probably are not suited I 
studying the impact of the consumption of a small amount of fish on CH 
mortality. 
A difference in the type of fish consumed, for example, fatty fish or lean fisl 
might explain further inconsistency in the relation between fish intake and CH 
mortality across populations. In the diet and reinfarction trial, carried out amor 
Fish consumption and coronary heart disease mortality 
cardiac patients, a modest intake of fatty fish was found to reduce all-cause 
mortality by about 29%, which was entirely attributable to a reduction in the 
number of deaths from coronary heart disease.14 Consumption of fatty fish may 
be protective because this type of fish contains high levels of the n-3 fatty acids 
eicosapentaenoic acid and docosahexaenoic acid. N-3 fatty acids have important 
metabolic effects, such as inhibiting the platelet aggregation and lowering serum 
triglyceride levels, which could play a role in the prevention of CHD.15 In 
addition, instead of the inconsistent results found in some prospective studies 
that examined the dose-response relation between fish consumption and CHD 
mortality, one study observed a dose-response relation between n-3 fatty acids, 
quantified in both the diet and red blood cell membranes, and the risk of primary 
cardiac arrest.16 
We hypothesized that because of its higher n-3 fatty acid content, especially 
fatty fish may be responsible for the protective effect of fish consumption. We 
analyzed the association between total, lean and fatty fish consumption and 20-
year CHD mortality in the Finnish, Italian, and Dutch cohorts of the Seven 
Countries Study. 
MATERIALS A N D METHODS 
Study populat ion 
Between 1958 and 1964, 16 population samples of men aged 40-59 years from 
seven countries were enrolled in and were examined for the Seven Countries 
Study.17 In five population samples from Finland, Italy, and the Netherlands, 
individual dietary information was collected during follow-up. The two Finnish 
cohorts from two geographically defined areas, Ilomantsi in east Finland and 
Poytya and Mellila in west Finland, were enrolled in 1959, and participation rates 
were high (99.3% and 97.0%, respectively). The cohorts from two small, rural 
villages in Italy, Crevalcore and Montegiorgio, and from a small town in the 
Netherlands, Zutphen, were enrolled in 1960 (participation rates: Italy, 98.5% 
and 99.0%; the Netherlands, 84.3%). Baseline dietary information used in this 
study was gathered in 1969 for participants in east Finland (N=608) and west 
Finland (N=694) and in 1970 for participants in the Netherlands (N=615) and in 
Crevalcore (N=592). For Montegiorgio, dietary information collected in 1965 was 
used for the men still alive in 1970 (N=627), because the 1970 dietary data 
were collected for only a subset of men. 
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Data col lect ion 
Experienced dieticians and nutritionists conducted dietary interviews with all 
cohorts in Finland from September to November and in the Netherlands and Italy 
from March to June. Food consumption data were collected by using the cross-
check dietary history method,18 which was adapted to each specific country; the 
methodology used was comparable across cohorts. This method provides 
information about the habitual food consumption during the 6-12 months 
preceding the interview. First, the habitual food consumption pattern of a person 
was assessed during the week and weekends. This part of the interview 
contained questions about the foods used at breakfast, lunch, dinner and 
between meals. Second, a checklist with an extensive number of foods was 
used, and the frequencies and quantitaties of the different foods consumed were 
recorded. The information about the food consumption pattern was then 
compared with the information from the checklist. Total fish consumption was 
computed by adding the number of grams of all fish consumed per day per 
subject. The following subgroups of types of fish were discerned: 1) lean 
(unprepared, < 10% fat; prepared, < 12% fat; e.g. plaice, cod-fish, bream, 
perch, pike); 2) fatty (e.g. mackerel, (salted) herring, eel); and 3) canned (e.g. 
5g sardines, salmon). Local food tables were used to convert food intake data into 
—— intake of energy and nutrients, including alcohol, for participant in the three 
different countries.19"21 
Information about the number of cigarettes smoked was collected by using a 
standardized questionnaire; participants were categorized as men who had never 
smoked, had stopped smoking, or currently smoked fewer or more than 20 
cigarettes a day. Other risk factors such as serum total cholesterol, blood 
pressure and anthropometric measures were determined according to a 
standardized protocol.18 Body mass index (kg/m2) was calculated from weight 
and height measurements. 
Ascertainment of mortality and causes of death was complete for all men in the 
subsequent 20 years. None of the men was lost to follow up. All mortality data 
collected from death certificates, hospital records or information from the 
general practitioner, family members and other witnesses of the death were 
coded by one reviewer according to the World Health Organization's 
International Classification of Diseases, Eighth revision by using standard criteria 
for interpretation and coding. In case of multiple causes of death, priority was 
given to accidents, followed by advanced-stage cancer, CHD and stroke. For the 
present analyses, CHD referred to the primary or secondary cause of death 
_ „ Fish consumption and coronary heart disease mortality 
based on International Classification of Diseases codes 410-414 (Finland, 223; 
Italy, 81; the Netherlands, 88) and, when a cardiac origin was mentioned, to the 
primary cause of sudden cardiac death based on code 795 (Finland, 19; Italy, 
35; the Netherlands, 17). 
Statistical methods 
All statistical analyses were conducted by using the SAS statistical analysis 
computer package (version 6.11; SAS Institute, Inc., Cary, North Carolina). Men 
with a field diagnosis of CHD based on the standardized criteria were excluded 
from analysis (Finland, n=214; Italy, n=122; the Netherlands, n=62) leaving a 
total of 2,738 men. For each country, the men were divided into categories 
based on the number of grams of fish they consumed per day (g/day). 
Categories of 0, 1-19, 20-39 and >40 g/day were used for total and lean fish 
consumption and 0, >0 g/day for fatty fish consumption, since only a small 
proportion consumed fatty fish. Canned fish was assigned to neither the lean nor 
the fatty fish category and, because of a low level of consumption, was not found 
to be related to CHD mortality. Because of small numbers, Finnish men who 
consumed 0 g/day of total or lean fish (no fish. n=33; no lean fish, n=48) were 
grouped with men who consumed 1-19 g/day. For the Netherlands, the total and ^9 
lean fish consumption category of 20-39 g/day was merged with the category of 
>40 g/day of total fish (n=63) or lean fish (n=41). However, excluding these 
men from the analyses did not change the results. 
To compare the baseline risk factors and dietary variables across categories of 
fish consumption, we used analysis of variance for normally distributed variables, 
the Kruskal-Wallis test for skewed variables, and the chi-square test for 
categorical variables. Cox proportional hazard analyses were performed by using 
SAS procedure PHREG, and the analyses were stratified by cohort using the 
STRATA statement.22 Relative risks, 95% confidence intervals and p values for 
linear trend were calculated to investigate the association between fish 
consumption categories and CHD mortality for each country. Fish consumption 
was not used as a continuous variable, since none of the tests for linear trend 
supported a linear relation. For total fish consumption, men who consumed no 
fish (Italy, the Netherlands) or the lowest amount of fish (Finland) were 
considered the reference group. For lean fish consumption, participants who 
consumed the lowest amount of lean fish (irrespective of their fatty fish intake) 
were taken as the reference group, and intake of fatty fish was included in the 
model as a confounder. For fatty fish consumption, the reference group 
Chapter 4 • 
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consumed no fatty fish. Additional adjustments were made for age, cigarette 
smoking, body mass index, intake of energy and alcohol, and consumption of 
vegetables, fruit, meat, margarine and butter -the food products associated with 
fish consumption in our data and potentially associated with CHD mortality. 
Alcohol intake (0, 1-39, 40-59, >60 g/day) was used as a categorical variable. If 
the association of fish consumption with CHD mortality was similar between the 
countries, data from the three countries were pooled and analyses were 
stratified by cohort. Two-tailed significance levels of 0.05 were used. 
RESULTS 
The average age of the men was 58.0 years at baseline. The mean daily fish 
intake was 39 g (standard deviation (SD), 47) in Finland, 20 g (SD, 21) in Italy 
and 18 g (SD, 20) in the Netherlands. In Finland, 77% of the fish consumed was 
lean and 23% was fatty. In Italy, 86% was lean and 14% was fatty; in the 
Netherlands, 80% was lean and 11% was fatty. Less than 1% of the fish 
consumed in Finland and Italy was canned compared with 9% in the 
Netherlands. We found that total fish consumption was positively associated with 
cigarette smoking and with serum cholesterol levels in Finland and inversely 
associated with age in Italy (table 1). No significant association between total 
fish consumption and major risk factors was observed for the Netherlands. 
Total fish consumption was positively associated with vegetable and fruit 
consumption in Finland and the Netherlands (table 2). In contrast, fish 
consumption was inversely associated with fruit consumption in Italy. Alcohol 
intake was positively associated with fish consumption, especially in Italy. Meat 
intake and butter intake were positively associated with fish consumption in 
Finland, whereas these associations were inverse in Italy. Total fish consumption 
was positively associated with energy intake in all three countries, with 
monounsaturated fatty acid intake in Italy, and with polyunsaturated fatty acid 
intake in the Netherlands. An inverse association was observed for saturated 
fatty acid intake in Italy and the Netherlands. For lean and fatty fish 
consumption, similar associations for dietary variables were observed (data not 
shown). 
During 20 years of follow-up, 242 (22.2%) men died of CHD in Finland, 116 
(10.6%) in Italy and 105 (19.0%) in the Netherlands. In Finland, for men with 
the highest compared with the lowest levels of fish consumption, the crude 
Fish consumption and coronary heart disease mortality 
Table 1. Baseline level of major risk factors for coronary heart disease, according to 
categories offish consumption, for men aged 50-69 years in Finland, Italy and the 
Netherlands, 1970-1990. 
Country and 
fish consumption 
(g/day) 
Finland 
0-19 
20-39 
>40 
Italy 
0 
1-19 
20-39 
>40 
The Netherlands 
0 
1-19 
>20 
No. of 
men 
476 
263 
349 
264 
347 
323 
163 
157 
169 
227 
Age 
(years) 
58.2 (5.7) 
57.4 (5.4) 
57.7 (5.4) 
59.1 (5.1) 
58.5 (4.7) 
57.6 (4.8) 
57.7 (5.2)t 
58.3 (5.4) 
58.6(5.3) 
58.2(5.3) 
Body mass 
index 
(kg/m2) 
24.5 (3.6) 
24.6 (3.5) 
24.9 (4.1) 
25.9 (3.7) 
25.4 (3.9) 
26.0 (4.0) 
26.1 (4.3) 
25.4 (2.9) 
24.9 (2.3) 
25.1 (2.8) 
Risk factor* 
Systolic blood 
pressure 
(mmHg) 
145 (23) 
146 (21) 
148 (23) 
153 (21) 
154 (22) 
153 (23) 
151 (22) 
145 (21) 
145 (19) 
149 (22) 
Serum 
total cholesterol 
(mmol/liter) 
6.77 (1.20) 
6.96 (1.33) 
7.18 (1.40)t 
5.64(1.22) 
5.67 (1.24) 
5.75 (1.13) 
5.66 (1.13) 
6.23 (1.15) 
6.06 (1.02) 
6.18 (1.08) 
Cigarette 
smoking 
(%) 
43.9 
51.7 
56.2t 
51.5 
53.6 
48.0 
50.9 
55.8 
54.4 
50.2 
*Values in the first four columns are expressed as mean (standard deviation), 
tstatistically significant different (p<0.05) between fish consumption categories (analysis of 
variance for normally distributed variables, chi-square for dichotomous variables). 
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relative risk for CHD mortality was 1.39 (95% confidence interval (CI) 1.00-
1.92) (table 3). Adjustment for age, energy intake, body mass index, and 
cigarette smoking, and further adjustment for dietary variables, attenuated this 
relative risk to 1.25 (95% CI 0.89-1.76). In Italy, men who consumed >40 g/day 
fish had a relative risk for CHD mortality of 0.67 (95% CI 0.33-1.39) compared 
with men who consumed no fish, after adjustment for potential confounders. In 
the Netherlands, no association -neither crude nor after adjustment for potential 
confounders- between total fish consumption and CHD mortality was observed. 
The overall estimated relative risks for total fish consumption compared with no 
fish consumption in the three countries, pooled after stratification by cohort, 
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-Fish consumption and coronary heart disease mortality 
Table 3. Relative risks (95% confidence intervals) for 20-year CHD* mortality according 
to categories of f ish consumption, for men aged 50-69 years in Finland, Italy and the 
Netherlands, 1970-1990. 
, Relative risk (95% confidence interval) 
Country and No. of CHD Mortality Crude Adjusted * Adjusted § 
fish consumption men deaths ratet 
(g/day) (%) 
Finland 
0-19 476 100 (21.0) 13.9 1.00 1.00 1.00 
20-39 263 52(19 .8 ) 13.1 0 .95(0 .67-1 .34)0 .98(0 .69-1 .40)0 .97(0 .68-1 .38) 
>40 349 90 (25.8) 18.5 1.39 (1.00-1.92) 1.31 (0.94-1.84) 1.25 (0.89-1.76) 
PfortrendU 0.05 0.12 0.20 
Italy 
0 264 32 (12.1) 8.2 1.00 1.00 1.00 
1-19 347 37 (10 .7 ) 7.1 0 .87(0 .52-1 .46)0 .93(0 .55-1 .57)0 .94(0 .55-1 .59) 
20-39 323 34 (10.5) 6.7 0.81 (0.47-1.38) 0.99 (0.57-1.72) 0.93 (0.53-1.63) 
>40 163 13 (8.0) 5.0 0.56 (0.27-1.13) 0.69 (0.34-1.42) 0.67 (0.33-1.39) 
PfortrendU 0.11 0.38 0.33 
The Netherlands 
0 157 29 (18.5) 11.7 1.00 1.00 1.00 
1-19 169 30(17 .8 ) 11.6 1 .00(0 .60-1 .66)1 .01(0 .60-1 .69)1 .00(0 .59-1 .68) 
>20 227 46 (20 .3 ) 13.1 1 .13(0 .71-1 .80)1 .16(0 .72-1 .86)1 .10(0 .68-1 .79) 
PfortrendU 0.60 0.55 0.69 
* CHD, coronary heart disease. 
t Per 1,000 person-years. 
* Adjusted for age, body mass index (kg/m2), cigarette smoking and energy intake. 
§ Adjusted for age, body mass index (kg/m2), cigarette smoking, intake of energy, vegetables, fruit, 
alcohol, meat, butter and margarine. 
H Values for linear trend across categories of total fish consumption. 
were 0.93 (95% CI 0.68-1.27) for 1-19 g/day, 0.95 (95% CI 0.69-1.31) for 20-
39 g/day and 1.08 (95% CI 0.76-1.53) for>40 g/day. 
Lean fish was consumed by 96% of the men in Finland, 7 1 % in Italy and 6 1 % in 
the Netherlands; the proportions of fatty fish consumers were 36%, 16%, and 
63 
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18%, respectively. The average fatty fish consumption for those who consumed 
fatty fish was 25 (SD, 28) g/day in Finland, 17 (SD, 16) g/day in Italy and 11 
(SD, 9) g/day in the Netherlands. Crude inverse associations were observed 
between fatty fish consumption and CHD mortality for all three countries; 
adjustment for potential confounders, including age, body mass index, cigarette 
smoking, energy intake and relevant dietary variables, did not substantially 
change the relative risks. In Italy, fatty fish consumption was most strongly 
associated with a reduced risk for CHD (adjusted relative risk=0.40, 95% CI 
0.19-0.84) (table 4). For fatty fish consumers in Finland and the Netherlands, 
the adjusted relative risks were 0.80 (95% CI 0.51-1.26) and 0.70 (95% CI 
0.38-1.27), respectively, compared with non-fatty-fish consumers. For the three 
countries, the overall estimated relative risks for fatty fish consumption, pooled 
after stratification by cohort, were 0.57 (95% CI 0.40-0.80) for 1-19 g/day, and 
0.87 (95% CI 0.59-1.27) for >20 g/day compared with no fatty fish 
consumption. The pooled estimated relative risk for fatty fish consumers in the 
three countries was 0.66 (95% CI 0.49-0.90). Lean fish intake was not 
associated with CHD risk in any of the three countries; neither the relative risks, 
nor the tests for linear trend were statistically significant (table 4). 
DISCUSSION 
This prospective study in three European countries showed an inverse 
association of fatty fish consumption, but not of lean or total fish consumption, 
with 20-year CHD mortality. The pooled results for fatty fish were consistent with 
a 34% (95% CI 10-51%) reduction in CHD mortality. 
Our results suggest that n-3 fatty acids are responsible for the protective effect 
of fish. Consumption of 15 g/day of lean fish (e.g., plaice or codfish), as 
consumed by our populations, results in a daily intake of about 50 mg of n-3 
fatty acids; in contrast, 15 g/day of fatty fish (e.g., mackerel or herring) 
provides about 400 mg of n-3 fatty acids a day.23 In this study, the direct 
relation between n-3 fatty acids and CHD mortality was not analyzed because of 
rather limited information about the type of fish consumed by our cohorts, which 
could have introduced misclassification regarding intake of this nutrient. 
Several earlier studies showed an inverse relation between n-3 fatty acids from 
seafood and (sudden) cardiac mortality.5'16,24 However, some prospective studies 
observed a stronger beneficial effect of fish consumption than of intake of n-3 
Fish consumption and coronary heart disease mortality 
Table 4. Adjusted* relative risks (95% confidence intervals) 
for 20-year CHDt mortali ty, according to categories of lean 
and fatty fish consumption, for men aged 50-69 years in 
Finland, Italy and the Netherlands, 1970-1990. 
Country and fish 
consumption 
(g/day) 
Finland 
Fatty fish 
0 
>0 
Lean fish 
0-19 
>20 
>40 
p for trend* 
Italy 
Fatty fish 
0 
>0 
Lean fish 
0 
< 20 
>20 
>40 
p for trend* 
The Netherlands 
Fatty fish 
0 
>0 
Lean fish 
0 
< 20 
>20 
p for trend* 
No. of 
men 
697 
391 
568 
253 
267 
923 
174 
318 
365 
281 
133 
451 
102 
216 
146 
191 
No. of 
CHD 
deaths 
155 
87 
124 
51 
67 
106 
10 
34 
41 
30 
11 
92 
13 
38 
24 
43 
Adjusted 
relative risk 
1.00 
0.80 (0.51-1.26) 
1.00 
0.95 (0.68-1.33) 
1.08 (0.78-1.50) 
0.63 
1.00 
0.40 (0.19-0.84) 
1.00 
1.09 (0.66-1.81) 
0.97 (0.55-1.69) 
0.80 (0.38-1.66) 
0.57 
1.00 
0.70 (0.38-1.27) 
1.00 
0.93 (0.55-1.55) 
1.29 (0.82-2.03) 
0.27 
* Adjusted for age, body mass index (kg/m2), cigarette smoking, 
intake of energy, vegetables, fruit, alcohol, meat, butter and 
margarine, with fatty and lean fish consumption as dummy-variables 
in one model. 
t CHD, coronary heart disease. 
* Values for linear trend across categories of lean fish consumption 
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fatty acids.8,24 This observation may be partly explained by a random 
misclassification of dietary exposure due to error in the quantification of n-3 fatty 
acids in food tables, which tends to attenuate existing associations. Another 
inconsistency in previous results concerned the dose-response relation between 
fish consumption and CHD mortality. Our results suggest that differences in lean 
and fatty fish consumption could also explain this inconsistency, since the n-3 
fatty acid content of lean and fatty fish is dissimilar. 
A variety of actions could explain the beneficial effects of n-3 fatty acids on CHD 
mortality. Experimentally, n-3 fatty acids in the form of fish oil supplements 
lower triglyceride and very low density lipoprotein levels in animals and 
humans25 and inhibit platelet aggregation as a result of reduced synthesis of 
thromboxane A2.26 N-3 fatty acids also influence antiarrhythmic pathways 
because they have been shown in in vitro studies to synchronize the beating rate 
of the heart,27 and they have been shown to reduce the incidence of ventricular 
fibrillation in rats28 as well as in patients with frequent ventricular arrhythmias.29 
The physiologic effects of consuming small amounts of fish have been 
investigated in observational studies. Men from Zutphen who habitually 
55 consumed about 30 g/day of fish for 26 years had lower serum triglyceride levels 
—— and lower triglyceride concentrations in the intermediate density lipoprotein 
fraction than the control group.30 In this study, however, small amounts of fish 
were not associated with platelet function.31 On the other hand, in the ARIC-
Study, one serving of fish per day was inversely associated with hemostatic 
factors such as fibrinogen and factor VII.32 Furthermore, consumption of one fish 
meal per week versus no fish was associated with an increase in heart rate 
variability as large as that observed for fish oil supplementation.33,34 Arterial 
compliance was better in healthy subjects and diabetic patients who consumed 
one serving of fish per week than in those who consumed no fish.35 Finally, fish 
consumption at least two times per week was inversely associated with small 
myocardial lesions.35 Thus, our results are consistent with experimental and 
observational evidence on the beneficial physiologic effects of a small quantity 
of n-3 fatty acids. 
A recent epidemiological study suggests that fish consumption may have an 
especially beneficial effect on sudden cardiac death.24 In the present study, 
sudden cardiac death was included in the outcome variable coronary heart 
disease mortality; however, because the number of sudden cardiac death was 
small, it was not possible to separate them from nonsudden cardiac deaths. 
Fish consumption and coronary heart disease mortality 
In our analyses of the Zutphen cohort from the Netherlands, a small decrease in 
CHD mortality was observed for fatty fish but not for lean or total fish 
consumers. Previous results from this cohort showed that consumption of (total) 
fish once or twice a week in 1960 was associated with a 50% reduction in CHD 
mortality during 20 years of follow-up.2 One explanation could be that the 
coronary events that occurred during the first years of follow-up, when men 
were younger, were more severe and were strongly associated with fish 
consumption.24 
For Finnish men, we observed a small increase in CHD mortality for those who 
consumed >40 g/day of fish (mostly lean fish) and a small decrease for those 
who consumed fatty fish. A possible harmful effect of fish consumption was 
observed in two other studies from Finland.10,11 Several methodological issues 
may account for the difference in the effect of (type of) fish consumption 
observed in Finland compared with Italy and the Netherlands. First, the mercury 
content of fish may explain the more harmful effect of fish in Finland. In the 
eastern Finnish study, lean fish but not fatty fish was associated with mercury 
intake and with an excess CHD risk.10 In general, the mercury content in fish 
depends on its size, its age and the concentration of mercury in the area.37,38 
Thus, besides the difference in the n-3 fatty acid content of lean fish and fatty 67 
fish, in Finland the mercury content of the type of fish consumed may also differ. 
Second, the high level of fish consumption observed in all Finnish studies, 
including our cohorts, may limit the possibility of studying the effect of 
consuming small amounts of fish (especially of total and lean fish). This issue 
does not apply to the strength of this association between fatty fish intake and 
CHD risk, since the majority of the Finnish men in our study consumed no fatty 
fish. Third, we cannot exclude the possibility that the associations between 
consumption of lean and fatty fish and CHD risk observed in the Finnish cohorts 
were partly affected by random misclassification due to rather limited 
information about the type of fish consumed by each man in our Finnish 
population. 
Although an inverse association was observed between fatty fish consumption 
and CHD mortality in the three countries, no linear trend was found in the pooled 
analyses of fatty fish consumption. However, the quantity of fatty fish 
consumption in the three countries overlapped only to a small extent, and the 
highest consumption was in Finland. Therefore, by categorizing the fatty fish 
consumption in the pooled analysis, the difference in the effect of fatty fish 
consumption between the countries was examined rather than a dose-response 
Chapter 4 
relation of fatty fish consumption. In addition, the effects of total and lean fish 
consumption in Finland, Italy and the Netherlands were rather heterogeneous. In 
general, this finding might partly be explained by cultural influences, since fish 
consumption itself, as well as its association with dietary and lifestyle factors, 
varied among the three countries. 
Our results could have been influenced by residual confounding. Inadequate 
measurement of dietary habitual intake seems unlikely, since the cross-check 
dietary history method used in all three countries is acknowledged to be valid in 
an epidemiological setting.38,39 Additionally, the results could have been biased 
because of a healthier lifestyle practiced by (fatty) fish consumers. In our data, 
consumption of fish was associated with a lower intake of saturated fatty acids in 
the Netherlands and Italy, probably because fish-substitute foods, for example, 
meat, contain a relatively high level of saturated fatty acids. Furthermore, in all 
three countries, consumption of vegetables and fruit was positively associated 
with the amount of fish consumed. In the present study, no reliable measure for 
physical activity was available. Alternatively, an approximation of physical 
activity was calculated (energy intake per kg body weight); in all three countries, 
this variable was positively associated with fish consumption (data not shown). 
68 Because these associations were observed for fatty fish as well as for lean fish 
consumers, and no protective effect of lean fish consumption was observed, the 
more healthy lifestyle of fish consumers may not have biased the specific effect 
of fatty fish consumption. Also, when we adjusted our analysis for dietary 
variables such as intake of vegetables, fruit, and saturated fatty acids or included 
the proxy of physical activity instead of energy intake, the estimated relative 
risks did not change appreciably. 
In conclusion, our data suggest that especially fatty fish is protective against 
CHD mortality. Independent of lean fish consumption and potential confounders, 
we found that consumption of fatty fish was associated with a reduction of 34% 
(95% CI 10-51%) in the CHD mortality in three different European countries. 
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intake is not beneficially 
associated with 10-year risk 
of coronary heart disease, 
The Zutphen Elderly Study 
Claudia M Oomen, Marga C ucke, Edith JM Feskens, Frans J Kok, Daan 
Krnmhniit Am I ftlin Nntr raniUintRfll 
Evidence on the relation between a-linolenic acid intake and coronary heart disea; 
(CHD) is limited. Other dietary components appear to modify the reported relations. V\ 
examined whether dietary a-linolenic acid was inversely associated with the risk of CHI 
We prospectively studied 667 men of the Zutphen Elderly Study aged 64-84 years o 
and free of CHD at baseline. Dietary intake was assessed by the use of the cross-chei 
dietary history method, and detailed data on different fatty acids in foods. During 1 
years of follow-up, we documented 98 cases of CHD. After adjustment for age, standa 
coronary risk factors, and intake of trans fatty acids and other nutrients, a-linolenic ac 
intake was not statistically significantly associated with CHD risk. The relative risk (Rl 
of CHD for the highest compared with the lowest tertile of a-linolenic acid intake w< 
1.68 (95% CI: 0.86, 3.29). a-Linolenic acid intake from sources with trans fatty aci< 
was also non-significantly positively associated with CHD risk. a-Linolenic acid intal 
from foods without trans fatty acids was not associated with the CHD risk, the RR of CH 
for the highest compared with the lowest tertile was 1.15 (95% CI: 0.63, 2.11). : 
conclusion, we did not observe a beneficial effect of dietary a-linolenic acid intake on tr 
risk of 10-year CHD. The association between intake of a-linolenic acid and trans fat 
acids complicated studying this hypothesis. Given the results of current prospectiv 
studies, a protective cardiac effect of a-linolenic acid is questionable. 
INTRODUCTION 
Diets enriched with a-linolenic acid (C18:3 n-3) have been reported to increas 
the blood concentrations of a-linolenic acid as well as n-3 long-cha 
polyunsaturated fatty acids, especially eicosapentaenoic acid (EPA), in humans. 
8
 N-3 long-chain polyunsaturated fatty acids were considered to have a variety i 
favorable physiological cardiac effects.9 Although the efficiency of conversion < 
a-linolenic acid to EPA is relatively low,1,2,10,11 dietary intervention trials reports 
beneficial effects of a-linolenic acid intake on eicosanoid metabolism and plateli 
aggregation2"4,12 or on arterial compliance.7 In contrast, no consensus exists c 
the effect of a-linolenic acid on serum lipid concentrations12"14 and bloc 
pressure.3'7,8'12,13 
Case-control studies on the association between markers for a-linolenic ac 
intake and risk of myocardial infarction,15"17 angina pectoris,18 or sudden cardie 
death19 yield conflicting results. Also, platelet or plasma a-linolenic acid content 
a-Linolenic acid intake and coronary heart disease 
of nested-case control studies were inconsistently associated with the risk of 
coronary heart disease (CHD).20"22 
Until now, only a few prospective studies focused on the association between the 
intake of a-linolenic acid and CHD. In two dietary intervention trials, a 
remarkable reduction in the risk of cardiac events was achieved in survivors of 
myocardial infarction who took an oc-linolenic-acid-enriched Mediterranean-type 
diet,23 or mustard oil (containing a-linolenic acid).24 Previously reported cohort 
studies have suggested that a higher intake of a-linolenic acid may reduce the 
CHD risk.25"28 However, in most population based studies, other dietary factors 
such as total or trans fat were (potentially) associated with a-linolenic acid and 
(could) have influenced the results.17'23'25"28 
Accordingly, insight is needed into the association between the a-linolenic acid 
intake and the CHD risk in different populations with characteristic dietary habits. 
We previously reported the intake and sources of a-linolenic acid for men 
participating in the Zutphen Elderly Study.29 We have now examined the relation 
between a-linolenic acid intake and CHD incidence, carefully taking into account 
the intake of several other fatty acids. 
SUBJECTS A N D METHODS 
Study popula t ion 
The study population consisted of men who participated in the Zutphen Elderly 
Study, an extension of the Zutphen Study. In 1960, the Zutphen Study started 
with a cohort of 878 men from the town of Zutphen (the Netherlands) born 
between 1900 and 1919, as the Dutch contribution to the Seven Countries 
Study.30 In 1985, 367 of the 555 participants who were still alive were re-
examined. In addition, 711 other men from Zutphen in the same age category 
were asked to participate. A total of 939 men (response rate 74%) was 
examined in 1985,31 and complete information on diet and risk factors was 
available for 824 men. Men with previously diagnosed CHD were excluded from 
the present analyses (n=157), leaving 667 men at baseline in 1985. 
Data col lect ion 
Dietary and medical examinations were completed between March and June in 
1985. Information about the habitual food consumption was collected using the 
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cross-check dietary history method, adapted to the Dutch situation.32 Each 
participant, and if possible also his wife, was interviewed about his average food 
consumption pattern in the month before the interview. A checklist of foods and 
quantities of food bought per week were used to calculate and verify the 
participant's food consumption pattern. Nutrient intake data were calculated 
using the corresponding Dutch food table,33 that was partly updated34 and 
completed with data of a-linolenic acid,29 trans fatty acids,35 linoleic acid, EPA, 
docosahexaenoic acid (DHA),36 p-carotene and vitamin E.37 
During medical examinations non-fasting venous blood samples were taken. 
Serum total cholesterol and high-density lipoprotein (HDL) cholesterol were 
determined enzymatically.38,39 Weight and height were measured in light clothing 
without shoes, and body mass index (BMI) was calculated (weight/height2). 
Information on cigarette smoking (never, former, current) was obtained by a 
standardized questionnaire. The total minutes of physical activity per week were 
calculated using information from a self-administered questionnaire designed for 
retired men.40 
Fol low-up 
Incident cases included fatal CHD plus non-fatal myocardial infarction (whatever 
occurred first) occurring between the baseline assessment in 1985 and January 
1995. Information on vital status of the participants was obtained from the 
municipal registries. Three participants were lost to follow-up. Information on 
cause of death was obtained between 1985 and June 1990 from Statistics 
Netherlands. For deaths occurring thereafter, or if not available from Statistics 
Netherlands, information was obtained from hospital discharge data and/or 
general practitioners. Causes of death were coded following the ninth revision of 
the International Classification of Diseases. CHD refers to codes 410-414. 
Because the underlying cause of death in the elderly is often difficult to establish, 
both CHD as a primary (n=46) as well as a secondary (n=3) cause of death were 
considered in the analyses. 
Data on the prevalence of CHD was obtained by the Dutch translation of the 
Rose questionnaire,41 and after 1990 by a standardized medical questionnaire. In 
case of non-response, information of major chronic diseases was obtained from 
a short questionnaire filled out by the subjects themselves or their closest 
relative or caretaker. Diagnosis of each disease was confirmed with hospital 
discharge data. Also, for men who died, information on disease history was 
ot-Linolenic acid intake and coronary heart disease 
obtained from the general practitioner. Coronary heart disease at baseline in 
1985 was considered to be present when either myocardial infarction or angina 
pectoris was diagnosed. For myocardial infarction (between baseline and January 
1995) the final diagnosis required at least two of the following criteria: a specific 
medical history, characteristic electrocardiographic changes or specific enzyme 
elevations. During 10 years of follow-up, we documented 98 CHD cases in the 
men without a previously diagnosed CHD (14.7% of the baseline population), of 
which 49 were fatal. 
Stat is t ical methods 
Men were divided into tertiles based on the contribution of a-linolenic acid to 
energy intake at baseline. To test for differences in baseline major risk and 
dietary factors across categories of a-linolenic acid intake, we used analysis of 
variance for normally distributed variables, the Kruskal-Wallis test for skewed 
distributed variables, and the chi-square test for categorical variables. Spearman 
correlation coefficients (rs) were calculated between a-linolenic acid and other 
dietary fatty acids. Cox's proportional-hazard analysis was performed to 
calculate relative risks (RRs), with the lowest a-linolenic acid tertile as the 
reference group, or using a-linolenic acid intake as continuous variable. ~^7 
Additional analyses were conducted to examine associations with CHD incidence 
for intake of a-linolenic acid from sources with and without trans fatty acids 
separately, and for consumption of oil and salad dressing plus mayonnaise (a-
linolenic-rich foods). Adjustments were made for age, energy intake, BMI, 
smoking, alcohol consumption, use of vitamin supplements, and dietary factors 
(in the analyses on a-linolenic acid) or food groups (in the food analyses) 
potentially associated with CHD. Other risk factors were not included into the 
model because they were viewed as intermediate variable (as cholesterol or 
blood pressure) or were not associated with a-linolenic acid intake (physical 
activity, history of diabetes mellitus and history of hypertension). All statistical 
analyses were carried out using SAS (version 6.12) statistical analysis computer 
package. 
RESULTS 
The mean (+ SD) daily intake of a-linolenic acid was 1.32 + 0.47 g, which 
contributes 0.53 ± 0.15 % to total energy intake. The main sources of a-linolenic 
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Table 1. Characteristics (mean value and standard deviation) at baseline by 
tertiles of cc-linolenic acid intake in energy percent. The Zutphen Elderly Study. 
Range (% of energy) 
N 
Age (yr) 
Body mass index (kg/m2) 
Physical activity (min/week) 
Systolic blood pressure (mm Hg) 
Serum total cholesterol (mmol/L) 
Serum HDL cholesterol (mmol/L) 
Smoking 
current (%) 
past (%) 
Use of vitamin supplements (%) 
Daily intake of 
Energy (MJ) 
Total fat (% of energy) 
Saturated fat (% of energy) 
Trans fatty acids (% of energy) 
Cis unsaturated fat (% of energy) 
Linoleic acid (% of energy) 
EPA + DHA (% of energy) 
Cholesterol (mg) 
Carbohydrates (% of energy) 
Protein (% of energy) 
Alcohol - g 
non-drinkers (%) 
>20 g/d (%) 
Fiber (g) 
Vitamin E (mg) 
Vitamin C (mg) 
p-carotene (mg) 
Total group 
667 
71.1(5.2) 
25.5(3.2) 
611(533) 
151(21) 
6.08(1.11) 
1.14(0.30) 
32.4 
48.7 
15.9 
9.2(2.0) 
40.3(6.4) 
18.0(3.6) 
4.3(2.2) 
18.0(3.9) 
5.0(2.4) 
0.08(0.14) 
273(97.0) 
41.0(7.3) 
14.3(2.6) 
13.8(17.3) 
23.5 
26.7 
24.9(7.1) 
8.5(2.6) 
90.3(39.5) 
1.4(0.6) 
a-linolenic acid fertile 
<0.45 
222 
71.3 
25.3 
581 
154 
6.05 
1.15 
26.6 
55.4 
22.3 
9.1 
37.2 
17.3 
2.8 
17.1 
5.1 
0.05 
253 
42.5 
14.3 
18.3 
20.3 
34.7 
23.8 
8.0 
92.9 
1.3 
0.45-0.58 
223 
71.4 
25.3 
633 
149 
6.00 
1.12 
34.1 
42.6 
12.6 
9.4 
40.9 
18.8 
4.4 
17.7 
4.6 
0.09 
289 
41.0 
14.2 
12.5 
23.8 
24.2 
25.7 
8.7 
89.7 
1.4 
>0.58 
222 
70.8 
25.8 
620 
150 
6.19 
1.14 
36.5 
48.2 
13.1 
9.1 
42.9 
17.9 
5.8 
19.2 
5.4 
0.09 
274 
39.4 
14.3 
10.7 
26.6 
21.2 
25.1 
8.9 
88.2 
1.4 
P 
values1 
0.48 
0.13 
0.85 
0.02 
0.18 
0.58 
0.07 
0.03 
0.007 
0.24 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
0.22 
0.0004 
0.0001 
0.92 
0.001 
0.29 
0.003 
0.01 
0.0001 
0.54 
0.02 
EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid 
^-value for any difference between a-linolenic acid categories (analysis of variance for normally 
distributed variables, Kruskal-Wallis test for skewed variables, chi-square test for dichotomous 
variables). 
rx-Linolenic acid intake and coronary heart disease 
Table 2. Relative risks and 95% CIs of fatal plus non-fatal coronary heart disease 
and fatal coronary heart disease according to tertiles of a-linolenic acid intake. 
Range (% of energy) 
Median intake (% of energy) 
1 
<0.45 
0.40 
Tertile 
2 
0.45-0.58 
0.51 
3 
>0.58 
0.67 
P 
trend 
Fatal plus non-fatal coronary heart disease 
No. (%) of cases 21 (9.5%) 34 (15.3%) 43 (19.4%) 
Relative risks 
Crude 1 1.68 (0.97-2.89) 2.24 (1.33-3.77) 0.003 
Age + energy adjusted 1 1.69(0.98-2.92) 2.23(1.32-3.76) 0.003 
Fully adjusted1 1 1.49(0.82-2.70) 1.68(0.86-3.29) 0.17 
Fatal coronary heart disease 
No. (%) of cases 12 (5.4%) 
Relative risks 
Crude 1 
Age + energy adjusted 1 
Fully adjusted1 1 
15 (6.7%) 22 (9.9%) 
1.27 (0.59-2.71) 1.97 (0.97-3.98) 0.05 
1.26 (0.59-2.69) 1.95 (0.96-3.94) 0.05 
0.99 (0.43-2.28) 1.59 (0.62-4.08) 0.26 
1
 95% CI in parentheses. Models included the following variables: age, intake of energy, 
BMI, ex-smoking (yes/no), current smoking (yes/no), alcohol intake, use of vitamin 
supplements (yes, no), intake of saturated fatty acids, trans fatty acids, linoleic acid, 
eicosapentaenoic+ docosahexaenoic acid, other cis unsaturated fatty acids, protein (all in 
energypercentages) intake of dietary cholesterol, fiber, vitamin E, vitamin C and p-
carotene. Alcohol intake (0, 1-19, >20 g/d) was used as a categorical variable (included as 
two dummies into the model, with the non-drinkers as a reference). 
79 
acid in the diet of these elderly men were margarines, meat, bread and 
vegetables, contributing together over 50% of the total intake of a-linolenic acid. 
The daily intake of a-linolenic acid at baseline expressed as a percentage of total 
energy was positively associated with cigarette smoking, and the daily intake of 
total, saturated and unsaturated fat, cholesterol, fiber, vitamin E and p-carotene 
and inversely with systolic blood pressure, the use of vitamin supplements, the 
daily intake of carbohydrates and alcohol (table 1). Concerning the correlation 
with other fatty acids, a-linolenic acid intake strongly correlated with intakes of 
total fat (rs =0.40), trans fatty acid (rs =0.61) and cis monounsaturated fatty 
acids (rs =0.44), and weakly with linoleic acid (rs =0.19) and saturated fat 
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(rs=0.08). The correlation coefficient between the intake of a-linolenic acid and 
that of n-3 fatty acids from fish was not statistically significant (rs =0.03). 
The crude relative risk of 10-year fatal plus non-fatal CHD was 2.24 (95% CI 
1.33-3.77) for the highest compared with the lowest tertile of a-linolenic acid 
intake (table 2). After adjustment for age, BMI, smoking, use of vitamin 
supplements and dietary vitamin intake, intake of energy, alcohol, dietary 
cholesterol, fiber and specific fatty acids including trans fatty acids, the 
association betweena-linolenic acid intake and CHD was reduced, and no longer 
statistically significant. The adjusted relative risk of incident CHD for the highest 
compared with the lowest tertile of a-linolenic acid intake was 1.68 (95% CI 
0.86-3.29, p-trend=0.17) (table 2). In addition, the adjusted relative risk of CHD 
for a 0.5 energy percent increase in intake of a-linolenic acid was 1.58 (95% CI 
0.67-3.74). The association was similar for fatal CHD. The adjusted relative risk 
of fatal CHD for the highest compared to the lowest tertile of a-linolenic acid 
intake was 1.59 (95% CI 0.62-4.08, p-trend=0.26) (table 2). In addition, for an 
increase of 0.5% of energy, the adjusted relative risk of fatal CHD was 1.40 
(95% CI 0.36-5.41). 
go In the present study, the largest contribution to the intake of a-linolenic acid is 
—-~ provided by foods containing also trans fatty acids, e.g. margarines and meat, 
that may be connected to the increased risk. We therefore examined a-linolenic-
acid-sources with trans fatty acids (e.g. margarines, cooking fat, butter, cookies, 
pastries, meat, dairy products and bread) and without trans fatty acids (e.g. 
cereals, legumes, vegetables and fruit) separately in relation to CHD risk. There 
was a significant positive association between a-linolenic acid intake from 
sources with trans fatty acids and CHD risk, which became non-significant after 
additional adjustment for trans fatty acid intake (table 3). In contrast, the intake 
of a-linolenic acid from foods without trans fatty acids was not associated with 
the CHD risk. 
The main sources of a-linolenic acid in the present study differed from those in 
other studies, i.e. vegetable oils,42,43 or salad dressing and mayonnaise.28 We 
also examined the relations of oil consumption and consumption of creamy salad 
dressing plus mayonnaise, with the CHD risk. The most important oils consumed 
by this elderly population were sunflower oil (n=50; 4 1 % of the total oil 
consumption), soybean oil (n=46; 33% of the total oil consumption), olive oil 
(8%) and safflower oil (8%). The men consuming oils were younger, consumed 
more alcohol and vegetables, and had a lower trans fatty acids intake. 
a-Linolenic acid intake and coronary heart disease 
Table 3. Relative risks and 95%CIs of fatal plus non-fatal coronary heart disease 
according to tertiles of a-linolenic acid intake from sources with and without trans 
fatty acids. 
Tertile p 
3 trend 
a-Linolenic acid from sources with trans fatty acids 
Range (% of energy) <0.40 0.40-0.52 >0.52 
Median intake (% of energy) 0.35 0.46 0.61 
No. (%) of cases 21(9.5%) 35(15.7%) 42(18.9%) 
Relative risks 
Crude 1 1.71 (0.99-2.94) 2.18 (1.29-3.68) 0.004 
Age + energy adjusted 1 1.71(1.00-2.95) 2.20(1.30-3.71)0.004 
Adjusted1 1 1.56 (0.88-2.77) 1.90 (1.06-3.40) 0.04 
Fully adjusted2 1 1.42(0.78-2.57) 1.51(0.75-3.04)0.31 
a-Linolenic acid from sources without trans fatty acids 
Range (% of energy) 
Median intake (% of energy) 
No. (%) of cases 
Relative risks 
Crude 
Age + energy adjusted 
Adjusted1 
Fully adjusted2 
<0.04 
0.03 
32 (14.4%) 
1 
1 
1 
1 
0.04-0.06 
0.05 
31 (13.9%) 
0.93 (0.57-1.52) 
0.90 (0.55-1.48) 
1.06 (0.62-1.81) 
1.06 (0.62-1.81) 
>0.06 
0.07 
35 (15.8%) 
1.08 (0.67-1.75) 
0.97 (0.58-1.63) 
1.17 (0.63-2.15) 
1.15 (0.63-2.11) 
0.77 
0.90 
0.63 
0.67 
1
 95% CI in parentheses. Models included the following variables: age, intake of energy, 
BMI, ex-smoking (yes/no), current smoking (yes/no), alcohol intake, use of vitamin 
supplements (yes, no), intake of saturated fatty acids, linoleic acid, eicosapentaenoic+ 
docosahexaenoic acid, other cis unsaturated fatty acids, protein (all in 
energypercentages) intake of dietary cholesterol, fiber, vitamin E, vitamin C, p-carotene 
and intake of a-linolenic acid from sources with (in case of a-linolenic acid from sources 
without trans fatty acids) or without (in case of a-linolenic acid from sources with trans 
fatty acids) trans fatty acids. Alcohol intake (0, 1-19, >20 g/d) was used as a categorical 
variable (included as two dummies into the model, with the non-drinkers as a reference). 
2
 Additional adjustment for trans fatty acid intake. 
A crude significant inverse association was observed between oil consumption 
and CHD incidence (table 4). After adjustment for potential confounders, the 
relative risk for oil consumers compared with no oil consumers was 0.53 (95% 
CI 0.26-1.06). Additional adjustment for intake of a-linolenic acid, linoleic acid, 
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Table 4. Relative risks and 95% CIs of fatal plus non-
fatal coronary heart disease according to consumption 
of oil and salad dressing. 
Oil 
N 
Median intake (g/d) 
No. (%) of cases 
Relative risks 
Crude 
Fully adjusted1 
No 
552 
0 
89 (16.1%) 
1 
1 
Yes 
115 
2 
9 (7.8%) 
0.47 (0.23-0.92) 
0.53 (0.26-1.06) 
Mayonnaise and other creamy dressing 
N 442 225 
Median intake (g/d) 0 3 
No. (%) of cases 
Relative risks 
Crude 
Fully adjusted1 
63 (14.3%) 
1 
1 
35 (15.6%) 
1.00 (0.66-1.51) 
1.09 (0.71-1.66) 
1
 95% CI in parentheses. Models included the following 
variables: age, intake of energy, BMI, ex-smoking (yes/no), 
current smoking (yes/no), alcohol intake, use of vitamin 
supplements (yes/no), intake of vegetables, fruit, meat, fish, 
and fats for household use (e.g. margarine, butter, cooking 
fat, frying fat). Alcohol intake (0, 1-19, >20 g/d) was used as 
a categorical variable (included as two dummies into the 
model, with the non-drinkers as a reference). 
trans fatty acids or vitamin E did not appreciably change the results (data not 
shown). Furthermore, no association was observed between the intake of 
creamy salad dressing and mayonnaise and CHD (table 4). 
DISCUSSION 
In the present study, we observed a non-significant positive association between 
a-linolenic acid intake and CHD risk. This seems to be due to the strong 
association between intake of a-linolenic acid and trans fatty acids. It is likely 
o-Linolenic acid intake and coronary heart disease 
that also in other populations with comparable sources of a-linolenic acid as in 
the present study, intake of a-linolenic acid is (strongly) associated with intake 
of trans fatty acids. Moreover, in a Norwegian case-control study, contents of 
trans fatty acid and a-linolenic acid in adipose tissue were also intercorrelated 
and associated with increased risk.17 This emphasizes the importance to adjust 
for other dietary factors and the difficulty to pursue this hypothesis 
epidemiologically or to generalize the epidemiological findings to other 
populations. 
Imprecision in the estimate of a-linolenic acid could have obscured an 
association with CHD. Habitual food composition was measured by use of the 
cross-check dietary history method, that is acknowledged as a valid method in 
an epidemiological setting.32 The a-linolenic acid content of approximately 1000 
products that were consumed by the participants of the Zutphen Elderly Study 
was used to calculate the intake of a-linolenic acid.29 Random misclassification of 
dietary exposure, due to error in the quantification of food composition data 
including a-linolenic acid, cannot be excluded. However, values in the nutrient 
database were updated as much as possible, taking into account improvements 
in the quality of analytical methods and changes in food composition in time.34,44 
Intercorrelation between a-linolenic acid and other dietary factors, mainly trans 83 
fatty acids, complicated the estimation of the independent effect of a-linolenic 
acid. We confirmed the results of our analyses by relating the a-linolenic acid 
intake of foods with and without trans fatty acids to CHD risk. However, due to 
the strong association between intake of a-linolenic acid and trans fatty acids, 
residual confounding cannot be totally excluded. It might be that the effects of 
a-linolenic acid on CHD are especially present when larger amounts of a-linolenic 
acid from sources without trans fatty acids are consumed. 
A limitation of the present study was that it included only men aged 64-84 years 
at baseline. The etiology of CHD in elderly people may be altered, due to 
advanced coronary atherosclerosis. The beneficial effects of a-linolenic acid on 
platelet aggregation or arterial compliance might be larger in younger 
populations, however, there are no data available on the effect of age on the 
association between a-linolenic acid and CHD risk or risk factors. Our results 
were consistent using fatal CHD as well as including non-fatal myocardial 
infarction. Because of power, we mainly focused on the association of fatal plus 
non-fatal CHD. 
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A few prospective cohort studies have previously reported on the association 
between a-linolenic acid intake and CHD.2528 A strong inverse association was 
observed in the Nurses' Health Study.28 In the other cohort studies, however, 
the results were less clear.25"27 Firstly, the results of the other cohort studies 
were strongly affected by adjustment for other dietary factors. Adjustment for 
total fat in the Health Professional Study,26 or adjustment for trans-, cis-
monounsaturated and saturated fatty acids in the ATBC Prevention Study,27 
strengthened the associations. In the MRFIT Study, the association may have 
been confounded by other dietary factors, because such adjustments were not 
made.25 Secondly, there was no suggestion of a linear dose-response 
relationship for quintiles of intake of a-linolenic acid in data of the MRFIT and the 
Health Professional Study. In the MRFIT Study, the adjusted relative risks for the 
quintiles of a-linolenic acid intake were respectively 1, 0.98, 0.57, 0.98 and 
0.68.25 In the Health Professionals Study, the relative risk on fatal CHD was not 
reduced in the highest quintile, however, a reduced risk of fatal CHD was 
observed in the analyses using a-linolenic acid as a continuous variable.26 Thus, 
prospective studies provide not enough evidence to support the hypothesis that 
a higher intake of a-linolenic acid will reduce the risk of CHD. 
Our results for a-linolenic acid are not consistent with those observed in the 
Nurses' Health Study. The range in a-linolenic acid intake in our cohort is 
comparable with that in the Nurses' Health Study. However, in the Nurses' 
Health Study, approximately 70% of the a-linolenic acid intake was derived from 
vegetable or plant sources, of which salad dressings were the most important 
food group (30%).28 In the present study, a borderline-significant inverse 
association was observed between the intake of oils and CHD incidence. In 
addition, no association was observed between the intake of salad dressing and 
CHD. Neither a-linolenic acid, nor linoleic acid or vitamin E, also abundantly 
present with these oils, seems to be responsible for the protective effect of oil, 
because including these components into the model yield similar results. The 
results could have been biased, because oil consumption was limited in these 
Dutch Elderly men and may be a marker for healthier lifestyle. However, 
adjusting for potential confounders, or additionally adjusting for physical activity, 
history of hypertension or history of diabetes mellitus (data not shown) did not 
change the relative risks appreciably. Therefore, the potential protective effect of 
oil consumption, including the responsible components, deserves further 
research. 
a-Linolenic acid intake and coronary heart disease 
In a secondary prevention trial, recurrence of cardiac events was substantially 
lower among patients randomly assigned to a Mediterranean diet enriched with 
a-linolenic acid compared with those in the control group.23 However, other 
dietary changes occurred simultaneously in this trial. In another secondary 
prevention trial, cardiac events were significantly lower after 1 year treatment 
with mustard oil compared with the placebo group.24 However, the experimental 
and control group differed in other characteristics relevant to cardiovascular 
health (e.g. smoking habit), whereas these were not taken into account in the 
final risk estimates. Therefore, also based on these trials it cannot be concluded 
that the protective effect was solely due to a-linolenic acid. 
In conclusion, we observed no beneficial association between dietary a-linolenic 
acid intake and the risk of 10-year CHD in Dutch elderly men. The substantial 
differences between crude and adjusted relative risks of CHD for a-linolenic acid 
intake in prospective studies, together with the limited evidence on the 
mechanisms, indicates that the protective cardiac effect of a-linolenic acid is 
questionable. 
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B-vitamin intake may be associated with the risk of coronary heart disease (CHD 
through their role in homocysteine metabolism. However, data from prospective studie 
relating B-vitamin intake to CHD risk are limited. We investigated whether dietary folat* 
vitamins B2, B6 and B12 are associated with serum homocysteine concentrations an 
CHD risk in 815 men of the Zutphen Elderly Study aged 64-84 years. Information on die 
and risk factors including serum homocysteine was obtained at baseline. After 10 yeai 
of follow-up, 140 CHD cases had occurred. Only intake of folate and vitamin B6 wer 
independently inversely associated with homocysteine. After adjustment for age, intak 
of other B-vitamins and other potential confounders, the mean homocystein 
concentration for the men in the lowest tertile of folate was 15.3 nmol/L compared t 
13.9 (imol/L in the highest tertile of folate. The homocysteine concentration was 15. 
nmol/L in the lowest vitamin B6 tertile compared to 13.9 nmol/L i n the highest vitami 
B6 tertile. However, folate and vitamin B6 intake were not associated with CHD risk i 
these elderly men. Vitamin B2 was non-significantly inversely associated with CH 
(relative risk=0.61 for the highest compared to the lowest vitamin B2 tertile; p for tren 
0.08). Vitamin B12 was positively associated with CHD risk (p for trend=0.03). Th 
present study did provide evidence that dietary folate and vitamin B6 are related t 
serum homocysteine. B-vitamin intake was not protective for CHD, although there was 
suggestion of a protective effect of vitamin B2. 
INTRODUCTION 
An elevated blood concentration of total homocysteine (tHcy) is suggested to b 
an independent risk factor for cardiovascular diseases.1 Because the results froi 
prospective studies are weaker than those from case-control studies, an 
because there is lack of certainty about underlying mechanisms, causality in th 
association between tHcy and vascular diseases is still in dispute.2,3 B-vitamir 
(folate, vitamins B2, B6 and B12) are involved in the tHcy metabolism as cc 
enzymes and cofactors.4 Several dietary intervention trials have provide 
evidence for a tHcy lowering effect of supplemental B-vitamins, especially of fol 
acid.5 
Until now, a number of case-control studies6"12 and prospective studies13" 
relating blood levels of folate, vitamin B6 and vitamin B12 to the risk of coronal 
heart disease (CHD) were performed, showing inconsistent results. Howeve 
- - - _ B-vitamins, homocysteine and coronary heart disease 
circulating levels of B-vitamins are known to change within days, and may 
therefore not be satisfactory as a marker of long-term intake. 
As underlying diseases or short-term variations in nutrient intake may influence 
plasma vitamin levels, prospective studies on associations between dietary B-
vitamins intake and CHD are most informative. Until now, two prospective 
studies have investigated the association between dietary intake of B-vitamins 
and CHD. In the ARIC study, neither folate, vitamin B6 nor vitamin B12 was 
associated with CHD.16 In contrast, in the Nurses' Health Study an inverse 
association was noted between both folate and vitamin B6 intake and CHD risk.20 
In the Nurses' Health Study, however, due to the high intake of B-vitamins by 
supplements, the independent effect of folate and vitamin B6 could not be 
investigated. 
To provide additional prospective data on the association of B-vitamin intake 
with CHD, we analyzed data of the Zutphen Elderly Study. Among this cohort of 
elderly men, we previously reported that tHcy levels are positively associated 
with 10-year CHD mortality. The association between tHcy and CHD incidence 
was less consistent.21 The present study provides information on the association 
between dietary intake of folate, vitamins B2, B6, B12 and both CHD incidence 91 
and CHD mortality. Also the associations between B-vitamin intake and serum — 
tHcy levels are studied. 
METHODS 
Study popula t ion 
The Zutphen Elderly Study is a longitudinal investigation of chronic disease risk 
factors in elderly male inhabitants of Zutphen, a town in the eastern part of the 
Netherlands. It represents a continuation of the Zutphen Study, the Dutch 
contribution to the Seven Countries Study.22 In 1985, 367 of the 555 participants 
of the original cohort still alive, were re-examined. In addition, a random sample 
of 711 other men from the town of Zutphen in the same age group were asked 
to participate. This resulted in a total population of 939 men (response rate 
74%) born between 1900 and 1919, which formed the cohort of the Zutphen 
Elderly Study. All participants signed an informed consent form. Complete 
information on diet and risk factors was available for 815 men. 
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Data collection 
Dietary and medical examinations were completed between March and June in 
1985. We obtained information about the habitual food consumption with the 
cross-check dietary history method, adapted to the Dutch situation.23 Each 
participant, and if possible his partner, was interviewed about his average food 
consumption pattern in the month before interview. A checklist of foods and 
quantities of food bought per week was used to calculate and verify the 
participant's usual food consumption pattern. 
We calculated nutrient intake with the Dutch food table, completed with data of 
folate,24 p-carotene, vitamin E,25 and trans fatty acids.26 
During medical examinations we took non-fasting venous blood samples. After 
about 1 hour, samples were centrifuged and the serum was separated and 
stored at -20°C until tHcy determination in 1995.21 We measured weight and 
height in light clothing without shoes, and calculated body mass index (BMI; 
weight/height2). We calculated total minutes of physical activity per week with a 
self-administered questionnaire designed for retired men.27 We ascertained 
information on cigarette smoking, history of hypertension and diabetes mellitus 
92
 With a standardized questionnaire. 
Incident cases included fatal CHD plus non-fatal myocardial infarction (whichever 
arose first) occurring between baseline assessment in 1985 and January 1995. 
Three participants were lost to follow-up and censored at 1991. We obtained 
information on vital status of the participants from the municipal registries and 
on cause of death between 1985 and June 1990 from Statistics Netherlands. For 
deaths occurring thereafter, or if data were not available from Statistics 
Netherlands, information was obtained from hospital discharge data and/or 
general practitioners. We coded causes of death in accordance with the 
International Classification of Diseases (ICD). CHD refers to ICD-9 codes 410-
414. Because the underlying cause of death in the elderly is often difficult to 
establish, we classified CHD as a primary (n=81) and secondary (n=6) cause of 
death in the analyses. 
We obtained information about myocardial infarction and angina pectoris 
between 1985 and 1990 by the Dutch translation of the Rose questionnaire,28 
and after 1990 by a standardized medical questionnaire. In case of non-
response, a short questionnaire was used completed by the subjects themselves 
or their closest relative. Diagnosis of each disease was confirmed with hospital 
B-vitamins, homocysteine and coronary heart disease 
discharge data. Also, for men who died, information on disease history was 
obtained from the general practitioner. CHD at baseline in 1985 was considered 
to be present when either myocardial infarction or angina pectoris was 
diagnosed. Diagnosis of myocardial infarction (between baseline and January 
1995) required at least two of the following criteria: a specific medical history, 
characteristic electrocardiographic changes or specific enzyme elevations. 
Stat is t ical methods 
To improve normality of the distributions of the different B-vitamin intakes and 
tHcy levels, we performed logarithmic transformations. Thereafter, B-vitamin 
intakes were energy-adjusted by regressing B-vitamin intake on total energy 
intake.29 Men were divided into tertiles on the basis of energy-adjusted intake of 
folate, vitamin B2, B6 or B12. To study the associations between intake of B-
vitamins and tHcy, we calculated the mean tHcy level per tertile of B-vitamin 
intake with analysis of covariance. Trends were evaluated with linear regression, 
by using the median value of each category and modeling this as a continuous 
variable. To study the association between intake of B-vitamins and CHD 
incidence, we used Cox proportional hazard (survival) analysis to calculate 
relative risks with the lowest tertile of each B-vitamin intake as a reference 
group. 
RESULTS 
At baseline, the mean age of the Zutphen Elderly men was 71.3 years (SD=5.2 
years). Thirty percent of the men were cigarette smokers and about 19% had a 
previous diagnosed CHD. The mean intakes were 200 ng/d (SD=61 ng/d) for 
folate, 1.70 mg/d (SD=0.50 mg/d) for vitamin B2, 1.62 mg/d (SD=0.38 mg/d) 
for vitamin B6 and 5.29 ng/d (SD=3.27 ng/d) for vitamin B12. Intake of folate, 
vitamin B2, B6 and B12 were positively correlated. The correlation coefficient 
was highest between vitamin B2 and vitamin B12 (rs=0.57). Other correlation 
coefficients were between rs=0.18 (between intake of vitamins B6 and B12) and 
0.50 (between intake of folate and vitamin B2). 
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Table 1. Baseline level of major risk factors for coronary heart disease, according to 
energy-adjusted terti les of B-vitamins intake in 824 men aged 64-84 years old. 
B-vitamins Age Body mass Physical Smoking Use of Prevalence 
(years) index activity Current never vitamin of CHD 
(kg/m2) (min/week) (%) (%) supplements (%) 
(%) 
Folate intake 
< 173 (ig/d 
173-215 ng/d 
>215 ng/d 
Vitamin B2 intake 
< 1.5 mg/d 
1.5-1.8 mg/d 
>1.8 mg/d 
Vitamin B6 intake 
< 1.5 mg/d 
1.5-1.7 mg/d 
>1.7 mg/d 
271 
272 
272 
271 
272 
272 
271 
272 
272 
Vitamin B12 intake 
< 3.6 ng/d 
3.6-5.0 ng/d 
>5.0 ng/d 
271 
272 
272 
71.9 
71.5 
70.6* 
71.9 
70.9 
71.1 
71.8 
71.6 
70.5* 
71.9 
71.2 
70.8 
25.5 
25.3 
25.6 
25.4 
25.5 
25.5 
25.0 
25.6 
25.8* 
25.0 
25.6 
25.8* 
540 
634 
624 
546 
673 
581* 
591 
559 
649 
596 
583 
620 
34.0 
30.2 
27.6 
33.2 
32.0 
26.5 
34.0 
31.3 
26.5 
27.7 
30.5 
33.5 
17.7 
19.5 
17.3 
15.7 
20.6 
18.2 
17.0 
22.1 
15.4 
17.3 
19.5 
17.7 
14.8 
14.3 
16.9 
11.8 
15.1 
19.1 
17.3 
15.4 
13.2 
12.9 
16.2 
16.9 
18.1 
19.9 
18.4 
18.5 
18.8 
19.2 
19.6 
18.8 
18.0 
19.6 
19.5 
17.3 
CHD=coronary heart disease 
* statistically significantly different (p<0.05) between B-vitamin intake tertiles (analyses of variance 
for normally distributed variables, Kruskal-Wallis test for skewed variables, chi-square test for 
dichotomous variables) 
Relation between B-vitamin in take and possible confounders 
To determine potential confounders in the relation between B-vitamin intake, 
tHcy and CHD, differences in characteristics were tested across B-vitamin 
tertiles. The men in the highest tertiles of B-vitamin intake were younger 
(statistically significant for folate and vitamin B6), and had a higher BMI 
(statistically significant for vitamin B6 and B12) compared to the lowest tertiles 
of B-vitamin intake (table 1). In addition, levels of physical activity significantly 
B-vitamins, homocysteine and coronary heart disease 
differed between the tertiles of vitamin B2 intake. B-vitamin intake was 
significantly positively associated with intake of protein (including methionine) 
and dietary fiber (data not shown). Furthermore, intake of folate, vitamin B2 and 
B6 was significantly inversely associated with intake of saturated fat and trans 
fatty acids, and significantly positively with intake of vitamin C and beta-
carotene. Also, there was a significant positive association between intake of 
folate and vitamin E, and a significant inverse one between vitamin B2 intake 
and alcohol consumption. 
Table 2. Geometric means of serum homocysteine concentrations (nmol/L) 
according to energy-adjusted tertiles of B-vitamin intake. 
Median intake (ng/d) 
Unadjusted tHcy 
Adjus ted* tHcy 
Median intake (mg/d ) 
Unadjusted tHcy 
Adjus ted* tHcy 
Median intake (mg/d ) 
Unadjusted tHcy 
Adjus ted* tHcy 
Median intake (|ig/d) 
Unadjusted tHcy 
Adjus ted* tHcy 
T l 
(n=271) 
153 
15.9 
15.3 
1.3 
15.4 
14.3 
1.3 
15.8 
15.0 
2.9 
15.2 
14.4 
Tertiles 
T 2 
(n=272) ( 
Folate intake 
192 
14.4 
14.5 
Vitamin B2 
1.6 
14.2 
14.3 
Vitamin B6 
1.6 
14.7 
14.7 
Vitamin B12 
4.1 
14.6 
14.6 
ntake 
ntake 
intake 
T 3 
n=272) 
246 
13.4 
13.9 
2.1 
14.0 
15.0 
1.9 
13.2 
13.9 
6.9 
13.9 
14.6 
P-
trend 
0.0001 
0.007 
0.002 
0.16 
0.0001 
0.02 
0.002 
0.80 
T=tertile, tHcy=total homocysteine concentration 
*Adjusted for age, prevalence of coronary heart disease, smoking, body mass 
index, intake of energy, other B-vitamins, alcohol, vitamin supplements, 
methionine and coffee. 
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Cross-sect ional re la t ion between B-v i tamin in take and tHcy 
The intake of all B-vitamins was inversely associated with tHcy (table 2). After 
adjustment for other B-vitamin intake and major determinants of tHcy, including 
age, prevalence of CHD, smoking, BMI, use of vitamin supplements, intake of 
energy, alcohol, methionine and coffee, the associations between intake of all B-
vitamins and tHcy became weaker. Significant decreased tHcy levels were 
observed for higher intake of folate and vitamin B6 (table 2). Intake of vitamin 
B2 and vitamin B12 were both not significantly associated with tHcy in the 
adjusted models. 
Relation between B-v i tamin in take and 10-year CHD risk 
During 10 years of follow up, 140 men out of 815 men had developed CHD, of 
which 87 were fatal. Folate intake was not associated with the 10-year risk of 
CHD, neither crude not after adjustment for determinants of CHD (table 3). 
Vitamin B2 intake was borderline significantly inversely associated with CHD risk 
(adjusted p-trend=0.08). For vitamin B6 intake, we observed a small non-
significant reduction in CHD risk for the men in the medium and highest tertile 
compared to those in the lowest tertile of vitamin B6, but there was no 
significant trend. Furthermore, we noted a significant positive association 
between vitamin B12 intake and CHD incidence, which became stronger after 
adjustment for major coronary risk factors and dietary factors. Additional 
adjustment for tHcy levels in the analyses on B-vitamin intake showed similar 
relative risks (table 3). Additional adjustment for prevalence of diabetes mellitus, 
prevalence of hypertension, or physical activity, or excluding men with a 
previous diagnosed CHD at baseline from the analyses (n=153), did not 
substantially changed the results (data not shown). 
Due to the intercorrelation between intake of vitamin B12 and vitamin B2, 
adjustment for vitamin B12 in the analyses of vitamin B2 intake and CHD risk 
substantially affected the results. After adjustment for all major risk and dietary 
factors except for vitamin B12 intake, the relative risk of the highest versus the 
lowest tertile of vitamin B2 was 0.80 (95% confidence interval (CI) 0.50-1.34; P 
for trend=0.45), compared to the relative risk of 0.61 after additional 
adjustment for vitamin B12 (table 3). Other associations between B-vitamin 
intake and CHD, respectively tHcy, remained similar before and after adjustment 
for other B-vitamin intakes (data not shown). 
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Table 3. Relative risks (RR) and 95% confidence intervals of 10-year fatal plus non-fatal 
coronary heart disease according to energy-adjusted tertiles of B-vitamin intake. 
Median intake (ng/d) 
No. (%) of cases 
Unadjusted RR 
Adjusted* RR 
Adjusted* + tHcy RR 
Median intake (mg/d) 
No. (%) of cases 
Unadjusted RR 
Adjusted* RR 
Adjusted* + tHcy RR 
Median intake (mg/d) 
No. (%) of cases 
Unadjusted RR 
Adjusted* RR 
Adjusted* + tHcy RR 
Median intake (jig/d) 
No. (%) of cases 
Unadjusted RR 
Adjusted* RR 
Adjusted* + tHcy RR 
(n 
42 
T 1 
=271) 
153 
(15.5%) 
1 
1 
1 
1.3 
56 (20.7%) 
1 
1 
1 
1.3 
52 (19.2%) 
42 
1 
1 
1 
2.9 
(15.5%) 
1 
1 
1 
Tertiles 
T 2 
(n=272) 
Folate intake 
192 
51 (18.8%) 
1.26 (0.84-1.90) 
1.29 (0.82-2.01) 
1.31 (0.83-2.06) 
Vitamin B2 intake 
1.6 
42 (15.4%) 
0.74 (0.50-1.11) 
0.73 (0.47-1.12) 
0.73 (0.47-1.13) 
Vitamin B6 intake 
1.6 
42 (15.4%) 
0.79 (0.53-1.19) 
0.82 (0.53-1.28) 
0.83 (0.53-1.30) 
T 3 
(n=272) 
246 
47 (17.3%) 
1.16(0.76-1.75) 
1.12 (0.64-1.96) 
1.13 (0.65-1.98) 
2.1 
42 (15.4%) 
0.73 (0.49-1.09) 
0.61 (0.36-1.03) 
0.60 (0.35-1.02) 
1.9 
46 (16.9%) 
0.83 (0.56-1.24) 
0.82 (0.48-1.40) 
0.82 (0.48-1.40) 
Vitamin B12 intake 
4.1 
47 (17.3%) 
1.12(0.74-1.70) 
1.33 (0.85-2.09) 
1.34 (0.85-2.10) 
6.9 
51 (18.8%) 
1.26 (0.84-1.89) 
1.82 (1.09-3.05) 
1.83 (1.09-3.08) 
p-trend 
0.55 
0.77 
0.75 
0.15 
0.08 
0.07 
0.35 
0.45 
0.45 
0.28 
0.03 
0.03 
97 
T=tertile, tHcy=total homocysteine 
*Adjusted for age, prevalence of coronary heart disease, smoking, body mass index, intake of 
energy, other B-vitamins, alcohol, vitamin supplements, saturated fat, trans fatty acids, fiber, 
vitamin E, vitamin C and p-carotene. 
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A total of 125 men (15.3%) used vitamin supplements, of which 69 men used B-
vitamin containing supplements. There was no significant difference in CHD risk 
for B-vitamin supplements users compared to no B-vitamin supplement users, 
the relative risk was 0.90 (95% CI 0.47-1.73) after adjustment for age, 
smoking, BMI, energy intake and alcohol consumption. However, due to the lack 
of information on the frequency of taking B-vitamin supplements and their 
vitamin content, we could not assess the B-vitamins intake from supplements 
quantitatively. After excluding men using vitamin supplements (n=125), the 
results remained similar (data not shown). 
We repeated our analyses including fatal events only. Similar results were 
observed for all B-vitamins. In addition, the relative risks of CHD mortality did 
also not change after adjustment for tHcy (data not shown). 
DISCUSSION 
In the present study among elderly men, only intake of folate and vitamin B6 
were independently inversely associated with tHcy. We observed no clear 
association of intake of folate and vitamin B6 with the risk of CHD. Furthermore, 
we observed a non-significant inverse relation between vitamin B2 intake and 
CHD risk, which was suggested to be independent of tHcy. Vitamin B12 intake 
was positively associated with CHD risk in elderly men. 
The major advantages of the present study are its prospective design, and the 
detailed data on dietary intake. Habitual food consumption was measured using 
the cross-check dietary history method, which is acknowledged as a valid 
method in an epidemiological setting.23 The independent effect of each B-vitamin 
could be evaluated since adjustment was made for the intake of other B-
vitamins. However, we could not study the B-vitamin intake from supplements 
quantitatively. Nevertheless, the results remained similar after excluding the 
vitamin supplement users. 
Consistent with the results of the present study, an inverse association between 
intake of folate and tHcy was also observed in other cross-sectional studies 
among adults or the elderly.30'32 An inverse association between dietary vitamin 
B6 and tHcy as shown in the present study is observed in some30 but not all31,32 
observational studies. Consistent with the present findings, in general, no 
— B-vitamins, homocysteine and coronary heart disease 
association between the intake of vitamin B1230"32 or vitamin B232 with tHcy was 
observed. 
Until now, only two other prospective studies investigated the association 
between dietary intake of B-vitamins and the risk of CHD. In the ARIC study, no 
significant associations between the intake of folate, vitamin B6 or B12 and CHD 
were observed.16 In the Nurses' Health Study, an inverse association was 
observed between folate and vitamin B6 intake and CHD, while there was no 
association for either vitamin B2 or B12.20 This is inconsistent with our findings of 
a positive association of vitamin B12 intake, a non-significant inverse association 
of vitamin B2, and no association of folate and vitamin B6 with the risk of CHD. 
The differences in intake of the three prospective studies are large. In the 
Nurses' Health Study,20 the mean intake of folate (366 n-g/d) and vitamin B6 (3 
mg/d) was about twice as high as the intake of the participants of the Zutphen 
Elderly Study. This was due to the high intake of folate and vitamin B6 from 
vitamin supplements and fortified breakfast cereals. Also in the ARIC study,16 
use of vitamin supplementation was higher (about 27%) compared to the 
supplement use in the Zutphen Elderly Study. In our study, despite a lack of 
association with CHD, an inverse association between the intake of folate and 99 
vitamin B6 and tHcy was observed. This indicates that the level of intake of ~ 
folate and vitamin B6 from foods was high enough to influence tHcy. This 
suggest that other determinants of tHcy than intake of folate and vitamin B6, or 
other risk factors (i.e. blood cholesterol33 or blood pressure34) might play a more 
important role in CHD in this population of elderly men. 
In the present study, vitamin B12 intake was positively associated with the risk 
of CHD. Because vitamin B12 is derived from animal products (meat 52%, milk 
and milk product 25%), other dietary factors occurring in the same foods or 
lifestyle and dietary factors associated with high animal food consumption could 
have affected the association between vitamin B12 intake and CHD. However, 
after adjustment for confounders the direct relationship remained. A positive 
association with CHD was also observed in two previous observational studies 
using blood levels of vitamin B12.6,15 Other studies observed
 no
7
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 o r a n 
inverse11 association between vitamin B12 and CHD. Based on this evidence, a 
detrimental effect of vitamin B12 itself, e.g. due to enzyme induction associated 
with long-life vitamin B12 accumulation in the liver,35 can not be totally excluded. 
This is one of the first studies that performed analyses on the association 
between vitamin B2 intake and the risk of CHD. After adjustment for risk and 
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dietary factors, vitamin B2 intake was borderline significantly inversely 
associated with the risk of CHD. This association was independent of tHcy. In the 
data of the Nurses' Health study, no association between the intake of vitamin 
B2 and CHD was observed.20 Besides the role of vitamin B2 as a cofactor for the 
enzyme 5,10-methylenetetrahydrofolate reductase, vitamin B2 has a vital role in 
cellular oxidation. However, its biochemical functions do not easily explain the 
role in CHD. Other dietary factors in the same foods could have affected the 
results for vitamin B2. The underlying mechanism for a possible inverse 
association between vitamin B2 and CHD deserves further investigation. 
Our findings indicate that, of the B-vitamins, folate and vitamin B6 intake are 
independent determinants of tHcy, while only vitamin B2 intake is non-
significantly inversely associated with risk of CHD in a population of elderly men. 
The positive association between vitamin B12 intake and CHD risk requires 
further investigation. Randomized trials are needed to better clarify the potential 
protective effect on CHD of folate, vitamin B2 or B6. 
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heart disease mortality: the 
Seven Countries Study 
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coronary heart disease, as it is a precursor of nitric oxide. Results from huma 
and animal experiments showed that arginine treatment was antiatherogenic.2 
We have investigated the relationship between arginine intake and risk < 
coronary heart disease within the cohort of the Zutphen Elderly Study, amon 
men aged 64-84 years old (chapter 8).4 In this study, we observed n 
association between arginine intake and coronary heart disease mortalit' 
possibly because of the limited range of variation in arginine intake (mean 4.3 
g/d, SD 1.07 g/d) 
Recently, we completed the investigation of arginine and coronary heart diseas 
in the Seven Countries Study. This study has been designed to investigate th 
diet-heart issue using a broad range of variation in dietary intake. It started i 
between 1958 and 1964, and involved 12,763 men aged 40-59 from 16 cohort: 
The vital status of the men was checked at regular intervals and after 25 yeai 
of follow-up. Primary cause of death was established centrally. Dietar 
information was collected at baseline in small random samples using th 
'weighed record' method. In 1985 and 1986 the original dietary data wer 
recoded and the average food intake of the men was calculated. In 1987, th 
foods representing the baseline diet were bought locally and sent to th 
Netherlands. Foods were combined into representative food equivaler 
composites. These were homogenized, freeze-dried and stored (-20°C) for late 
use. The arginine content of the food composites was analysed twice in 199 
using an HPLC-method with fluorescence detection and precolumn fluorgen 
labelling with 9-flurorenylmethylchloroformate (OPA). 
Arginine intake varied from 5.4 g/d in Corfu (Greece) to 13.8 g/d in Ushibuk 
(Japan). The correlation between arginine intake and coronary heart diseas 
mortality amounted to -0.35 (p=0.17). High intake of arginine was associate 
with relatively low levels of coronary heart disease mortality (such as in Japar 
(Figure 1), but at low levels of arginine intake high (East-Finland) as well as lo' 
coronary heart disease rates (Corfu) were observed. In an earlier study w 
observed that 90% of the variation in coronary heart disease mortality could b 
explained by three factors: saturated fat intake, flavonol intake and smoking 
Arginine intake was strongly associated with flavonol intake (r=0.66, p=0.006 
with smoking (r=0.46, p=0.07) and inversely with the energy-percentage < 
saturated fatty acids (r=-0.49, p=0.05). In the unadjusted regression analysis 
— • Arginine intake and coronary heart disease: the Seven Countries Study 
an increase in arginine intake of 1 g/d was associated with a coronary heart 
disease risk reduction of 1.11% (p=0.17). However, when adjusted for the three 
main explaining factors, separately or combined, the association between 
arginine intake and coronary heart disease mortality was reduced towards zero 
(e.g. a reduction of -0.26% coronary heart disease risk per 1 g/d of arginine, 
p=0.53, adjusted for saturated fatty acids and smoking; additional adjustment 
for flavonols was hampered by multicollinearity). 
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Figure 1. Association between population average of arginine intake (g/d) at 
baseline and 25-year age-adjusted mortality rates from coronary heart 
disease (%) in the Seven Countries Study. 
EF=East Finland, WF=West Finland, ZU=Zutphen, the Netherlands, US=US Railroad, 
BE=Belgrade, Serbia (former Yugoslavia), ZR=Zrenjanin, Serbia (former Yugoslavia), 
VK=Velika Krsna, Serbia (former Yugoslavia), SL=Slavonia, Croatia (former 
Yugoslavia), DA=Dalmatia, Croatia (former Yugoslavia), RR=Rome Railroad, Italy, 
CR=Crevalcore, Italy, MO=Montegiorgio, Italy, CT=Crete, Greece, CO=Corfu, Greece, 
UB=Ushibuka, Japan, TA=Tanushimaru, Japan. 
These results indicate that arginine is not clearly associated with coronary heart 
disease mortality at the population level. This is in agreement with our findings 
at the individual level (chapter 8).4 In both study designs, arginine intake was 
strongly associated with the intake of energy and other nutrients through its 
widespread presence in animal and vegetable foods. The potential impact of 
arginine is therefore difficult to disentangle. Additional observational studies, 
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preferably in populations with a relatively high range of intake, and including e.g. 
biomarkers for arginine intake, should be carried out to confirm the hypothesis of 
a protective effect of arginine on coronary heart disease as suggested by recent 
human and animal experiments. 
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intake and risk of coronary 
heart disease mortality 
in elderly men 
Claudia M Oomen, Marjan J van Erk, Edith JM Feskens, Frans J Kok, 
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From experimental studies, the hypothesis is derived that the amino acid arginine, th 
precursor of nitric oxide, could restore the impaired endothelial function and increase 
platelet activation observed in atherosclerosis. We investigated whether dietary intake i 
arginine is associated with reduced coronary heart disease risk in elderly persons. Th 
study population consisted of 806 men aged 64-84 years at baseline who participated 
the Zutphen Elderly Study, a population-based cohort followed up for 10 year 
Information about habitual food consumption was collected by use of the cross-chet 
dietary history method. Ninety men (11.2%) died from coronary heart disease. Mee 
baseline arginine intake was 4.35 g/d (SD=1.07). Meat was the main source of arginir 
intake (37.1%), followed by bread (13.1%) and milk and milkproducts (12.1%). Arginir 
intake was not associated with coronary heart disease mortality. After adjustment fi 
age, the relative risk (RR) for the medium tertile of arginine intake was 0.72 (95' 
confidence interval (CI): 0.44-1.18) and the RR for the highest tertile was 0.71 (95% C 
0.43-1.19; p for trend=0.19) compared to the lowest tertile of arginine intake. Aft 
additional adjustment for history of coronary heart disease and diabetes mellitus, enerc 
intake, body mass index, smoking habit, physical activity and other relevant dietary ar 
biological risk factors the RR was 1.86 (95% CI: 1.06-3.27) for the medium intake ar 
1.56 (95% CI: 0.83-2.93) for the highest intake (p for trend=0.17). These results do m 
support the hypothesis that dietary arginine intake lowers the risk of coronary hea 
disease mortality. 
INTRODUCTION 
The discovery of nitric oxide as a signaling molecule in the cardiovascular systei 
was rewarded with the 1998 Nobel Prize in Medicine. The semi-essential amir 
acid L-arginine is the precursor of nitric oxide. I t has been demonstrated thi 
administration of L-arginine can improve endothelium-dependent vascul. 
relaxation through the release of nitric oxide.1 Chronic dietary supplementatic 
of L-arginine in hypercholesterolemic animals has been associated with reduce 
atherosclerosis and anti-atherogenic effects such as reduction in surface are 
and intimal thickness of atheromatous lesions, decrease of platelet aggregatic 
and attenuation of cell proliferation and of vascular monocyte accumulation.2"8 
In humans, endothelial dysfunction could be restored after dietai 
supplementation9"12 and intravenous administration of L-arginine13"15 in patien 
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with hypercholesterolemia,9,13,14 heart failure,12 and nonobstructive or advanced 
coronary artery disease.10,11,15 Reduction in platelet aggregation by L-arginine 
has also been observed.16"18 
Consequently, arginine was recently presented as a possible new 
pharmacological therapy for the atherogenic process leading to coronary heart 
disease.19 Antiatherogenic effects of arginine are especially demonstrated in 
human subjects with more or less advanced atherosclerosis. Coronary 
atherosclerosis is increasingly present in the elderly. Possibly, arginine is 
associated with reduced coronary heart disease risk in elderly persons. 
Therefore, we investigated the hypothesis that dietary arginine intake is 
inversely associated with coronary heart disease mortality among participants in 
the Zutphen Elderly Study. 
METHODS 
Study populat ion 
The study population consisted of men who participated in the Zutphen Elderly ^QQ 
Study, an extension of the Zutphen Study, the Dutch contribution to the Seven —— 
Countries Study.20 In 1960, the Zutphen Study started with a cohort of 878 men 
from Zutphen (the Netherlands) born between 1900 and 1919. In 1985, 367 of 
the 555 participants who were still alive were re-examined. In addition, 711 
other men from the town of Zutphen in the same age category were asked to 
participate. A total of 939 men (response rate 74%) were examined in 1985 and 
complete information on diet and risk factors was available for 806 men. In 
1990, 781 of these 939 men were still alive, and 560 took part in a follow-up 
examination. Dietary intake in 1990, together with complete information on diet 
and risk factors at baseline (1985) was available for 508 men. 
Data col lect ion 
Dietary and medical examinations were completed between March and June 
1985 and after 5 years of follow-up, between March and June 1990. Information 
about the habitual food consumption was collected by use of the cross-check 
dietary history method, adapted to the Dutch situation.21 Participants, together 
with the person who prepared the meals, were interviewed about their usual 
food consumption pattern during weekdays and weekends for the 2-4 weeks 
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preceding the interview. Quantities of food bought per week were used to 
calculate and verify the food consumption of a participant on an average 
weekday. 
Nutrient intake data, including ethanol, were based on the Dutch food table.22 
Because of lack of information on the amino acid composition of Dutch foods, 
arginine contents of chemical analysis were used, preferably from the United 
Kingdom,23 and subsequently from the United States.24 The arginine contents 
were converted by use of the protein contents from the Dutch food table.22 
During medical examinations non-fasting venous blood samples were taken. 
Serum total cholesterol and high density lipoprotein (HDL) cholesterol were 
determined enzymatically.25,26 In 1995, serum total homocysteine was measured 
in serum stored at -20°C as described previously.27 Weight and height were 
measured while participants were wearing underwear only, and body mass index 
was calculated (kg/m2). At the end of the physical examinations blood pressure 
was measured twice with participants in the supine position. Information on 
smoking status (nonsmoker, exsmoker, current smoker), medication use, and 
history of hypertension and diabetes mellitus was obtained by a standardized 
HQ questionnaire. Patients with insulin-dependent and non-insulin-dependent 
—— diabetes mellitus were considered in the present study. Minutes of physical 
activity (mainly walking, cycling, hobbies, sports, gardening and work) per week 
were calculated by use of a self-administered questionnaire originally designed 
for retired men.28 Information regarding a history of coronary heart disease was 
obtained by using the Dutch translation of the Rose questionnaire.29 
Fol low-up 
Information involving vital status of all participants was obtained from the 
municipal registries until January 1995. Three participants were lost to follow-up. 
Information about the cause of death was obtained from the Dutch Central 
Bureau of Statistics for deaths occurring between baseline assessment and June 
1990, after verification with hospital discharge data and information from the 
deceased's general practitioners, and for deaths occurring thereafter from the 
hospital discharge data and/or participants' general practitioners and if such 
information was not available from the Dutch Central Bureau of Statistics. 
Causes of death were coded according to the ninth revision of the International 
Classification of Diseases (ICD). Coronary heart disease refers to ICD codes 410-
414. Because the underlying cause of death in the elderly is often difficult to 
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determine, the primary (n=84) and the secondary (n=6) causes of death were 
both considered in the analysis. 
Statistical methods 
Differences in baseline characteristics of the participants between tertiles of 
arginine intake were evaluated by analysis of variance for normally distributed 
variables, by Kruskal-Wallis test for skewed variables and by Chi-square test for 
categorical variables. Pearson correlation coefficients (rp ) were calculated 
between the intake of arginine and other dietary factors. 
Energy-adjusted nutrient intake (i.e. arginine) was computed as residuals from 
the regression model with energy intake as the independent variable and 
nutrient intake as the dependent variable.30 Before computing the residuals of 
nutrient intake, the logarithmic transformation of each nutrient variable including 
arginine was calculated to improve the normality. Cox proportional hazard 
(survival) analysis was used to calculate crude and adjusted relative risks (RRs), 
95% confidence intervals (CIs) and p-values for linear trend. The lowest tertile 
of arginine intake was taken as a reference group. Several multivariate analyses 
were performed to take into account potential confounding by major risk factors i l l 
such as age, history of coronary heart disease, smoking status, body mass index 
and other factors associated with arginine intake and potentially associated with 
coronary heart disease mortality. To evaluate confounding a p-value smaller 
then 0.2 was considered. Energy-adjusted analysis included the energy-adjusted 
tertiles of arginine intake plus a term for energy intake. Interactions between 
arginine intake and relevant factors, such as age, history of coronary heart 
disease and smoking status were explored to determine whether the association 
between arginine intake and coronary heart disease mortality differed among 
subgroups of the population. Proportional hazard analyses including arginine 
intake and all the covariables as time-dependent covariates were also 
performed. The baseline measurement (1985) for the first 5 years of follow-up 
and the measurement for the second 5 years of follow-up (1990) were used. 
When the measurement for 1990 was not available, only the baseline 
measurement was used for the total follow-up period. 
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RESULTS 
Baseline 
Mean (±SD) baseline arginine intake of the 806 participants was 4.35 (±1.07) 
g/d. Meat provided the largest contribution to the total arginine intake (37.1%), 
followed by bread (13.1%) and milk and milk products (12.1%). A relatively 
large amount of arginine was also provided by peanuts (2.5%); this was due to 
the high percentage of arginine in the protein of peanuts (13.0%). 
Table 1 . The Zutphen Elderly Study: Baseline (1985) characteristics according to terti les 
of arginine intake in 806 men. 
Characteristic 
tertiles of arginine intake (g/d) 
0 to 3.85 3.86 to 4.65 more than 4.65 
(low) (medium) (high) 
(n=268) (n=269) (n=269) 
P* 
Age (y.) 
U 2 Body mass index (kg/m2) 
Smoking - current (%) 
- past (%) 
Alcohol users (%) 
Physical activity (min./week) 
Systolic blood pressure (mmHg) 
Serum total cholesterol (mmol/L) 
Serum HDL cholesterol (mmol/L) 
Serum homocysteine (nmol/l) 
Medication use - hypertension (%) 
- cholesterol lowering (%) 
History of coronary heart disease (%) 
History of diabetes mellitus (%) 
History of hypertension (%) 
72.3 + 5.4 
25.6 ±3 .2 
29.9 
51.9 
66.4 
490 ± 484 
151 ± 2 2 
6.12 ± 1.18 
1.11 ±0 .33 
17.8 ±10 .5 
11.9 
2.6 
23.9 
3.0 
22.8 
71.7 + 5.3 
25.4 ± 2 . 6 
29.0 
52.8 
77.3 
642 ±562 
152 ± 2 1 
6.01 ± 1.08 
1.13 ±0 .29 
15.2 ± 6 . 8 
14.5 
1.1 
16.4 
6.7 
21.2 
70.0 ± 4 . 8 
25.5 ± 3 . 5 
31.2 
49.8 
75.5 
660 ± 559 
149 ± 20 
6.21 ±1 .07 
1.13 ±0 .26 
13.9 ±6 .0 
9.3 
0.8 
16.0 
7.8 
17.1 
0.0001 
0.57 
0.85 
0.78 
0.01 
0.0001 
0.25 
0.12 
0.16 
0.0001 
0.18 
0.17 
0.03 
0.02 
0.24 
* Analysis of variance for normal distributed variables, Kruskal-Wallis test for skewed variables, chi 
square for dichotomous variables. 
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We examined the distribution of risk factors within categories of arginine intake. 
Arginine intake was inversely associated with age, history of coronary heart 
disease and serum homocysteine levels and positively associated with physical 
activity, alcohol use and history of diabetes mellitus (table 1). However, the 
distributions of other risk factors did not differ appreciably across the arginine 
categories. Concerning dietary factors, arginine intake was positively associated 
with the intake of (saturated and unsaturated) fat, carbohydrates, protein, fiber, 
cholesterol and total energy (table 2). 
Daily intake of arginine was strongly correlated with the intake of energy (rp 
=0.65, P=0.001). After adjustment for energy, the associations between 
arginine intake and dietary factors were weakened (table 3). Energy-adjusted 
Table 2. The Zutphen Elderly Study: Baseline (1985) mean daily nutrient intake 
according to tertiles of arginine intake in 806 men. 
Nutrient 
tertiles of arginine intake (g/d) 
0 to 3.85 3.86 to 4.65 More than 4.65 
(low) (medium) (high) 
(n=268) (n=269) (n=269) 
Arginine (g) 
Energy (MJ) 
Total fat (g) 
Saturated fatty acids (g) 
Monounsaturated fatty acids (g) 
Polyunsaturated fatty acids (g) 
Carbohydrates (g) 
Total protein (g) 
Vegetable protein (g) 
Animal protein (g) 
Alcohol (g) 
Fiber (g) 
Cholesterol (mg) 
3.31 ±0.42 
8.0 ± 1.7 
83.2 ±24.3 
36.3 ± 11.6 
31.1 ± 10.5 
12.6 ±6.2 
206 ±60 
62.9 ±8.7 
20.2 ±5.1 
42.9 ±8.4 
12.1 ± 16.1 
21.2 ±5.6 
275 ± 95 
4.22 ±0.23 
9.4 ±1.6 
101.6 ±27.8 
43.7 ± 12.7 
37.9 ± 12.2 
16.2 ±7.7 
228 ± 56 
78.8 ±6.6 
23.9 ±5.4 
55.1 ±8.5 
14.7 ± 18.6 
25.1 ±6.4 
340 ±102 
5.50 ±0.90 
11.0 ±2.0 
121.3 ±33.6 
51.1 ± 15.2 
46.0 ± 14.8 
19.5 ±8.8 
265 ± 65 
98.5 ± 14.5 
29.6 ±8.2 
69.1 ± 14.4 
12.8 ± 16.2 
29.9 ±7.9 
399 ±123 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
0.07 
0.0001 
0.0001 
* Analysis of variance for normal distributed variables, Kruskal-Wallis test for skewed 
variables, chi square for dichotomous variables. 
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arginine intake remained significantly positively associated with protein, dietary 
cholesterol and fiber. In addition, energy-adjusted arginine intake was positively 
associated with history of diabetes mellitus and body mass index, and inversely 
associated with age and serum homocysteine levels (data not shown). 
Table 3. The Zutphen Elderly Study: Baseline (1985) mean daily nutrient intake 
according to tertiles of energy-adjusted arginine intake in 806 men. 
Nutrient 
Energy (MJ) 
Total fat (g) 
Saturated fatty acids (g) 
Monounsaturated fatty acids (g) 
Polyunsaturated fatty acids (g) 
Carbohydrates (g) 
Total protein (g) 
Vegetable protein (g) 
Animal protein (g) 
Alcohol (g) 
Fiber (g) 
Cholesterol (mg) 
Tertiles of energy 
0 to 3.91 
(low) 
(n=268) 
9.5 ±2.3 
103.4 ±34.5 
44.8 ±15.8 
38.4 ± 14.8 
15.8 ±8.3 
243 ± 67 
68.5 ±8.7 
23.0 ±6.4 
45.7 ± 12.1 
14.8 ± 18.2 
23.3 ±6.9 
316 ±122 
-adjusted arginine intake (g/d) 
3.92 to 4.53 
(medium) 
(n=269) 
9.5 ±2 .1 
102.2 ±31.6 
44.2 ±14.1 
38.5 ± 12.9 
15.6 ±7.4 
236 ± 65 
79.5 ±13.1 
24.5 ±6.6 
55.3 ±10.7 
12.5 ± 17.8 
25.6 ±6.4 
338 ±107 
more than 4.53 
(high) 
(n=269) 
9.4 ±2 .1 
100.6 ±32.2 
42.1 ± 13.6 
38.1 ± 14.3 
17.0 ±8.6 
220 ±61 
92.2 ±17.4 
26.3 ±8.8 
66.2 ±14.9 
12.3 ±14.9 
27.3 ±8.3 
360±122 
P* 
0.67 
0.63 
0.07 
0.94 
0.11 
0.0001 
0.0001 
0.0001 
0.0001 
0.47 
0.0001 
0.0001 
* Analysis of variance for normal distributed variables, Kruskal-Wallis test for skewed 
variables, chi square for dichotomous variables. 
Fol low-up 
During ten years of follow-up 374 participants died, of which 90 (11.2%) died 
from coronary heart disease. In the crude analysis, arginine intake was inversely 
associated with the risk of coronary heart disease, with a RR of 0.63 (95% CI: 
0.38-1.04) for the highest intake (p for trend=0.07, table 4). In different 
multivariate models, with potential confounding by factors associated with 
arginine intake and potentially associated with coronary heart disease mortality 
— Arginine intake and coronary heart disease: the Zutphen Elderly Study 
taken into account, no inverse association between arginine intake and coronary 
heart disease mortality was observed. Especially because of adjustment for 
energy intake, the RR adjusted for age, history of coronary heart disease, history 
of diabetes mellitus and energy intake were higher, 1.55 (95% CI: 0.93-2.58) 
for the medium tertile and 1.19 (95% CI: 0.68-2.07) for the highest tertile of 
arginine intake. After adjustment for body mass index, cigarette smoking, 
physical activity, alcohol consumption and energy-adjusted intake of saturated 
fatty acids, polyunsaturated fatty acids, cholesterol and fiber, the RRs for the 
medium and high tertiles compared to the lowest were 1.68 (95% CI: 0.97-
2.90) and 1.48 (95% CI: 0.80-2.72), respectively. Tests for linear trend were 
not statistically significant. The inclusion of serum total and HDL cholesterol, 
blood pressure and serum homocysteine as potential confounders in the analysis 
increased the RRs further (table 4). 
Table 4. Relative risks and 95% CIs for mortality from coronary heart disease in 
806 men during 10-year follow-up according to tertiles of arginine intake. 
Coronary heart disease mortality 
No. of deaths 
Mortality rate, per 1000 person-years 
Relative risks 
Crude 
95% CI 
Age adjusted 
95% CI 
Multivariatet 
95% CI 
tertiles of arginine 
Low 
(n=268) 
36 
18.8 
1.0 
1.0 
1.0 
Medium 
(n=269) 
28 
13.6 
0.72 
0.44-1.19 
0.72 
0.44-1.18 
1.87 
1.06-3.29 
intake* 
High 
(n=269) 
26 
12.0 
0.63 
0.38-1.04 
0.71 
0.43-1.19 
1.58 
0.84-2.96 
p for 
trend 
0.07 
0.19 
0.16 
* Cut-off points 3.85 g/d and 4.66 g/d for the tertiles unadjusted for energy intake, 
3.91 g/d and 4.53 g/d for tertiles adjusted for energy intake (residual from regression 
analysis with energy intake). 
t Factors include age, history of coronary heart disease and diabetes mellitus, energy 
intake, body mass index, smoking, alcohol, physical activity, intake of saturated and 
polyunsaturated fatty acids, cholesterol, fiber (all as residuals from the regression model 
with energy intake), systolic blood pressure, total and HDL cholesterol, homocysteine. 
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It may be questioned whether energy intake is a confounder in this population, 
because the association between energy intake and coronary heart disease 
mortality was not statistically significant in the adjusted analysis. Therefore, we 
repeated the multivariate analysis (the full model, with systolic blood pressure, 
cholesterol and homocysteine) without adjustment for energy intake. The RR 
was 0.88 (95% CI: 0.49-1.56) for the medium intake and 0.99 (95% CI: 0.50-
1.98) for the highest intake (p for trend=0.98). 
We further examined whether the association between arginine intake and 
coronary heart disease mortality was modified by other risk factors, with use of 
an interaction term in the multivariate analysis. Only for age was a significant 
interaction observed. The association was significant and more strongly positive 
in men below the median age of 71 years and inverse, but not significant, in men 
aged > 71 years. 
Finally, to reduce the likelihood that our results were biased by changes in 
dietary intake and lifestyle, analyses were also performed with the use of time-
dependent covariates. This resulted in significantly increased risks; in the full 
multivariate model the RR was 2.19 (95% CI: 1.22-3.95) for medium intake and 
U 6 2.44 (95% CI: 1.30-4.59) for the highest intake (p for trend=0.01). 
DISCUSSION 
This is the first observational study investigating the association between dietary 
arginine intake and coronary heart disease mortality. We observed no beneficial 
effect of dietary arginine intake on the risk of coronary heart disease in elderly 
men. 
Our results regarding arginine intake and coronary heart disease mortality are 
not consistent with the anti-atherogenic effects of arginine experimentally 
demonstrated in human subjects with more or less advanced atherosclerosis.9"18 
In healthy subjects, some experimental studies observed no effect on endothelial 
function after infusion or supplementation of arginine.31,32 Plasma arginine levels 
in these subjects were also unaffected after supplementation.32 This finding 
suggests that, at least under normal conditions, sufficient endogenous arginine 
can be synthesized to maintain the rate of nitric oxide-synthesis.33 However, 
some findings in healthy young subjects showed that infusion of arginine could 
increase vasodilatation and blood viscosity and reduce platelet aggregation.34 
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Studies using a tracer for arginine also have shown that dietary arginine can 
affect the endogenous arginine metabolism and plasma arginine levels in 
humans.33,35 These findings, and those from experiments in humans with a high 
risk profile for coronary heart disease, suggest a relative lack of endogenous 
arginine for the synthesis of nitric oxide, which could be restored by arginine 
administration. Uncertainty remains regarding the exact conditions in which 
insufficient endogenous arginine is present. 
An important limitation of the present study was that it included only men aged 
64-84 years at baseline. The beneficial effects of arginine on vasodilatation might 
be higher in younger populations, because stiff arteries are not as prevalent in 
the young. However, in the elderly, atherosclerosis is increasingly present, just 
as in the subjects of experiments in which anti-atherogenic effects of oral L-
arginine supplementation were demonstrated. Subgroup analysis indicated that 
in the oldest men arginine was inversely associated with coronary heart disease 
mortality, albeit non-significantly. On the basis of these data, however, 
generalizability with respect to other age-groups and women is uncertain. 
In experiments in which anti-atherogenic effects of oral L-arginine 
supplementation were demonstrated, subjects were supplemented with 3 to 21 g 117 
L-arginine per day during a short10,17 or long period.9,1112 The dose used in those "~~~" 
experiments was generally much higher than the average arginine intake in the 
present study. Therefore, it cannot be excluded that the effects of arginine on 
atherosclerosis are especially present when large amounts of arginine are 
supplemented, and that the range of dietary arginine intake in our cohort was 
not wide enough to observe an association. 
A true inverse association between arginine intake and coronary heart disease 
mortality could also be missed if the measurement of the arginine content of the 
diet is imprecise. Habitual food composition was measured by use of the cross 
check dietary history method, which is acknowledged as a valid method in an 
epidemiological setting.21 Random misclassification of dietary exposure, due to 
error in the quantification of arginine in food tables, cannot be excluded. Plasma 
arginine levels were not measured; however, these might reflect short-term 
rather than long-term dietary intake, because of endogenous synthesis and 
conversion of arginine.35 The estimate of daily average arginine intake of 4.4 g of 
the Zutphen elderly population was comparable to the estimated arginine intake 
of 4.2 g/d after 5 years of follow-up (rp=0.50, P=0.001) and to the estimated 
average arginine intake of the American diet of 5.4 g/d, which is based on the 
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arginine contents of foods available in 1970.36 In addition, using the baseline 
measurement of arginine and the measurement after 5 years of follow-up, 
arginine intake was even more strongly positively associated with coronary heart 
disease mortality compared with the measurement using arginine intake at 
baseline only. Thus, it is unlikely that misclassification of dietary exposure 
explains our findings. 
Because higher arginine intake was associated with a healthier lifestyle and diet, 
including a high energy intake, in our study population, we used several 
multivariate models to reduce residual confounding. A higher risk of coronary 
heart disease mortality with arginine intake was observed with the multivariate 
model. This apparent positive association is probably due to chance, because 
there is no biological explanation for this finding. Furthermore, the effect of L-
arginine on coronary heart disease mortality could be confounded by other 
dietary factors that were not included in our analysis. Since arginine is derived 
from different foods, other dietary factors occurring in the same foods could 
have affected the results for arginine. For instance, in addition to arginine, nuts 
also contain other potentially protective constituents.37 Furthermore, arginine 
intake is highly associated with the intake of other amino acids, such as 
118 methionine (rp=0.89, P=0.001). However, our results are adjusted for serum 
"~~~ homocysteine, the intermediate in the potential association between methionine 
and coronary heart disease. Also, other dietary factors influencing the arginine-
nitric oxide pathway, such as L-glutamine38,39 or vitamin C,40 could have 
interfered with the role of arginine. Vitamin C could inhibit the inactivation of 
nitric oxide by oxygen-derived free radicals. However, adjustment for intake of 
vegetables, fruit, or vitamin C in the analysis did not appreciably change the 
results (data not shown). 
In conclusion, we observed no association between dietary arginine intake and 
coronary heart disease mortality in a cohort of elderly men. However, this result 
can not be generalized, because of the elderly population studied and 
unmeasured dietary factors (potentially) associated with arginine. Additional 
observational studies are needed, preferably in other age groups in populations 
with a relatively high arginine intake or on more specific parameters, such as 
endothelial function. Furthermore, other lines of research, including studies 
involving biomarkers for arginine intake, should be carried out to confirm or 
reject the beneficial impact of arginine on coronary heart disease suggested by 
human and animal experiments. 
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intake and the 10-year risk of coronary heart disease among the participants in 
the Zutphen Elderly Study (chapter 5). 
Of the B-vitamins that are involved in the metabolism of the intracellular amino 
acid homocysteine, only intake of folate and vitamin B6 were inversely 
associated with homocysteine concentrations (chapter 6). However, both 
vitamins were not associated with the risk of coronary heart disease. 
Independent of homocysteine, vitamin B12 intake was significantly positively 
associated with the risk of coronary heart disease, and vitamin B2 intake was 
non-significantly inversely associated with the risk of coronary heart disease. 
Finally, intake of the amino acid arginine was not beneficially associated with the 
risk of coronary heart disease mortality, neither at the population level (chapter 
7) nor at the individual level (chapter 8). 
A overview of the main findings of this thesis is presented, according to the 
endpoint studied, in table 1. 
Table 1. Main findings of the studies described in this thesis. 
Endpoint Association? Exposure: effect estimate Ch. 
PUFA: -0.03 mmol/L per 1 energy% 2 
Weight: 0.02 mmol/L per 1 kg 2 
SFA, MUFA, trans fatty acids, cholesterol, fiber, alcohol, quit 2 
smoking, physical activity 
SFA: 0.008 mmol/L per 1 energy% 2 
Cholesterol: 0.0008 mmol/L per 1 mg 2 
Alcohol: 0.004 mmol/L per 1 g 2 
Weight: -0.008 mmol/L per 1 kg 2 
MUFA, PUFA, trans fatty acids, fiber, quit smoking, physical act. 2 
Folate: -1.4 |xmol/L in T3 vs. T l 6 
Vitamin B6:-1.1 nmol/L in T3 vs. T l 6 
Vitamin B2, vitamin B12 6 
Trans fatty acids: RR =1.28 (95% CI 1.01-1.61) per 2 energy% 3 
Fatty fish: pooled RR=0.66 (95% CI 0.49-0.90) (yes vs. no) 4 
Vitamin B2: RR=0.61 (95% CI 0.36-1.03) in T3 vs. T l 6 
Vitamin B12: RR=1.82 (95% CI 1.09-3.05) in T3 vs. T l 6 
Total fish, lean fish 3 
a-Linolenic acid 5 
Folate, vitamin B6 6 
Arginine 7, 8 
Ch= chapter, SFA= saturated fatty acids, MUFA=monounsaturated fatty acids, 
PUFA=polyunsaturated fatty acids, T=tertile, RR= relative risk, CI= confidence interval 
Total 
cholesterol 
HDL 
cholesterol 
Homocysteine 
Coronary 
heart 
disease 
Yes 
No 
Yes 
No 
Yes 
No 
Yes 
No 
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Chapter 9 — 
METHODOLOGICAL CONSIDERATIONS 
Several methodological issues deserve attention in this final chapter. We will 
discuss the precision and validity (internal and external) of the results of the 
study. 
Precision 
In the Zutphen Elderly Study, after 10 years of follow up, there were 98 
coronary heart disease cases out of 667 men without previously diagnosed 
coronary heart disease and having complete data on risk and dietary factors. For 
detecting a relative risk for coronary heart disease of 0.6 for the highest tertile of 
dietary exposure compared to the lowest tertile of the Zutphen Elderly Study at 
conventional level of statistical significance (p<0.05), the power is about 80%.1 
This power calculation indicates that it is not possible to go into subgroup 
analyses or analyses of interaction. Lack of power due to the relatively small 
sample size will primarily have resulted in rather wide confidence intervals and in 
the case of a weak true association in the absence of statistical significance. 
Internal validity 
Internal validity is the extent to which the results are valid for the target 
population. Internal validity is mainly determined by selection bias, information 
bias and bias due to confounding. Selection bias results from procedures used to 
select subjects, that lead to an effect estimate among participants of the study 
that differs from the estimate obtainable from the entire study population. 
Information bias occurs whenever there are errors in the classification of the 
diet, outcome measurement or confounding variables of subjects. Differential 
and non-differential error may lead to misclassification of a variable. An error is 
regarded as differential when the value of a variable (i.e. exposure) tends to 
vary across the true values of other relevant variables (i.e. disease status). 
Differential error can either exaggerate or underestimate an effect.2 When the 
proportion of subjects misclassified on exposure does not depend on disease 
status or when the proportion of the subjects misclassified on disease does not 
depend on exposure, the error is non-differential.2 Random non-differential error 
will generally weaken the results (dilution towards the null). However, systematic 
non-differential misclassification may also bias measures of the exposure-disease 
association away from the null, e.g. for exposure variables with more than two 
categories, when there is misclassification in two of the categories and not in the 
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others.3,4 Furthermore, non-differential misclassification of a confounding 
variable will usually reduce the degree to which confounding can be adjusted for 
and thus can cause a bias in either direction, depending on the direction of the 
confounding. 
Internal validity of our results is discussed with regard to selection bias, 
information bias of dietary intake and outcome measurement, and bias due to 
confounding. 
Selection or response bias 
When selecting a cohort at risk for disease, selection bias will usually not 
threaten validity because disease outcome has not yet manifested itself. In that 
case, loss to follow up can lead to selection bias. However, follow-up data were 
(almost) complete in the studies described in this thesis. Furthermore, in a 
population-based study, selection bias may have occurred if the respondents 
differed systematically from the non-respondents (non-response bias). However, 
since the response rate was very high for the examinations of the Seven 
Counties study in the sixties and the seventies, no major impact of non-response 
on the results is expected. For the Zutphen Elderly Study, the participation rate 
was 74% in 1985. Results from a non-response survey during the 1993 127 
examination period of the Zutphen Elderly Study, with a similar response rate as 
in 1985, showed that participants had a lower prevalence of myocardial 
infarction than non-respondents.5 Selective non-response may lead to bias in the 
assessment of the impact of diet on coronary heart disease. For example, 
systematic overestimation could have occurred if men with a low trans fatty acid 
intake and the healthiest risk profile for coronary heart disease and men with a 
high trans fatty acid intake and a high risk for coronary heart disease are 
systematically more frequently included than low trans fatty acid consumers with 
high coronary heart disease risk or high trans fatty acid consumers with low 
coronary heart disease risk. However, it is unlikely that this has occurred in the 
Zutphen Elderly Study. 
Information bias in dietary intake 
A major concern in nutritional epidemiology is the quality of dietary intake data. 
The cross-check dietary history method, which was used in the Zutphen Elderly 
Study, is, like all dietary assessment methods, difficult to validate. The 
reproducibility, an important part of the validation process, provides information 
about random error in the dietary measurement. The reproducibility of the cross-
check dietary history method was judged by repeated dietary surveys carried out 
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3 and 12 months after the initial survey of the Zutphen Elderly Study in 1985.6 
Correlation coefficients were higher than 0.70 for bread, milk products and 
alcohol beverages, while for meat and for vegetables correlation coefficients 
ranged from 0.44 to 0.51. This may have adversely influenced the reproducibility 
of nutrients for which vegetables and meat are the main source e.g. folate. For 
energy, saturated and unsaturated fat, cholesterol, protein and vitamin B2, 
attenuation factors between 0.65 and 0.90 are found. This implies that the 
nutrient-disease association will be lowered only slightly because of error in the 
dietary measurement. Relative validity of the cross-check dietary history method 
has been investigated by several authors, using e.g. the diet record method or 
the fatty acid composition of lipid fractions as a reference.7,8 In these studies, 
correlation coefficients between the dietary history method and the reference 
method ranged from 0.4 to 0.9. If these differences in ranking individuals with 
regard to dietary intake between the two methods are the result of random 
error, this indicates that dietary measurement error will weaken the results to 
some extent. 
The within-person error which occurs when the cross-check dietary history 
method is used may be either random or systematic. However, systematic 
128 within-person error is difficult to measure in validation studies since, for most 
food components, no current method has so far been able to measure 'true' 
long-term dietary intake. Persons may consciously or unconsciously tend either 
to underestimate or to exaggerate their food intake. Nutrients that are often 
underreported are e.g. fat and alcohol. Consumption of fruit and vegetables, and 
consequently intake of vitamins from these foods, is often overreported. 
Systematic incorrect reporting of food intake could have lead to differential error 
because it may depends on persons' risk profile for coronary heart disease, e.g. 
age or body mass index. However, besides persons' risk profile, the subject's 
ability to report food consumption accurately depends on many other factors e.g. 
memory, awareness of dietary risk factors and the variety of foods consumed.9 
Probably some misclassification of dietary exposure may therefore have occurred 
due to both differential and non-differential error. Expression as a proportion of 
total energy9 or adjustment for these risk factors in the analyses will reduce, but 
not totally exclude, misclassification of dietary exposure. 
In the chapters 2, 3, 5, 6 and 8 of this thesis, food composition data for 
approximately 1000 foods that were consumed by the participants of the 
Zutphen Elderly Study were used to calculate the nutrient intake of interest. A 
lot of effort was put to limit measurement error in nutrient intake due to errors 
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and missings in the food composition data. We used a nutrient database that 
was improved on inconsistencies, new analytical methods and missing data.10 
Furthermore, the database was updated with changes of nutrient contents in 
foods over time.10,11 This was particularly important for the intake of fatty acids, 
because meat products and many prepared foods changed considerably in their 
fat content and fatty acid composition between 1985 and 1995, the examination 
period of the Zutphen Elderly Study. The percentage of trans fatty acids in fats 
for use in households decreased substantially in the Netherlands during that 
period. In addition, as a result of selective breeding, a reduction in fat content of 
meat took place already before 1985. However, due to a delay in registration 
inherent to a nutrient database, the fat intake from meat calculated with the 
1985 database would have resulted in an overestimation, while the updated 
database took these changes into account.10 Consequently, improving food 
composition data to calculate nutrient intake would have reduced 
misclassification, however, residual non-differential error of nutrient intake 
cannot totally be excluded. 
For trans fatty acids, differences in the analytical methods may have introduced 
systematic measurement error. Therefore, in the compilation of the trans fatty 
acids food composition table, we adjusted for differences in analytical methods 129 
used for the determination of the trans fatty acids content. However, these 
adjustment for differences in analytical methods were shown to have only a 
small effect on ranking persons based on their trans fatty acids intake.11 
Another source of variation with respect to food composition data that is more 
difficult to estimate is the variation with respect to type, brand or preparation of 
the food.12 For example, processing, cooking or storage of foods can lead to 
large differences in the food content of many vitamins. In our assessment of 
folate intake used in chapter 8, we used detailed analyzed data about the food 
folate composition, taking into account the great variability in the folate content 
of foods.13 Therefore, bias in our calculation of folate intake due to non-random 
sampling for chemical analysis is limited. However, due to lack of information of 
e.g. brand names in our consumption data, we could not capture all variation in 
nutrient intake at the individual level. 
A single measurement of dietary intake may not represent long-term exposure, 
especially if dietary exposure tends to change over a period of time relevant to 
the risk of disease. In addition, it is important to know for which dietary 
component what period of time before diagnosis is relevant. Therefore, baseline 
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as well as time-dependent or cumulative analyses were performed in all chapters 
to take exposure at different periods of time into account. 
In addition to methodological aspects of measuring dietary intake, bioavailability 
of nutrients (the variation in utilization by the body of a nutrient present in 
different foods) could have influenced the fraction of nutrients absorbed and 
used, and consequently the association between nutrient intake and disease. It 
is known that bioavailability of folate may differ in vegetables and fruits, 
depending on the food matrix and the chain length of folate in food.14 
Homocysteine is a functional parameter of folate status. In chapter 6 we 
observed that a mean difference in the highest and lowest tertile of folate intake 
of 93 \ig/d was associated with a mean decrease in homocysteine concentrations 
of 1.4 nmol/L A reduction of 25% or about 3 nmol/L in homocysteine 
concentrations can be achieved with folic acid supplements in randomized 
trials.15 However, these data are difficult to compare with dietary intake data 
because supplementation trials used a much higher dosage (0.5-5 mg/d) of folic 
acid, and folic acid from supplements has about twice the bioavailability of food 
folate.14 The association between homocysteine and dietary folate as observed in 
chapter 6 was comparable with that observed in other observational studies 
130 (about -1 nmol/L homocysteine per 100 |xg/d folate).16,17 This suggests that the 
measurement of folate intake provides a good index of the bioefficacy of folate. 
Besides folate, bioavailability is applicable to virtually all nutrients.12 However, 
until now, it has been scarcely studied. 
Other methodological limitations in dietary intake may have occurred in the 
observational studies on arginine intake and coronary heart disease mortality. 
We reported no beneficial association with coronary heart disease mortality in 
two studies described in chapter 7 and 8. First, this could be due to the amount 
of arginine in the diet found in observational studies. Beneficial effects of 
arginine were observed in experimental studies, however, using a much higher 
dose (6-21 g/d) compared to the intake of arginine from habitual food 
consumption.18 Second, in chapter 7, cross-cultural data of the Seven Countries 
Study were used to establish this relationship. An advantage of ecological studies 
is the much larger variation in dietary intake between-populations than within-
populations. In contrast, no causal inferences can be made about individual-level 
phenomena.19,20 Third, the degree of variation in arginine intake might not be 
adequate to study associations between arginine and coronary heart disease 
mortality in the individual data of the Zutphen Elderly Study (chapter 8). In the 
Zutphen Elderly Study, the variation coefficient (=standard deviation/mean) was 
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25% for arginine intake. This is much lower compared to e.g. the variation 
coefficient of 58% for trans fatty acid intake, which was significantly associated 
with coronary heart disease risk in this cohort. 
In conclusion, in the Zutphen Elderly Study, the dietary intake was assessed 
accurately, taking into account limitations of the use of a food composition table 
as much as possible. However, misclassification of dietary exposure will be 
present to some extent. This is especially a problem when true associations are 
weak and contrasts in the intake of dietary factors are small. Methodological 
limitations with respect to dietary intake may partly explain the absence of an 
association between coronary heart disease risk and the intake of different B-
vitamins (chapter 6) and arginine (chapter 8). 
Information bias in outcome measurement 
Information bias in the ascertainment of coronary heart disease (mortality) could 
have introduced measurement error in the outcome variable. Municipal registries 
were used to obtain the date of death, which are known to provide valid data. 
Cause of death was obtained from Statistics Netherlands, or collected through 
hospital discharge data and/or general practitioners. For some dietary factors, 
i.e. arginine and fish, we focused only on coronary heart disease mortality 131 
because experimental evidence showed that coronary heart disease mortality ~~—" 
appeared to be of primary importance. However, it is important to realize that 
when only coronary heart disease mortality was chosen as outcome, men with a 
non-fatal myocardial infarction were classified as non-case. It may be questioned 
whether this decision was always supported by etiological evidence. Similarly, 
other diseases associated with coronary heart disease, i.e. non-identified silent 
infarctions, could have influenced the results if associated with diet. This could 
have weakened our findings on e.g. arginine intake. Concerning the other 
relations between dietary factors and coronary heart disease (chapters 3, 5, 6), 
we studied associations between different dietary factors and fatal coronary 
heart disease as well as non-fatal myocardial infarction. Because of power, we 
focused on the association of fatal plus non-fatal coronary heart disease. The 
notion that the results on both outcome measurements were consistent makes it 
unlikely that misclassification in the outcome variable has affected our results. 
Confounding 
Inadequate adjustment for confounding is another major threat to the internal 
validity of the results. In studying relations between dietary factors and coronary 
heart disease, all currently known potential confounders including age, smoking, 
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alcohol consumption, physical activity and other dietary factors were adjusted 
for. However, in case of misclassification, residual confounding may still occur 
after adjustment for confounding, leading to underestimation or overestimation 
of the strength of an association.2 As addressed in chapter 5, the non-significant 
positive association between a-linolenic acid intake and coronary heart disease 
may have occurred due to the strong correlation between intake of a-linolenic 
acid and trans fatty acids. Even when adjustment for trans fatty acids is 
performed, the potential for residual confounding by trans fatty acids remains. 
This was excluded by studying a-linolenic acid from sources without trans fatty 
acids. However, due to the small amount of a-linolenic acid from sources without 
trans fatty acids, the relationship between a-linolenic acid intake and coronary 
heart disease incidence could not be studied adequately. Arginine intake was 
also strongly associated with the intake of other dietary factors, including 
energy, methionine and flavonols through its widespread presence in animal and 
vegetable foods. The potential protective effect of arginine on coronary heart 
disease is therefore difficult to disentangle. No such strong confounders have 
been known in case of the significant associations observed in this thesis, i.e. the 
inverse association between fish consumption and coronary heart disease 
mortality, and the positive association between trans fatty acid intake and 
coronary heart disease. The crude and adjusted results were similar and support 
the large body of experimental and observational evidence on these associations. 
This convinced us that the reported associations are probably causal. 
We performed analyses on energy-adjusted nutrient intakes in relation to the 
occurrence of coronary heart disease. This was done in order to compare 
nutrient intakes of subjects independent of variations in energy intake, to adjust 
for confounding and to reduce extraneous variation.21 In addition, from a public 
health point of view, changes in energy intake cannot be made unless changes in 
weight or physical activity also occur, therefore, changes in nutrient intake must 
be accomplished by changes in the composition of the diet. Due to their 
contribution to energy, intake of fat, protein and carbohydrate are difficult to 
isolate from energy. Other nutrients, however, were also correlated with total 
energy intake even though they did not contribute to energy intake. For 
example, the correlation coefficients between intake of energy and the individual 
B-vitamins studied in chapter 6 were between 0.28-0.59. These correlations 
highlight the need to consider total energy intake when interpreting associations 
between specific nutrients and disease occurrence in epidemiological studies. In 
each of the studies reported in this thesis, we considered several approaches to 
adjust appropriately for energy intake.21 In the data of the Zutphen Elderly 
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Study, there was an inverse association between energy intake and coronary 
heart disease (9% reduction in coronary heart disease (p=0.03) for each 
increase in energy of 1 MJ), which became weaker and non-significant after 
adjustment for age, smoking, body mass index, physical activity and prevalence 
of coronary heart disease. This crude inverse association between energy intake 
and coronary heart disease may not be assigned to energy intake, but to a 
general healthier (including more physically active) lifestyle which is associated 
with energy intake. For this reason, in epidemiological studies nutrient intakes 
adjusted for energy intake are of primary interest in relation to disease risk.21 
Another important confounder in the relation between dietary factors and risk of 
coronary heart disease is the baseline prevalence of coronary heart disease. In 
chapter 3, 4 and 5, the men with a history of coronary heart disease were 
excluded from the analyses. Restriction to men without previously diagnosed 
coronary heart disease was particularly important in the Zutphen Elderly Study, 
due to the high proportion of men with a history of coronary heart disease 
(19%) having a high 10-year recurrence rate of coronary heart disease (29%; 
coronary heart disease mortality 26%). In addition to the results described in 
chapter 3, we observed no association between trans fatty acid intake and 
coronary heart disease in prevalent cases of coronary heart disease (data not 133 
shown). Probably the recurrence of coronary heart disease is not influenced by 
trans fatty acid intake. An alternative explanation is that coronary heart disease 
cases could have changed their food and nutrient intake. Individuals who suffer 
from coronary heart disease may follow the advice to reduce their intake of hard 
margarines rich in trans fatty acids. For other dietary factors studied in the 
Zutphen Elderly Study, i.e. B-vitamins, arginine, and oc-linolenic acid, no clear 
association was observed with coronary heart disease incidence neither in the 
total population, nor after excluding the men with a history of coronary heart 
disease. 
In addition to the confounders that were taken into account, residual 
confounding may occur for possible known or unknown confounders that have 
not been included in the analyses. It is important to be sure that the beneficial 
effect of fatty fish consumption on coronary heart disease as well as the 
detrimental effect of trans fatty acids intake on coronary heart disease cannot be 
explained by confounders. On the other hand, some true associations might 
have been obscured due to residual confounding. Known risk factors, but difficult 
to operationalize, may have influenced the results. Persons who choose to 
consume fish are generally more health conscious (chapter 4). We included 
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several variables into the analyses to adjust for indicators of a healthy diet and 
lifestyle e.g. use of vitamin supplements or physical activity. However, since 
energy intake per kg body weight was used as an approximation of physical 
activity, the degree of adjustment for physical activity in the association between 
fish consumption and coronary heart disease mortality might be limited. Also, 
other factors such as drug use or self-rated health may be more appropriate 
health indicators. Socio-economic status is another parameter associated with 
both dietary intake and coronary heart disease. In the Zutphen Elderly Study, 
associations between dietary factors and coronary heart disease remained 
similar after additional adjustment for occupational history of the men. However, 
one may question whether socio-economic status is a risk factor for coronary 
heart disease, or a marker for lifestyle or dietary habits including trans fatty 
acids intake or fish consumption. In case of the latter, adjusting for socio-
economic status would have overadjusted the results. Finally, there may also be 
unknown risk factors which are both associated with dietary intake (including 
trans fatty acids intake and fish consumption) and coronary heart disease. We 
adjusted for the intake of antioxidant vitamins in the Zutphen Elderly Study, and, 
in the study on fish consumption, for potential protective foods such as 
vegetables and fruits. However, intake of other bioactive compounds in foods 
e.g. polyphenols could not be included in the analyses, therefore, residual 
confounding cannot be totally excluded. 
In conclusion, residual confounding will not have a great impact on the 
association between coronary heart disease risk and fatty fish consumption or 
trans fatty acid intake. Residual confounding may still exist in the relation 
between a-linolenic acid and coronary heart disease risk, and between arginine 
intake and coronary heart disease risk, due to the strong correlation with other 
dietary and/or other risk factors. 
External validity 
External validity of the studies refers to the generalizability of the findings with 
respect to relations between dietary factors and coronary heart disease risk. For 
the interpretation of our findings, the biological relevance i.e. the use of an 
elderly male population has to be considered. Specific features of elderly 
populations with regard to methodology and etiology are discussed in this 
paragraph. Furthermore, generalizability of our findings with regard to women is 
considered. 
General discussion 
The prevalence of diagnosed and undiagnosed disease at baseline is high in a 
population as the Zutphen Elderly Study. This could have influenced the results if 
the underlying disease is associated with diet as well as with coronary heart 
disease occurrence and is no intermediate in the relation between diet and 
disease. Adjustment or stratification for prevalence of diabetes mellitus or 
hypertension did not influence the results. In chapter 2, history of common 
chronic diseases (cardiovascular diseases, cancer and diabetes mellitus) after 10 
years of follow-up was an effect modifier in the relation between changes in body 
weight and changes in total cholesterol. This suggests that morbidity could have 
contributed to the positive association between body weight and total cholesterol 
in this population of elderly men. However, in men without chronic diseases, 
other (undiagnosed) diseases like infections, physical health problems or 
depression may also have (differently) modified body weight or total cholesterol 
concentrations. This indicates that the proportion of men without any disease 
relevant to studying the effect modification of disease in the association between 
body weight and total cholesterol is expected to be low. Therefore, in this 
population of elderly men, it was not possible to study the interaction with 
disease status in detail. 
Other methodological issues with respect to elderly populations need to be 135 
considered for interpretation of the results. Most considerations have already 
been extensively discussed previously.22 It is, for example, possible that the 
associations between diet and coronary heart disease are weaker in an elderly 
population, since the susceptible individuals with unhealthy dietary habits have 
already been eliminated from the population (selective survival). Besides, an 
elderly population has a high risk for coronary heart disease, which is reflected 
by the high incidence rate and the high prevalence of risk factors. This positively 
influences the power of the study, making it possible to study associations 
between dietary factors and coronary heart disease incidence in relatively small 
sample sizes. Associations between dietary factors and disease occurrence e.g. 
fish consumption and coronary heart disease mortality will have a large absolute 
impact in a high-risk population as the elderly. However, because the magnitude 
of a relative risk depends on the incidence rate in the reference group, the same 
absolute risk can correspond to smaller relative risks in a high-risk compared to 
a low-risk population.2 
Alterations in etiology of coronary heart disease in elderly people may also have 
an impact on the association between the dietary factors and coronary heart 
disease risk. Although we observed no association between arginine intake and 
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coronary heart disease mortality in the elderly (chapter 8), we cannot exclude 
the possibility that arginine intake is beneficially associated with coronary heart 
disease mortality in younger populations. Experimental studies demonstrated the 
anti-atherogenic effects of high dosage of arginine mainly in human subjects 
with atherosclerosis. The beneficial effects of arginine intake might be weaker in 
the elderly, e.g. if arginine could improve especially the early stages of 
atherosclerosis.23 In addition, the requirements for essential amino acids and 
total protein of elderly people are higher than for younger persons, because of 
the higher prevalence of disease in the elderly.24 Until now, except for the 
observational studies described in chapter 7 and 8, no other prospective studies 
on arginine intake and the risk of coronary heart disease were reported. 
In concurrence with the high prevalence of atherosclerosis in the elderly, dietary 
factors potentially affecting the progression of coronary heart disease including 
e.g. thrombosis may become stronger associated with the risk of coronary heart 
disease. An elevated blood concentration of homocysteine may be an 
independent risk factor for coronary heart disease in prospective studies, as 
shown in the Zutphen Elderly Study,25 due to promotion of both atherogenesis 
and thrombosis. On the other hand, although in the Zutphen Elderly Study folate 
136 and vitamin B6 intakes were associated with lower homocysteine concentrations, 
" they were not associated with coronary heart disease risk. In addition, a-linolenic 
acid, which is considered to have effects on thrombosis and arterial 
compliance,26"30 was not associated with the risk of coronary heart disease in the 
Zutphen Elderly Study. 
It is also possible that the severity of the manifestation of coronary heart disease 
has changed over time, and consequently has influenced the impact of diet on 
coronary heart disease. The elderly population is becoming older: the number of 
persons over 80 years of age is growing rapidly in many countries including the 
Netherlands.31 There has been a substantial reduction in coronary heart disease 
mortality among older persons in the past decades. This reduction may be due to 
a lower incidence (fewer new events), and to a substantial reduction in in-
hospital case-fatality rates for acute myocardial infarction (i.e. a higher survival 
rate).31 Manifestation of coronary heart disease might has become less severe as 
a result of already improved lifestyles and better management of risk factors. 
This is supported by e.g. the decline in total cholesterol levels in the Netherlands 
during the last decade.32,33 
— General discussion 
In conclusion, methodological and etiological issues with respect to the use of an 
elderly population in epidemiological research could have influenced the strength 
of the associations in either direction. Therefore, and because of lack of previous 
observational studies on the relation between arginine intake and coronary heart 
disease, the results of chapter 7 and 8 should not be generalized. However, for 
the other dietary factors studied in this thesis, there is no indication of effect 
modification by age from other prospective studies in large populations with a 
wide range in age.34"38 In addition, chapter 2 of this thesis shows that the 
strength of the associations between changes in diet and weight and changes in 
cholesterol in an elderly population is comparable with to those obtained in 
younger populations. Therefore, the associations observed in this thesis are not 
necessarily different from those in younger populations. 
Finally, in the Seven Countries Study, women were excluded during the baseline 
survey because coronary heart disease was viewed as a major health problem of 
middle-aged men only. Gender-differences in coronary heart disease rates 
worldwide31 suggest differences in the manifestation of coronary heart disease 
by gender. Other prospective studies among populations that included women, 
however, do not suggest that the associations between dietary factors and 
coronary heart disease are modified by gender.37,39 Therefore, it is unlikely that 137 
the results of this thesis are only applicable to men. 
CONCLUSIONS 
This thesis focused on the role of dietary factors in coronary heart disease 
occurrence. 
We observed that changes in intake of saturated fat, polyunsaturated fat, dietary 
cholesterol and alcohol, and changes in body weight were significantly related to 
changes in total and/or HDL cholesterol concentrations (chapter 2). 
In chapter 3 of this thesis, we showed a positive association between trans fatty 
acid intake and coronary heart disease risk in a prospective cohort study of 
Dutch elderly men. These results are comparable with those from other 
prospective studies. Combining the observational evidence, the pooled relative 
risk of coronary heart disease associated with an increase of 2 energy percent in 
trans fatty acid intake is 1.25. 
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In chapter 4 of this thesis we showed that men who consumed fatty fish 
experienced a 34% lower risk of coronary heart disease mortality compared to 
no fatty fish consumers after 20 years of follow up (chapter 4). These data, 
together with the results of studies on the effect of n-3 fatty acids, suggest that 
n-3 fatty acids are responsible for the protective effect of fish. 
Intake of a-linolenic acid (chapter 5), B-vitamins (chapter 6), and arginine 
(chapter 7 & 8) were not related to the risk of coronary heart disease in the 
Zutphen Elderly Study or Seven Countries Study. 
I n te rp re ta t i on of the f ind ings 
Concerning the interpretation of these results, some methodological issues have 
to be taken into account (table 2). 
Table 2. Summary of the interpretation of the results concerning the relation 
between dietary factors and coronary heart disease studied in this thesis. 
Chapter 
3 
4 
5 
6 
7, 8 
Dietary factor 
Trans fatty acids 
Marine n-3 fatty acids 
a-linolenic acid 
Folate, vitamins B2, B6, B12 
Arginine 
Impact on 
CHD proven? 
Yes 
X 
X 
No 
X 
X 
X 
Comment 
(from this thesis) 
Consistent 
Consistent 
Residual confounding 
trans fatty acids 
Methodological 
limitations (see text) 
Methodological 
limitations (see text) 
First, the relation between a-linolenic acid and coronary heart disease could not 
be studied independently from trans fatty acid intake because the intake of cc-
linolenic acid and that of trans fatty acids was strongly correlated in the Zutphen 
Elderly Study. In addition, the true associations between the intake of different 
B-vitamins and coronary heart disease may have been too weak to observe due 
to the limited power of the present study or to a relatively small variation in the 
intake of B-vitamins from only foods (information about the intake of B-vitamins 
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from supplements was not available). For arginine, methodological limitations 
refer to a limited variation in arginine intake or the failure of ecological-level 
associations to reflect individual-level associations. Therefore, the impact of a-
linolenic acid, arginine and B-vitamins on coronary heart disease is evaluated as 
inconclusive (table 2). 
P U B L I C HEALTH RELEVANCE 
In chapter 2, we noted that the strength of the associations between changes in 
body weight, consumption of alcohol, saturated, polyunsaturated, trans fatty 
acids and dietary cholesterol and changes in total or HDL cholesterol are 
comparable with those from observational studies in different age-groups and to 
those observed in experimental studies performed in younger populations. 
Prevention strategies to improve cholesterol concentrations are therefore 
relevant also at old age. The benefits and risks of weight loss, however, are 
difficult to determine from observational studies because it is not possible to 
distinguish voluntary from involuntary or disease-induced weight loss. However, 
the similarity of observed associations with the results from intervention studies . gg 
makes it likely that weight reduction in general results in improvement of —— 
cholesterol concentrations. Further, research is needed to determine whether, 
under what circumstances, and by what means weight loss is beneficial in the 
elderly. 
The inconsistent results in the literature on a-linolenic acid, arginine and B-
vitamins make it impossible to propose public health recommendations yet. We 
will discuss the public health recommendations of trans and marine n-3 fatty 
acids in the following paragraphs. 
Trans fatty acids 
The positive association between trans fatty acid intake and the risk of coronary 
heart disease as described in chapter 3 is supported by the results from dietary 
intervention studies which have shown that trans fatty acid intake increases LDL 
cholesterol and decreases HDL cholesterol.40 Insufficient and inconsistent data 
are available about the effect of trans fatty acids on insulin sensitivity41,42 or 
hemostatic factors.43,44 There are no prevention trials conducted that 
investigated the effect of trans fatty acids intake on coronary heart disease. 
However, the available evidence from both observational and dietary 
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intervention studies on serum total and HDL cholesterol indicates a causal 
relation between trans fatty acid intake and coronary heart disease risk. 
The industrial lowering of the trans fatty acid content in Dutch edible fats was 
suggested to be important from a public health perspective.45 In chapter 3, we 
estimated that a decrease in trans fatty acid intake of 2.4% of energy as shown 
in our cohort could have contributed to about 23% less coronary deaths. In 
Dutch margarines trans fatty acids were partly replaced by saturated fatty acids. 
However, the sum of trans and saturated fatty acids in margarines decreased by 
about 10-15% in favor of cis unsaturated fatty acids.46 In addition, the studies 
on the replacement of trans fatty acids in margarine with saturated fatty acids 
suggest a favorable effect on plasma lipid levels.47 
A reduction in trans fatty acid intake from both manufactured and ruminant 
sources may be important from a public health perspective. In chapter 3, we did 
not find any difference in associations between coronary heart disease and 
ruminant trans fatty acid intake, intake of C18:l trans isomers and other trans 
isomers from manufactured sources. The difference in effect of trans fatty acids 
from ruminant sources and manufactured sources as observed in some 
I4Q population-based studies may be attributable to a small between-person 
—-— variability in ruminant rather than manufactured trans fatty acid intake.36,48,49 
Dietary intervention studies on blood lipids that used different trans isomers 
have shown identical results.50"53 However, there are no studies addressing 
specifically the effects of trans-vaccenic acid from ruminant fat. In addition, 
some differences in metabolism of different trans fatty acids are suggested.54 A 
study using an in-vitro model of the human intestinal cell suggests that, of the 
trans isomers, the effects of elaidic acid may be more pronounced on serum 
triglyceride and HDL cholesterol, while the effect of vaccenic acid or palmitelaidic 
acid may be more pronounced on LDL cholesterol.55 The multiple mechanisms 
which are suggested to underlie the effects of the individual trans fatty acids on 
lipid profiles need further investigation. So far, the issue about the health effects 
of trans fatty acids from ruminant sources is not settled yet. 
In the Netherlands, age-adjusted coronary heart disease incidence, mortality and 
case-fatality decreased between 1972 and 1994.56 Several registration data, 
standardized for the size and composition of the population, were used to 
quantify this decline. The number of hospitalizations for acute myocardial 
infarction decreased by 19% in men and 5% in women between 1972 and 1994. 
Some more specific data were available on the decline in coronary heart disease 
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incidence during the examination period of the Zutphen Elderly Study. Between 
1988 and 1994, incidence of a first-ever myocardial infarction decreased about 
30% in men and women in the Netherlands. In addition, the decrease in 
suspected myocardial infarction between 1983 and 1994 was about 2 1 % in men, 
whereas no such decrease was observed in women during this period.56 This 
decline may be explained by the better management of risk factors and 
improved lifestyles, including the decline in trans fatty acid intake. However, 
since other changes may also have occurred, e.g. changes in prescription 
guidelines and drug use with improved efficacy, no direct conclusions can be 
derived on these trend data on coronary heart disease. 
Our study showed that food manufacturers can play an important role in 
population-based strategies to reduce coronary heart disease risk. Individualized 
dietary counseling has primarily been proposed as a method of achieving 
population goals for reducing coronary heart disease. However, when dietary 
interventions are implemented in community settings the effectiveness is 
generally moderate.57,58 Especially the effectiveness of simple low fat and low 
cholesterol diets is small, probably due to difficulties in complying with the 
prescribed dietary advice. Larger effects, however, were seen when studies have 
focused on promoting fatty fish consumption59 or on promoting a Mediterranean 141 
diet combined with changes in the composition of margarine.60 
For public health purposes, changes in food composition together with individual 
dietary counseling may improve the effectiveness of preventive strategies. 
Recently, a decrease in total fat intake of 2.8% of energy in the Netherlands was 
achieved due to changes in consumption patterns (e.g. shift to skimmed milk 
products) and new products with low fat content that became available in the 
past 10 years.10 Besides a lower content of trans fatty acids, the current 
margarines contain also a-linolenic acid. More specific changes in food 
composition may support individual dietary counseling. Recently new margarines 
containing plant stands or sterols were launched that are useful for more 
effective low density lipoprotein cholesterol lowering in high-risk individuals or 
cardiac patients.60 The compliance to the consumption of these products, their 
long-term side-effects and, consequently, their effectiveness in prevention 
strategies, however, needs to be evaluated. 
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Fish, n-3 fa t t y acids 
Many studies have investigated the effect of fish consumption or n-3 fatty acids 
and coronary heart disease. Combining the results of these studies, conclusions 
can be drawn about the public health impact of fish consumption. 
Most, but not all, observational studies observed an association between fish or 
marine n-3 fatty acids and the risk of coronary heart disease mortality. Several 
explanations for the inconsistency in results can be mentioned. In a review on all 
prospective cohort studies on the association between fish intake and coronary 
heart disease mortality, fish consumption was suggested not to be associated 
with coronary heart disease mortality in low-risk populations.62 Furthermore, a 
high mercury content in fish could counteract the protective metabolic effects of 
fatty acids in fish. The mercury content of fish from Finnish lakes is known to be 
high. In the Finnish data of chapter 4, a smaller protective effect of fatty fish was 
observed compared to the results in the two other countries. A recent 
prospective study from Finland showed that the protective effect of fish was 
dependent on its mercury content.63 Finally, in chapter 4 of this thesis, we 
suggest that further inconsistencies could be explained by the n-3 fatty acid 
content in fish. An inverse association between n-3 fatty acids intake and 
(sudden) cardiac death is observed in most,34,38,64 although not all65 
observational studies. Non-differential misclassification of n-3 fatty acids intake 
may partly explain this, due to measurement error in the food tables. 
The beneficial biochemical effects of marine n-3 fatty acids were studied in many 
human intervention as well as observational studies. Marine n-3 fatty acids have 
been shown to decrease triglyceride and very low density lipoprotein levels in 
dietary intervention studies.66 In an observational study, besides a significant 
reduction in serum total triglycerides also a significant reduction in the 
triglycerides of the very atherogenic intermediate density lipoprotein faction was 
observed of the men who consumed fish once a week compared to a control 
group.67 Results of intervention studies on the impact of marine n-3 fatty acids 
on hemostatic factors are insufficient and inconsistent. There is some evidence, 
however, for a beneficial effect on bleeding time and erythrocyte flexibility from 
studies using a high dose (>1.8 g/d) of n-3 fatty acids.68 No differences between 
thromboxane formation, bleeding time and platelet number were observed 
among habitual fish consumers compared with controls.69 An inverse dose-
response effect on blood pressure for a high n-3 fatty acid intake (>3 g/d) is 
observed in a meta-analyses of controlled trials.70 In epidemiological studies no 
relation could be detected between fish consumption and blood pressure.71 
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Marine n-3 polyunsaturated fatty acids may also have an effect on the elasticity 
of the arterial wall. In humans, marine n-3 fatty acids may improve endothelial 
function by increased synthesis of nitric oxide.72 Another index of arterial 
function, compliance, was better in healthy subjects and diabetic patients who 
consumed fish compared with no-fish consumers.73 
Until now, three secondary prevention trials studied the protective effect of fish 
or n-3 fatty acids on cardiac events. In the Diet and Reinfarction trial (DART), 
cardiac patients received either or not the advice to use fatty fish two or three 
times per week.59 The difference in fatty fish consumption was associated with a 
significant reduction of 29% in all cause mortality during 2 years of follow up, 
which was entirely attributable to coronary heart disease mortality. In a trial 
from India (IEIS-4), patients with suspected myocardial infarction were 
randomized to daily supplementation with fish oil, mustard oil or placebo.74 
Cardiac events were significantly reduced after 1 year in the fish oil group. 
However, the interpretation of this finding is problematic because no 
adjustments were made for differences in other characteristics (e.g. smoking 
habits) between the experimental and control groups. In the GISSI-prevention 
trial, survivors of a myocardial infarction were randomly assigned to one of four 
groups receiving dietary supplementation of marine n-3 fatty acids of 850 mg/d, 143 
vitamin E, a combination or no supplements, and were followed for 3.5 years.75 
In a four-way analysis investigating each group, there was a significant relative 
reduction of 35% in cardiac death (combined coronary heart disease death and 
sudden death) in patients assigned to n-3 fatty acid treatment. In the two-way 
factorial analysis, the relative reduction in risk for cardiac death was 28% and 
also significant. 
The reductions in cardiac events in the DART and GISSI trial could have partly 
been explained by the effects of n-3 fatty acids on triglyceride levels and 
hemostatic profile. In addition, since there was no significant reduction in non-
fatal myocardial infarction in the experimental groups of these trials, benefits 
may also have resulted from an antiarrhythmic effect of n-3 fatty acids. Also in 
the observational data of the Physicians' Health Study, an inverse association 
was observed between fish consumption and the risk of sudden cardiac death,38 
while no association was observed on nonfatal coronary heart disease.76 
However, the Western Electric Study reported an inverse association between 
fish consumption and the risk of non-sudden but not sudden myocardial 
infarction.77 Differences in ascertainment of the endpoint sudden death may 
explain these inconsistencies. The antiarrhrythmic effects of marine n-3 fatty 
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acids were supported by a retrospective, population-based case-control study on 
primary cardiac arrest.64 Until now, antiarrhythmic properties of marine n-3 fatty 
acids have primarily been shown in in-vitro and animal studies.78,79 The 
antiarrythmic effect of n-3 fatty acids investigated dietary human intervention 
trials by the means of heart rate variability is suggested in patients as well as 
healthy individuals.80 In a cross-sectional study, a modest intake of n-3 fatty 
acids from fish was also positively associated with heart rate variability among 
patients referred for coronary angiography.81 
Combining the evidence of observational and experimental studies on the effect 
of fish or n-3 fatty acids, the optimal intake to prevent coronary heart disease 
mortality could be assessed. In chapter 4, we observed a reduced risk of 
coronary heart disease mortality for the men consuming fatty fish compared to 
those who consumed no fatty fish. The mean intake of those who consumed 
fatty fish ranged from 11 in the Netherlands to 25 g/d in Finland, or between 
about 250-500 mg/d marine n-3 fatty acids. Most observational studies 
(including our study described in chapter 4) did not observe additional protection 
for coronary heart disease with a higher intake of (fatty) fish. In the DART trial, 
the difference in average intake of eicosapentaenoic acid (EPA) between two 
144 groups was reported to amount 230 mg/d.59 The total intake of n-3 fatty acids 
"""""" (including docosahexaenoic acid=DHA) in the DART trial, however, may be at 
least about 500 mg/d (given that the content of EPA and DHA in fish is at least 
similar, and that the fish advice was at least 28 g/d). In the GISSI trial, although 
a n-3 fatty acid supplementation of 850 mg/d was prescribed, about 30% of the 
patients permanently stopped taking n-3 fatty acids after 1 year.75 Therefore, 
the average intake of about 600 mg/d n-3 fatty acids may have been responsible 
for the reduction in cardiac deaths in this trial. 
High consumption of n-3 fatty acids could be associated with higher susceptibility 
to oxidation of LDL cholesterol, and consequently to increased atherosclerosis. 
Whether an increased intake of n-3 fatty acids leads to a clinically relevant 
enhanced in vivo oxidation of LDL cholesterol, however, is debatable.82 Data 
from the GISSI trial do not suggest that the protective effect of n-3 fatty acids 
depends on the intake of vitamin E, an antioxidant which could protect LDL 
cholesterol from lipid peroxidation.75 In addition, supplementation of n-3 fatty 
acids with 1.5 g/d for 2 years did not suggest to increase atherosclerosis.83 
We support the recommendations of a published expert workshop summary.71 
Results obtained so far from epidemiological studies, animal experiments and 
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controlled trials in humans suggest that the risk of coronary heart disease 
mortality and sudden cardiac death may be reduced by intake of marine n-3 
fatty acids. This effect may only occur in high-risk individuals, i.e. in cardiac 
patients or in those with unhealthy lifestyles including smoking, a high saturated 
fat intake and a low fish intake. People at risk for coronary heart disease are 
therefore advised to eat fish, preferably fatty fish at least once a week. Since in 
the Netherlands only 32% of the men and 29% of the women consumed fish at 
least once a week in 1996, and about 40% of the fish consumed is fatty fish,84 
this suggest that the public health impact of an advice on (fatty) fish 
consumption could be substantial. 
FUTURE RESEARCH 
The studies presented in this thesis emphasize the importance of diet in the 
occurrence of coronary heart disease. Changes in food composition with respect 
to the trans fatty acid content had probably an important impact on public 
health. Nowadays, attention has to be paid to lower the trans fatty acid content 
of other industrial derived foods and to the substitution of trans fatty acids by cis .. .,-
unsaturated fatty acids. —— 
Despite the large number of studies completed on the beneficial effect of fish and 
marine n-3 fatty acids, the quantification of risk reduction for a regular 
consumption of fish remains relatively imprecise. Intervention studies of marine 
n-3 fatty acids on sudden cardiac death could support, and more accurately 
estimate, the intake of n-3 fatty acids needed for maximal health benefit. With 
respect to the feasibility of such intervention, high-risk individuals should be 
recruited, e.g. cardiac patients, to limit the number of participants, and 
consequently the costs, needed to study this relationship. 
The number of prospective studies on the association between coronary heart 
disease risk and intake of a-linolenic acid, folate, vitamins B2, B6 and B12 and 
arginine is limited. Because of some methodological shortcomings in our studies, 
additional large population-based studies with detailed data on dietary intake 
and the use of vitamin supplement may be useful. 
Regarding prospective studies on the association between a-linolenic acid and 
coronary heart disease, the interaction between a-linolenic acid and trans fatty 
acids, and additionally, the relationship between a-linolenic acid and coronary 
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heart disease in a population with a low intake of trans fatty acids, needs special 
attention. 
Dietary intervention studies may be useful in further clarifying biological 
mechanisms underlying a possible beneficial effect of a-linolenic acid. Long-term 
dietary intervention studies of a-linolenic acid supplementation should be carried 
out especially with respect to coronary heart disease intermediates such as 
ventricular fibrillation, heart rate variability and endothelial function. Studies 
showing a beneficial effect of a-linolenic acid could not distinguish between a 
direct or indirect effect (through the synthesis of EPA) of a-linolenic acid. 
Supplementation trials of a-linolenic acid should be conducted to clarify 
determinants (e.g. other fatty acids in the diet or time period) of the conversion 
of dietary a-linolenic acid into plasma or platelet EPA. Finally, intervention 
studies which estimate the impact of a-linolenic acid supplementation on 
coronary heart disease should be conducted. 
Regarding the association between B-vitamins and coronary heart disease, the 
independent impact of each B-vitamin, and, more specifically, the possible 
inverse relationship of vitamin B2 with coronary heart disease are of interest. 
Several planned and ongoing trials of B-vitamin supplements on clinical 
•*-^" cardiovascular endpoints85 will give more insight on the effect of B-vitamin intake 
on coronary heart disease. Recently, two intervention trials studied the 
relationship between B-vitamins (folate, vitamin B6 and in one trial also vitamin 
B12) and atherosclerosis.86,87 However, methodological problems, e.g. the lack of 
a control group86 or inconsistent effects on different measures of 
atherosclerosis87 limited the interpretation of these findings. Furthermore, future 
trials should be able to distinguish the relative importance of the different B-
vitamins. 
With respect to arginine, prospective studies on the association between arginine 
intake and coronary heart disease risk should be performed in populations with a 
wide range in arginine intake, e.g. populations with a high variation in 
consumption of animal products, or multi-center studies with detailed dietary 
data, such as EPIC Heart. Also prospective studies performed in younger age 
groups may provide new insights in the association between arginine and 
coronary heart disease. 
Long-term interventions with different dosages (including practical dose) of 
arginine, on endothelial function or atherosclerosis are of interest. Dietary 
intervention trials should also be directed toward the use of biomarkers, e.g. 
blood concentrations of arginine, as a reflection of (short-term) arginine intake. 
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Finally, also dietary intervention trials in high risk groups are needed to improve 
insight in the risk profile of individuals who could benefit from arginine 
supplementation. 
In the near future, more insight in the mechanisms that are involved in the 
relation between diet and coronary heart disease may be useful to identify 
persons who could particularly benefit from dietary therapy to reduce their risk 
of coronary heart disease. In addition, future dietary intervention studies should 
investigate the applicability of 'functional foods' (foods that, by virtue of 
physiologically active components, provide health benefits beyond basic 
nutrition)88 to support individual dietary counseling. This may improve the 
effectiveness of dietary interventions in the reduction of coronary heart disease 
risk. 
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SlIMlIlf 
In this thesis, the results of prospective studies on fatty acids, B-vitamins and 
arginine and the occurrence of coronary heart disease have been described. 
Coronary heart disease is the major cause of mortality in industrialized countries 
such as the Netherlands. In the coming decades, there will be an increase in the 
number of older people. This is expected to be accompanied by an increase in 
the prevalence of coronary heart disease. Therefore, it is important to get more 
insight in dietary factors related to coronary heart disease. 
For the results presented in this thesis, data were used of cohorts from the 
Seven Countries Study. This population-based study started between 1958 and 
1964, involving 12,763 men aged 40-59 years from 16 cohorts. Cross-cultural 
data of the Seven Countries Study were used to investigate the association 
between dietary intake and 25-year coronary heart disease mortality. Individual 
dietary information collected around 1970 in 3136 men aged 50-69 years from 
the Finnish, Italian and Dutch cohorts of the Seven Countries Study allowed us 
to study the relation between diet and 20-year coronary heart disease in an 
international setting. One of these cohorts, a cohort of 878 men from Zutphen, 
was selected as the Dutch contribution to the Seven Countries Study. In 1985, 
this cohort of men has continued to be examined within the framework of the 
Zutphen Elderly Study. The former cohort was therefore extended with other 
men from the town of Zutphen in the same age category, resulting in a total 
population of 939 men aged 64-84 years. Detailed information was available on 
dietary intake, biological risk factors, incidence of major chronic diseases, vital 
status and cause of death between 1985 and 1995. This allowed us to study the 
association between nutrient intake, serum cholesterol response and the risk of 
coronary heart disease, taking into account e.g. intake of other nutrients. 
In chapter 2 of this thesis, we have described the association between changes 
in lifestyle and dietary factors on changes in serum total and high density 
lipoprotein (HDL) cholesterol in the Zutphen Elderly Study. Data of 234 men 
were used who participated in each dietary and clinical examination at baseline 
(1985), and after 5 and 10 years of follow-up. Dietary factors studied were 
saturated, monounsaturated, polyunsaturated and trans fatty acids, cholesterol 
and fiber, lifestyle related factors studied were body weight, smoking, alcohol 
use and physical activity. After adjustment for age, carbohydrate intake and the 
other parameters, a 1 energy percent increase in polyunsaturated fat intake was 
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associated with a 0.03 mmol/L reduction in total cholesterol concentrations. 
Weight loss was associated with decreased total cholesterol concentrations. One 
extra glass of alcohol or 5 kg weight loss were both associated with 0.04 mmol/L 
increased HDL cholesterol concentrations. Increased intake of saturated fat and 
dietary cholesterol were significantly related to increased HDL cholesterol 
concentrations. For these statistically significant associations as well as for non-
significant associations, e.g. those between trans fatty acids and total cholesterol 
and between polyunsaturated fatty acids and HDL cholesterol, the strength of 
the estimates is comparable with those from experimental studies performed in 
younger populations. This study suggested that, even in old age, it remains 
important to change weight and diet to improve the lipid profile. 
Using again the data of the Zutphen Elderly Study, we estimated the association 
between trans fatty acid intake and the 10-year risk of coronary heart disease in 
667 men free of coronary heart disease at baseline in 1985 (chapter 3). During 
10 years of follow up, we documented 98 cases of coronary heart disease. 
Between 1985 and 1995, average trans fatty acid intake of the elderly men 
decreased from 4.3 to 1.9% of energy. Trans fatty acid intake at baseline was 
positively associated with the 10-year risk of coronary heart disease. The relative 
154 risk for a difference of 2 energy percent in trans fatty acid intake at baseline was 
1.28 (95% confidence interval (CI) 1.01 to 1.61). The association was observed 
for trans fatty acid intake from ruminant sources as well as different trans 
isomers from manufactured sources. Based on our results and those from 
previous prospective cohort studies, we estimated that the observed decrease in 
trans fatty acid intake, mainly due to industrial lowering of trans contents in 
Dutch edible fats, is compatible with a 23% reduction in risk of coronary heart 
disease. 
The association between total, lean and fatty fish consumption and the risk of 
coronary heart disease mortality was examined in 1,088 Finnish, 1,097 Italian 
and 553 Dutch men of the Seven Countries Study free of coronary heart disease 
around 1970 (chapter 4). After 20 years of follow-up, 242 men died of coronary 
heart disease in Finland, 116 in Italy and 105 in the Netherlands. Total and lean 
fish consumption were not associated with coronary heart disease mortality in 
any of the three countries. Fatty fish consumption, however, was associated with 
lower coronary heart disease mortality compared with non-fatty fish 
consumption. The adjusted pooled relative risk for fatty fish consumers was 0.66 
(95% CI 0.49-0.90) compared to no fatty fish consumption. These data suggest 
that especially fatty fish is protective against coronary heart disease mortality. 
Summary 
The association between a-linolenic acid intake and the 10-year risk of coronary 
heart disease was investigated in 667 men free of coronary heart disease of 
Zutphen Elderly Study (chapter 5). Intake of a-linolenic acid and trans fatty acids 
were strongly correlated (rs =0.61). This complicated studying the association 
between a-linolenic acid intake and coronary heart disease. a-Linolenic acid 
intake from sources with trans fatty acids was positively associated with 
coronary heart disease risk (adjusted relative risk 1.51; 95% CI 0.75-3.04 for 
the highest compared to the lowest tertile). a-Linolenic acid intake from foods 
without trans fatty acids was not associated with the risk of coronary heart 
disease. The adjusted relative risk was 1.15 (95% CI 0.63-2.11) for the highest 
compared to the lowest tertile. These results indicate that a-linolenic acid was 
not beneficially associated with the risk of coronary heart disease in this cohort 
of elderly men. 
We investigated whether intake of folate, vitamins B2, B6 and B12 are 
associated with homocysteine concentrations and 10-year coronary heart 
disease incidence in 815 men of the Zutphen Elderly Study (chapter 6). After 10 
years of follow-up, 140 cases of coronary heart disease had occurred. Only 
intake of folate and vitamin B6 were independently inversely associated with 
homocysteine. However, both vitamins were not associated with the risk of 155 
coronary heart disease. Independent of homocysteine, vitamin B2 intake was 
non-significantly inversely associated with coronary heart disease risk. The 
adjusted relative risk for the highest compared to the lowest tertile of vitamin B2 
was 0.61 (95% CI 0.36-1.03; p for trend 0.08). Vitamin B12 intake was 
significantly positively associated with coronary heart disease risk (p for 
trend=0.03). This study did provide no evidence that B-vitamins are protective 
for coronary heart disease, although there was a suggestion for a protective 
effect of vitamin B2. 
Cross-cultural analyses of the 16 population cohorts of the Seven Countries 
Study were performed to estimate the association between arginine intake and 
25-year coronary heart disease mortality in middle-aged men at the population 
level (chapter 7). After 25 years of follow up, the coronary heart disease 
mortality rate varied from 2.5% in Crete (Greece) to 26.8% in East-Finland. 
Arginine intake was not significantly associated with coronary heart disease 
mortality on the population level. In the unadjusted regression analysis an 
increase in arginine intake of 1 g/d was associated with a reduction in the risk of 
coronary heart disease mortality of 1.11% (p=0.17). In the adjusted analyses, 
this association was reduced towards zero. We also investigated this association 
Summary--
among 806 men aged 64-84 years at baseline who participated in the Zutphen 
Elderly Study (chapter 8). During 10 years of follow up, 90 men died from 
coronary heart disease. Arginine intake was not associated with the 10-year 
coronary heart disease mortality on the individual level. The adjusted relative 
risk for the men in the highest tertile of arginine intake was 1.56 (95% CI 0.83-
2.93) compared to the men in the lowest tertile of arginine intake. The results of 
both prospective studies do not support the hypothesis that dietary arginine 
intake lowers the risk of coronary heart disease mortality. 
In chapter 9, our results are discussed with regard to methodological 
considerations and public health implications. The consistency in strength of the 
associations between changes in diet and weight and changes in total and HDL 
cholesterol of our study described in chapter 2 and in the literature suggest that 
public health strategies on dietary interventions and weight reduction in order to 
improve cholesterol concentrations are relevant also at old age. Fatty fish 
consumption was estimated to reduce coronary heart disease mortality with 
34%. Based on epidemiological studies, animal experiments and controlled trials 
in humans, it is concluded in chapter 9 that (sudden) cardiac death risk will be 
reduced by an increased intake of n-3 fatty acids from (fatty) fish. People at risk 
156 for coronary heart disease are therefore advised to eat fish, preferably fatty fish 
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 at least once a week, to reduce their risk for coronary heart disease. Trans fatty 
acid intake was positively associated with coronary heart disease risk. The 
substantial decrease in trans fatty acid intake, mainly due to the industrial 
lowering of the trans fatty acid content in Dutch edible fats, is therefore 
important from a public health perspective. We did not find evidence for a 
protective effect of intake of a-linolenic acid, however, the strong association 
with trans fatty acids complicated studying this relationship. Of the B-vitamins, 
only the intake of folate and vitamin B6 were independently inversely associated 
with homocysteine in a population of elderly men. In our cohort, intake of 
different B-vitamins did not protect against coronary heart disease, although 
there is a suggestion for a protective effect of vitamin B2. Arginine intake was 
not associated with the risk of coronary heart disease mortality in two 
prospective studies. Results of large prospective and intervention studies are 
needed to before definite statements can be made about the potential protective 
effect on coronary heart disease of B-vitamins, arginine and a-linolenic acid. 
SAMENVATTING 
In dit proefschrift zijn de verbanden beschreven tussen enerzijds de inname van 
vetzuren, B-vitamines en arginine en anderzijds het optreden van coronaire 
hartziekten. Coronaire hartziekten vormen de belangrijkste doodsoorzaak in 
geTndustrialiseerde landen zoals Nederland. In de komende decennia zal het 
percentage ouderen toenemen. Naar verwachting zal dit gepaard gaan met een 
toename van het totaal aantal personen met coronaire hartziekten. Het is 
daarom van groot belang inzicht te krijgen in de mogelijke verbanden tussen 
voedingsfactoren en coronaire hartziekten. 
De resultaten zijn gebaseerd op longitudinale gegevens afkomstig uit de Zeven 
Landen Studie. Tussen 1958 en 1964 werden 16 cohorten bestaande uit in totaal 
12.763 mannen van 40-59 jaar oud uit 7 landen onderzocht. De informatie over 
het gemiddelde voedselpatroon van elk van de 16 cohorten werd gebruikt om 
het verband tussen voeding en de 25-jaars sterfte aan coronaire hartziekten te 
bestuderen. In de Zeven Landen Studie werden rond 1970 de 
voedingsgewoonten nagevraagd bij 3.136 Finse, Italiaanse en Nederlandse 
mannen van 50-69 jaar. Gedurende 20 jaar zijn de doodsoorzaken van de 
overleden deelnemers geregistreerd. Deze gegevens zijn gebruikt om in een 
internationale context het verband te bestuderen tussen voeding en de 20-jaars 
sterfte aan coronaire hartziekten. Het Nederlandse cohort van de Zeven Landen 
Studie werd gevormd door een onderzoekspopulatie bestaande uit 878 mannen 
die in 1960 in Zutphen woonden. In 1985 werd het onderzoek in Zutphen 
voortgezet. De oorspronkelijke onderzoekspopulatie werd hiervoor aangevuld 
met een nieuwe populatie van mannen uit dezelfde leeftijdscategorie, eveneens 
woonachtig in Zutphen. In 1985 werden in totaal 939 mannen van 64-84 jaar 
oud uitgenodigd voor dit onderzoek, dat bekend staat als de Zutphen Ouderen 
Studie. Gedetailleerde informatie was beschikbaar over voedingsgewoonten, 
risicofactoren, incidentie van belangrijke chronische ziekten, vitale status en 
doodsoorzaken verzameld tussen 1985 en 1995. Hiermee konden we verbanden 
tussen enerzijds de inname van voedingsstoffen en anderzijds veranderingen in 
serumcholesterol en het risico op coronaire hartziekten bestuderen. 
In hoofdstuk 2 van dit proefschrift bestudeerden we het verband tussen 
veranderingen in voeding en leefstijlfactoren en veranderingen in serumtotaal-
en hoge-dichtheidslipoprotei'nen (HDL)-cholesterol in de Zutphen Ouderen 
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Studie. Van 234 mannen zijn gegevens gebruikt. Deze namen deel aan zowel net 
voedselconsumptie- als het lichamelijke onderzoek aan het begin van de studie 
in 1985 en aan de vervolgonderzoeken respectievelijk 5 en 10 jaar later. De 
onderzochte leefstijlfactoren waren: lichaamsgewicht, roken, alcoholgebruik en 
lichamelijke activiteit. Als voedingsfactoren werden verzadigde, enkelvoudig 
onverzadigde en meervoudig onverzadigde vetzuren, transvetzuren, 
voedingscholesterol en vezel bestudeerd. Onafhankelijk van leeftijd, inname van 
koolhydraten en de andere onderzochte leefstijl- en voedingsdeterminanten ging 
een verhoging van 1 energieprocent aan meervoudig onverzadigde vetzuren 
gepaard met een daling in het totaalcholesterolgehalte van 0,03 mmol/l. 
Gewichtsverandering hing significant samen met een verandering in het 
totaalcholesterolgehalte. Toename van de alcoholconsumptie met 1 glas per dag, 
of een gewichtsafname van 5 kg gingen beide gepaard met een verhoogd HDL-
cholesterolgehalte van 0,04 mmol/l. Een verhoogde inname van verzadigde 
vetzuren en voedingscholesterol verlaagden het totaalcholesterolgehalte 
significant. Deze associaties zijn qua omvang vergelijkbaar met de resultaten 
van experimentele onderzoeken die bij jongere populaties zijn uitgevoerd. Dit 
gold ook voor de niet-significante verbanden, zoals de relaties tussen 
transvetzuren en totaalcholesterol en tussen meervoudig onverzadigde vetzuren 
en HDL-cholesterol. Dit onderzoek laat zien dat het op hoge leeftijd belangrijk 
blijft om het serumcholesterolgehalte te verbeteren door het gewicht en/of de 
voeding te veranderen. 
De gegevens van de Zutphen Ouderen Studie werden ook gebruikt om het 
verband tussen transvetzuurinname en het risico op coronaire hartziekten te 
bestuderen (hoofdstuk 3). De onderzoekpopulatie bestond uit 667 mannen van 
64-84 jaar zonder coronaire hartziekten aan het begin van de studie in 1985. 
Gedurende 10 jaar kregen 98 mannen een coronaire hartziekte. Tussen 1985 en 
1995 nam de transvetzuurinname af van 4,3% naar 1,9% van de totale energie-
inname. Deze daling in transvetzuurinname is voornamelijk een gevolg van een 
veranderd productieproces van voedingsmiddelen die bereid worden met 
geharde plantaardige olien. Transvetzuurinname bleek het 10-jaars risico op de 
ontwikkeling van coronaire hartziekten te verhogen. Het relatieve risico voor een 
verschil van 2 energieprocent in transvetzuurinname bedroeg 1,28 (95% 
betrouwbaarheidsinterval 1,01-1,61). Dit verband was aanwezig voor 
transvetzuren uit dierlijke producten en voor verschillende transvetzuren uit 
voedingsvetten van geharde plantaardige olien. Wanneer we onze bevindingen 
combineren met die van eerder uitgevoerde longitudinale cohortonderzoeken 
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blijkt dat, naar schatting, de daling in transvetzuren in Nederland het risico op 
coronaire hartziekten met ongeveer 23% kan hebben verminderd. 
We bestudeerden de dagelijkse consumptie van magere vis, vette vis en de 
visconsumptie in totaal in relatie tot sterfte aan coronaire hartziekten in de 
Finse, Italiaanse en Nederlandse cohorten van de Zeven Landen Studie 
(hoofdstuk 4). Gegevens waren beschikbaar van 1.088 Finse, 1.097 Italiaanse 
en 553 Nederlandse mannen die aan het begin van de studie rond 1970 50-69 
jaar waren en geen coronaire hartziekte hadden. Gedurende 20 jaar 
vervolgonderzoek stierven 242 Finse mannen aan coronaire hartziekten, 116 
Italianen en 105 Nederlanders. In de drie landen werd geen duidelijk verband 
waargenomen tussen enerzijds de consumptie van vis in totaal en magere vis en 
anderzijds de sterfte aan coronaire hartziekten. Consumptie van vette vis bleek 
wel gerelateerd te zijn aan een verminderd risico op sterfte aan coronaire 
hartziekten. Indien de gegevens van de drie landen samengevoegd werden, 
bedroeg het gecorrigeerde relatieve risico voor gebruikers van vette vis 0,66 
(95% betrouwbaarheidsinterval 0,49-0,90) vergeleken met degene die geen 
vette vis gebruikten. Deze gegevens suggereren dat vooral de consumptie van 
vette vis van belang is bij de preventie van fatale coronaire aandoeningen. 
Het verband tussen inname van a-linoleenzuur en het 10-jaars risico op de 
ontwikkeling van coronaire hartziekten is bestudeerd bij de 667 deelnemers van 
de Zutphen Ouderen Studie die vrij waren van coronaire hartziekten (hoofdstuk 
5). De inname van a-linoleenzuur en transvetzuren hingen sterk samen (rs 
=0,61). Dit bemoeilijkte het onderzoek naar de relatie tussen a-linoleenzuur 
inname en coronaire hartziekten. De inname van a-linoleenzuur uit 
transvetzuurrijke producten bleek positief geassocieerd te zijn met het risico op 
coronaire hartziekten (gecorrigeerde relatieve risico 1,51; 95% 
betrouwbaarheidsinterval 0,75-3,04 voor de hoogste tertiel ten opzichte van de 
laagste tertiel). Er werd geen verband gevonden tussen de inname van a-
linoleenzuur uit voedingsmiddelen zonder transvetzuren en het risico op 
coronaire hartziekten. Het gecorrigeerde relatieve risico bedroeg 1,15 (95% 
betrouwbaarheidinterval 0,63-2,11) voor de hoogste tertiel ten opzichte van de 
laagste tertiel. Hieruit kunnen we concluderen dat in de Zutphen Ouderen Studie 
de a-linoleenzuur inname niet duidelijk samenhangt met de ontwikkeling van 
coronaire hartziekten. 
Het verband tussen de inname van folaat, vitamines B2, B6 en B12 enerzijds en 
homocyste'ineniveaus en de 10-jaars ontwikkeling van coronaire hartziekten 
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anderzijds werd eveneens onderzocht in de Zutphen Ouderen Studie (hoofdstuk 
6). Gedurende 10 jaar vervolgonderzoek kregen 140 van de 815 mannen een 
coronaire hartziekte. Alleen de inname van folaat en vitamin B6 vertoonden een 
onafhankelijke inverse relatie met het homocyste'i'neniveau. Beide vitamines 
bleken echter geen verband te vertonen met het risico op coronaire hartziekten. 
Er bestond een niet-significant invers verband tussen vitamine B2 inname en het 
risico op coronaire hartziekten, onafhankelijk van het homocyste'ineniveau. Het 
gecorrigeerde relatieve risico voor de hoogste ten opzichte van de laagste tertiel 
van vitamine B2 bedroeg 0,61 (95% betrouwbaarheidsinterval 0,36-1,03; p voor 
trend 0,08). De vitamine B12 inname bleek het risico op coronaire hartziekten 
significant te verhogen (p voor trend=0,03). Dit onderzoek levert geen bewijs 
voor een mogelijke beschermende rol van B-vitamines op de ontwikkeling van 
coronaire hartziekten, al is een mogelijk beschermend effect van vitamine B2 
niet uitgesloten. 
In een cross-cultureel onderzoek met gegevens van de 16 cohorten van de 
Zeven Landen Studie werd de relatie tussen arginine inname en 25-jaars sterfte 
aan coronaire hartziekten onderzocht (hoofdstuk 7). Na 25 jaar varieerde het 
sterftecijfer voor coronaire hartziekten van 2,5% op Kreta (Griekenland) tot 
160 26,8% in Oost-Finland. De gemiddelde arginine inname vertoonde op 
™~~" populatieniveau geen verband met sterfte aan coronaire hartziekten. In de 
ongecorrigeerde regressieanalyse bleek een toename van arginine inname van 1 
g/dag gerelateerd te zijn aan een afname van het risico op coronaire hartziekten 
van 1,11% (p=0,17). Dit verband werd zwakker na correctie voor mogelijke 
verstorende variabelen. We bestudeerde deze relatie ook met behulp van de 
gegevens van 806 deelnemers van de Zutphen Ouderen Studie (hoofdstuk 8). 
Gedurende 10 jaar vervolgonderzoek overleden 90 mannen aan coronaire 
hartziekten. De arginine inname vertoonde geen relatie met de 10-jaars sterfte 
aan coronaire hartziekten. Het gecorrigeerde relatieve risico voor mannen in de 
hoogste tertiel van arginine inname bedroeg 1,56 (95% 
betrouwbaarheidsinterval 0,83-2,93) ten opzichte van mannen in de laagste 
tertiel van arginine inname. De resultaten van beide longitudinale onderzoeken 
leveren geen ondersteuning op voor de hypothese dat arginine inname het risico 
op coronaire hartziekten verlaagt. 
In hoofdstuk 9 bespreken we de in dit proefschrift gepresenteerde resultaten 
met betrekking tot methodologische tekortkomingen en 
volksgezondheidsimplicaties. De sterkte van de verbanden tussen veranderingen 
in de inname van voedingsstoffen en gewicht en veranderingen in totaal- en 
Samenvatting 
HDL-cholesterol zoals beschreven in hoofstuk 2 zijn vergelijkbaar met hetgeen 
gerapporteerd is in de literatuur. De uitkomsten hiervan suggereren dat 
strategieen gericht op veranderen van voedingsgewoonten of gewicht ter 
verbetering van totaal- en HDL-cholesterol ook relevant zijn op oudere leeftijd. 
Consumptie van vette vis kan volgens onze berekening de sterfte in coronaire 
hartziekten met 34% verlagen. Op basis van epidemiologische studies, 
dierexperimenten en gecontroleerde interventiestudies bij proefpersonen werd in 
hoofdstuk 9 geconcludeerd dat het aantal (acute) overlijdensgevallen ten 
gevolge van coronaire hartziekten kan afnemen door de inname van n-3 
vetzuren uit (vette) vis te verhogen. Personen met een hoog risico op het krijgen 
van coronaire hartziekten krijgen daarom het advies om vis te eten, bij voorkeur 
minimaal een keer per week vette vis, om hun risico op coronaire hartziekten te 
verminderen. De inname van transvetzuren is positief geassocieerd met het 
risico op coronaire hartziekten. De daling in de inname van transvetzuren door 
de betere samenstelling van voedingsvetten in Nederland kan daarom een 
belangrijke bijdrage hebben geleverd aan het verbeteren van de 
volksgezondheid. Onze resultaten ondersteunen een beschermend effect van de 
inname van a-linoleenzuur op coronaire hartziekten niet. De sterke associatie 
tussen a-linoleenzuur en transvetzuren bemoeilijkte echter de interpretatie van 
ons onderzoek. Van de B-vitamines bleken alleen de inname van folaat en 
vitamine B6 invers samen te hangen met homocysteineniveaus in de Zutphen 
Ouderen Studie. De inname van verschillende B-vitamines bleek geen 
bescherming te bieden tegen het ontstaan van coronaire hartziekten, hoewel een 
beschermend effect van vitamine B2 niet kon worden uitgesloten. De arginine 
inname bleek niet samen te hangen met het risico op coronaire hartziekten in 
twee prospectieve studies. Grote prospectieve en interventiestudies zijn nodig 
om het mogelijk beschermende effect van a-linoleenzuur, B-vitamines en 
arginine op coronaire hartziekten aan te tonen. 
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